innovate - GuideStar
Transcript of innovate - GuideStar
advance
heal
transform
discover
innovate
Memorial Sloan-Kettering Cancer Center2010 ANNUAL REPORT
pioneer
MSKCC …
Introduces 2 our new President
Message from the Chairman and the President 3
Transforms 8
Discovers 14
Innovates 20
Advances 24
Pioneers 26
Educates 30
Heals 34 Statistical Profile 50
Financial Summary 52
The Campaign for MSKCC 56
The Society of MSKCC 57
Ways of Giving 60
www.mskcc.org/annualreport2010
Change presents challenges but also opportunities — and the prospect of renewal and a reinvention of the future.
The year 2010 was a time of significant change at Memorial Sloan-Kettering Cancer Center.
Change is exciting, energizing, revitalizing.
MSKCC 1
2 MSKCC
In August 2010, nationally known cancer researcher and clinician Craig B. Thompson was named the new President and Chief Executive Officer of Memorial Sloan-Kettering Cancer Center. He succeeded Harold Varmus, now Director of the National Cancer Institute.
“Craig Thompson is an exemplary physician-scientist, educator, and academic leader,” says Douglas A. Warner III, Chairman of the MSKCC Boards of Overseers and Managers. “He brings to his new role significant contributions to the understanding of the biology of cancer, a strong and committed appreciation for the needs of patients with cancer, and superb
executive skills. We are fortunate to have him as we seek to maintain and enhance the accomplishments of Memorial Sloan-Kettering and move ambitiously into the future.”
Beginning in 2006, Dr. Thompson served as Director of the Abramson Cancer Center at the University of Pennsylvania and Associate Vice President for Cancer Services of the University of Pennsylvania Health System. As Director of the Abramson Cancer Center, Dr. Thompson — a board-certified internist and medical oncologist with extensive research experience in cancer, immunology, and translational medicine — oversaw the work of several hundred cancer
researchers as well as more than 300 full-time physicians and faculty across the University of Pennsylvania Health System involved in cancer prevention, diagnosis, and treatment. During his tenure, his accomplishments included the opening of a new multidisciplinary cancer outpatient treatment facility, the development of the first proton therapy center in the Mid-Atlantic region, and the expansion of Abramson’s translational research effort.
“We are at a time when transformative developments in biomedical research are greatly expanding the opportunities to understand disease and to improve human health,” Dr. Thompson says. “The mandate for MSKCC is to take the gains of the past
“ The mandate for MSKCC is to take the gains of the past 25 years to provide more-effective and safer treatments for patients; to define strategies to help people reduce their risks of developing cancers they might be genetically predisposed to develop; and, ultimately, to prevent the disease from occurring at all.”
– Craig Thompson, MD President of MSKCC
MSKCC
introduces
MSKCC 72010 ANNUAL REPORT
25 years to provide more-effective and safer treatments for patients; to define strategies to help people reduce their risks of developing cancers they might be genetically predisposed to develop; and, ultimately, to prevent the disease from occurring at all.”
“I want us to realize the full clinical potential of all the extraordinary research that goes on here,” Dr. Thompson elaborates. “We need to continue to strengthen the bridges between our basic scientists and clinicians — to bring these communities closer together — so that observations made
at the bedside inform the kind of research we do, and research discoveries made in the laboratory are adapted into therapies that can be delivered to patients.”
Dr. Thompson’s own research focuses on the role that metabolic changes play in the origin and progression of cancer. He has also done pioneering work on the genes that control programmed cell death and on how the misregulation of such genes can contribute to cancer. In earlier work, he contributed to the development of innovative treatments for autoimmune
diseases and leukemia. Dr. Thompson has established a laboratory in MSKCC’s Zuckerman Research Center.
“I could not be more enthusiastic about this new role and new challenge,” he concludes. “I look forward to building on MSKCC’s achievements and tradition of excellence and to working with my colleagues in making progress in controlling and ultimately curing cancer.”
MSKCC a2010 ANNUAL REPORT
Before Sandy and I begin our joint letter — and my first as President of Memorial Sloan-Kettering Cancer Center — I’d like to share a few personal observations.
I arrived on the MSKCC campus in November 2010 and every day since then has been inspiring. During the early months of my tenure, I traveled around the Center visiting as many locations and staff members as I could. I came away from these visits with one overwhelming impression: The dedication of the men and women of Memorial Sloan-Kettering is unparalleled. Whether they escort patients in the hospital or deliver the most advanced care, work in a laboratory or in the cafeteria — all are committed to serving a purpose higher than themselves.
What brought me to Memorial Sloan-Kettering is what I believe attracts the finest new staff, students, and generous donors — shared ideals: a promise to deliver the highest-quality patient care, to make major contributions to cancer research and discovery, and to educate the next generation. Pioneering efforts undertaken at MSKCC to advance science and apply our findings to the development of new treatments and therapies that reduce death and suffering has an impact that reaches far beyond the walls of this institution.
I look forward to many exciting years ahead, working together to bring the benefits of our world-class research to patients and setting national and international standards in advancing the knowledge that will ultimately conquer cancer.
– Craig Thompson
Message from the Chairman and the President
Craig B. Thompson
President and Chief Executive Officer
Douglas A. Warner III
ChairmanBoards of Overseers and Managers
During the past year, we have made great progress at Memorial Sloan-Kettering. Prospects for the future are bright — due in large measure to the members of our MSKCC community, who come to work every day united in their desire to make a difference in the fight against cancer.
A 2010 visit by the Joint Commission offers evidence of the excellence of our people. (The Joint Commission is the nation’s oldest and largest hospital accrediting organization.) At their exit interview with hospital leadership, the surveyors praised staff members in all areas of the hospital for their professionalism, expertise, and compassion. The on-site visit team emphasized that our results were outstanding for an institution of our size and complexity.
Our vibrant research community thrived in 2010. In this year’s Report we’ve highlighted just a few of the many achievements of MSKCC’s investigators and clinicians. Breakthrough contributions were made by our basic science researchers in areas ranging from immunology, to cancer genome sequencing, to elucidating the mechanisms that control tumor cell growth and survival. Our physician-scientists pioneered clinical research that has moved laboratory findings into clinical applications in patients, some of which you’ll read about in the pages that follow.
We continue to enhance the physical spaces housing our clinical and research enterprises. In 2010 construction resumed on Phase II of the Zuckerman Research Center, including the build-out of two below-ground vivarium floors, the main level auditorium and conference space, two floors of academic office space, and one floor that will house the Gerstner Sloan-Kettering Graduate School, the Computational Biology Program, and the cell therapy and cell engineering facility. We anticipate completion in early 2012.
Making Memorial Sloan-Kettering’s expert cancer care more accessible to patients is a fundamental touchpoint of our mission. Our clinicians and state-of-the-art technology need to be available where our patients live and work. And so we recently filed an application with the New York State Department of Health that will allow us to expand our regional care network even further. If approved, a new freestanding 114,000-square-foot outpatient facility in Harrison, New York, will join our family of ambulatory oncology centers in New Jersey, on Long Island, and in Westchester County, staffed by MSKCC physicians, nurses, and other healthcare professionals.
B MSKCC
Attracting the best and brightest talent is vital to the health of any organization and we had notable success in recruiting clinical and research staff to the Center in 2010. Among those who joined us was Joseph Deasy as Chair of the Department of Medical Physics and incumbent of the Enid A. Haupt Chair in Medical Physics. Dr. Deasey comes to MSKCC from the Washington University School of Medicine, in St. Louis, where since 2005 he had been Director of the Division of Bioinformatics and Outcomes Research in the Department of Radiation Oncology.
MSKCC’s distinguished physicians and scientists are consistently recognized with national and international awards. In 2010, two of our investigators received particularly outstanding honors. Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences (NAS). Zvi Fuks, the incumbent of the Alfred P. Sloan Chair in Radiation Oncology and a member of the Sloan-Kettering Institute’s Molecular Pharmacology and Chemistry Program, was elected a member of the Institute of Medicine (IOM), a branch of the National Academies. Memberships in the NAS and IOM are among the highest honors in the fields of science and medicine.
The Campaign for Memorial Sloan-Kettering maintained steady progress in 2010, with gifts and pledges reaching $2,224,825,637 since its inception in 2001. The Center received an all-time high of 1,022,400 contributions during the year, for a total of $208.7 million received. Led by Anne M. McSweeney and Richard K. Naum, the MSKCC development office has generated the strong forward momentum required for the ongoing success of the Center. We are delighted to report that the Boards of Overseers and Managers have recently authorized a five-year extension of the Campaign and have increased the total goal to $3.5 billion.
During 2010, MSKCC continued to operate efficiently and effectively as cost-saving opportunities allowed the institution to limit its cost growth to 3.2 percent for the year. Our clinical volume and revenues continued to grow. We are particularly pleased to report that our investment portfolio experienced an excellent year. The Center’s financial position is strong and we continue to enjoy an AA bond rating from each of the three major bond rating agencies.
The theme of this year’s Report is change. You will read about how the MSKCC community embraced change in 2010, transforming the way we deliver care and battle cancer in the clinic and the laboratory. And the stories of four MSKCC patients that conclude the Report dramatize how, in the final analysis, everything we do here is about them.
The men, women, and children who come to Memorial Sloan-Kettering entrust their lives to us. All our work is aimed at returning them to their families, to their work — to the lives that were once disrupted by cancer — healed.
John R. Gunn
Executive Vice President
Robert E. Wittes
Physician-in-Chief Memorial Hospital
Thomas J. Kelly
Director Sloan-Kettering Institute
James D. Robinson III
Honorary Chairman Boards of Overseers and Managers
Douglas A. Warner III
ChairmanBoards of Overseers and Managers
Craig B. Thompson
President and Chief Executive Officer
the way we do surgery
MSKCC
transforms
(Left) Stephen Solomon (far left), Director of CIGI and Chief of the Interventional Radiology Service, with interventional radiologist Majid Maybody. (Top) Breast surgeon Alexandra Heerdt (left) and surgical fellow Kshama Jaiswal (Above) A CT scanner.
the way we do surgery
In June 2010, Memorial Sloan-Kettering opened the Center for Image-Guided Interventions (CIGI). Located on the second floor of the hospital, CIGI also houses a suite of endoscopy rooms and new operating rooms for the Surgical Day Hospital (SDH).
10 MSKCC
The multidisciplinary facility is anchored by CIGI and features state-of-the-art imaging tools for guiding cancer diagnosis and treat-ment. Interventional radiologists, surgeons, and endoscopists working in CIGI collaborate to deliver minimally invasive cancer therapies that reduce risks, shorten hospital stays, and decrease patient costs.
“This magnificent facility is a result of shared vision and collaboration,” says Hedvig Hricak, Chair of the Department of Radiology, who, along with Peter T. Scardino, Chair of the Department of Surgery, was instrumental in conceptualizing and planning CIGI and the SDH. “The proximity of radiology, surgery, and endoscopy provides a superb environment for our patients and will also produce innovations that will advance the medicine of the 21st century.”
Interventional radiologists, also called interventional radiology (IR) physicians, specialize in minimally invasive treatments using image guidance. Their tools include fluoroscopy, computed tomography (CT), ultrasound, positron emission tomography (PET), and magnetic resonance imaging (MRI). CIGI has six procedure rooms that contain leading-edge imaging equipment.
“CIGI is an unbelievable platform for imaging and treating cancer,” says Stephen B. Solomon, Director of CIGI, Chief of the Interventional Radiology Service, and Co-Chair of the Image-Guided Intervention Program along with Yuman Fong, Vice Chair of Technology Development in the Department of Surgery. (CIGI falls under the umbrella of MSKCC’s Image-Guided Intervention Program, established in 2008 to oversee and coordinate activities in the medical disciplines that use image guidance.)
MSKCC
transforms the way we do surgery
MSKCC 112010 ANNUAL REPORT
Transforming the Patient Experience
The CIGI/SDH offers amenities that enhance the patient experience, the most significant of which is privacy. A patient preparation area consisting of 48 individual bays serves the facility. After checking in, each patient is escorted to his or her private bay in the pre-procedure area. The bays include a bed, sliding glass doors, a television, and a guest chair. In addition, they contain equipment to monitor vital signs and administer intravenous fluids, as well as a computer so medical staff can complete documentation without leaving the patient’s bedside. After a procedure is completed, the patient is brought to a similar bay in the post-procedure area for recovery before being discharged.
The CIGI/SDH also has a pharmacy and five consultation rooms where patients, family members, or friends can meet privately with physicians. CIGI and the SDH serve approximately 120 patients per day.
Transforming Operating Rooms
Seven new Surgical Day Hospital operating rooms replace MSKCC’s former SDH operating rooms. Procedures done in the SDH—such as breast lumpectomies, mastectomies, and reconstructions; prostate biopsies; or removal of certain head and neck lesions—are of shorter duration than those performed in MSKCC’s main surgical center.
However, the new SDH operating rooms have many of the same features found in the surgical center. These include ceiling-mounted “booms” that provide operating room essentials such as anesthesia, oxygen, and suction; “Walls of Knowledge” that display patient clinical and laboratory data; and video-conferencing capabilities with physicians in other rooms.
12 MSKCC
“ The proximity of radiology, surgery, and endoscopy provides a superb environment for our patients and will also produce innovations that will advance the medicine of the 21st century.” – Hedvig Hricak
Chair, Department of Radiology
MSKCC
transforms the way we do surgery
MSKCC 132010 ANNUAL REPORT
to think and work together for the benefit of patients.” Among CIGI’s features are procedure rooms that contain a communica-tion system that allows physicians in separate rooms to consult via video-conferencing and share real-time images.
Dr. Scardino elaborates, explaining that the new platform makes it possible to consolidate several procedures performed by different specialists into a single patient visit. “A patient with an unspecified mass in the chest could typically require a CT scan by an interventional radiologist to biopsy it, an ultrasound by an endoscopist to stage it and determine its size, and a surgical procedure called a mediastinoscopy to take out a lymph node,” he explains. “In the past, getting all three procedures would require three separate trips to the hospital over several weeks. Now we can do them consecutively on the same day and move promptly to therapy.”
“For example, we have an interventional PET/CT scanner in the center that allows us to take advantage of new markers and tracers to pinpoint cancers in ways that were impos-sible before,” explains Dr. Solomon. “Two new MRI rooms enable us to continue refining a new approach in which we use MRI not as a diagnostic tool but to guide and monitor therapies in real time.”
CIGI, a multidisciplinary facility in which IR physicians can work with surgeons and other medical interventionalists, offers opportunities for combining interventions in new ways. “If you think about how surgeons, interventional radiologists, gastroenterologists, and pulmonologists work — everyone with an instrument that physically manipulates an anatomic structure or tumor — we all have our area that we specialize in,” Dr. Fong says. “Now we have a facility that allows all these different people, from different disciplines,
Endoscopy Suites
(Top left) Robert C. Kurtz, Chief of the Gastroenterology and Nutrition Service, performs a procedure in one of the new gastrointestinal endoscopy suites. The suites are equipped with the most modern endoscopic technology available and help MSKCC physicians address the demand for complex interventional endoscopic procedures. (Below center) MRIs are used in diagnosis as well as to help guide and monitor therapy in real time. (Below left) An image-guided intervention room. These rooms contain a combined CT-angiography unit used by IR physicians to guide them in the performance of minimally invasive diagnostic and therapeutic procedures.
Glioblastoma cells (cell nuclei in blue) Circulating breast tumor cells (green and yellow) exiting from capillaries (red) into brain tissue
the biological underpinnings of cancer
discoversMSKCC
Developing T cells (in green)
16 MSKCC
MSKCC
discovers the biological underpinnings of cancer
MetastasisCells that have broken away from a primary tumor and entered the bloodstream — called circulating tumor cells (CTCs) — can travel to distant organs and seed new tumors. But an MSKCC study led by Joan Massagué, Chair of the Sloan-Kettering Institute’s Cancer Biology and Genetics Program, along with Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, and research fellow Mi-Young Kim, now shows that such spread of disease (metastasis) operates in the opposite direction as well: Some CTCs can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.
The newly described phenomenon, called self-seeding, might explain why, in some patients, tumors removed by surgery or radia-tion reappear in the same place later in life.
The researchers created experimental models of different human cancers — includ-ing breast, colon, and skin cancers — that allowed them to track the journey of CTCs. Their studies showed that primary tumors emit molecular signals that attract some CTCs back to their source. The investigators identi-fied two genes, IL-6 and IL-8, that produce the signals attracting the most aggressive segment of the CTC population, plus three other genes that the returning CTCs use to invade the tumor when they return. The researchers hope that opportunities to target these genes therapeutically will present new strategies to stop cancer from progressing.
(Above) Joan Massagué and (right) Larry Norton
(Above, right) Circulating tumor cells (also on overleaf); image created by Manuel Valiente and Aléjandro Lopez-Soto in the laboratory of Joan Massagué
MSKCC 172010 ANNUAL REPORT
(Above, right) Alexander Rudensky
T CellsResearchers led by immunologist Alexander Y. Rudensky have gained new understanding about regulatory T cells — a subtype of immune cell that suppresses the immune system’s reactivity. Regulatory T cells are critical for life. In their absence, the immune system — instead of attacking foreign intrud-ers — attacks normal cells and tissues, causing potentially fatal inflammatory responses.
In recent years, Dr. Rudensky and others have studied regulatory T cells, positing that they might one day be manipulated — for example, to prevent dangerous immune reac-tions in people with autoimmune disorders such as multiple sclerosis or in cancer patients who have received bone marrow transplants from donors.
But it has remained to be established that regulatory T cells could be exploited safely. “Concerns have been raised that regulatory T cells under certain conditions — for example,
in a disease setting — might be induced to transform into other T cell types of the immune system,” explained Dr. Rudensky, “in effect changing the cells’ function.” If such change of function occurred in a patient whose immune system was already overactive, the cells might boost that immune system even further, instead of calming it down.
By experiments in mice, the researchers were able to examine the lifespan of regulatory T cells. The study showed that the cells are constantly replenished as they divide to yield identical copies and so remain stable, their function unchanged — both under normal conditions and when a mouse’s immune system had been challenged by infection or autoimmune reaction. The findings give reassurance that future therapies based on regulatory T cells could provide a durable and safe way to control a patient’s immune system.
“ Concerns have been raised that regulatory T cells under certain conditions — for example, in a disease setting — might be induced to transform into other T cell types of the immune system, in effect changing the cells’ function.”
– Alexander Rudensky Immunologist
18 MSKCC
(Above) Ingo Mellinghoff (Left) Timothy Chan
Cancer GeneticsA team of MSKCC investigators has shown for the first time that the gene that causes the inherited form of Parkinson’s disease also plays a role in many types of cancer, including colon and lung cancers and glioblastoma, the most common form of brain cancer. The study was led by radiation oncologist Timothy A. Chan, a member of the Human Oncology and Pathogenesis Program and the Brain Tumor Center. The gene, called PARK2, acts as a tumor suppressor, preventing the formation of cancerous cells. When mutated and unable to function tumor suppressors can allow tumors to develop.
In inherited Parkinson’s disease, mutation of PARK2 leads to inappropriate activation of the cell-division cycle in neurons. But because neurons are cells that are unable to divide, they die, leading to Parkinson’s disease. When PARK2 is mutated in cell types that can divide, levels of a protein called cyclin E rise and cause the cells to multiply out of control, sometimes leading to cancer.
Future research will focus on develop-ing mouse models to study the mutation in cancer progression and on trying to deter-mine additional genetic mutations that cause PARK2-deficient tumors to develop into can-cer. Investigators are also looking at whether people with the inherited forms of Parkinson’s disease have a higher cancer risk.
Brain CancerA multicenter team led by neurologist and researcher Ingo K. Mellinghoff has uncov-ered the relationship between two proteins that play a critical role in the brain cancer glioblastoma. The discovery may lead to better treatments for glioblastoma patients whose tumors have certain molecular changes.
The protein epidermal growth factor receptor (EGFR) is frequently overexpressed or mutated in glioblastoma, yet studies have shown that less than 10 percent of glioblas-toma patients respond to drugs, such as erlotinib (Tarceva®) and gefitinib (IressaTM), that target EGFR.
In an earlier study, Dr. Mellinghoff found that a protein called PTEN, which belongs to a class of proteins known as tumor
MSKCC 192010 ANNUAL REPORT
(Above, from left) Peter Scardino, Kenneth Offit, Howard Scher
suppressors, is frequently inactivated in tumors from glioblastoma patients who did not respond to these drugs.
Dr. Mellinghoff ’s team has now deter-mined how PTEN and EGFR interact, demonstrating that PTEN plays a key role in the reduction of EGFR inside cells. When the function of PTEN is lost, EGFR becomes more abundant and stable, making it more difficult to block with targeted drugs. “Erlotinib is currently in clinical trials for glioblastoma,” Dr. Mellinghoff says. “Based on our findings, we have designed a clinical trial in which higher doses of erlotinib will be used to try to overcome the resistance resulting from PTEN mutations.” Future research will focus on pinpointing how PTEN regulates EGFR, and could lead to the development of new drugs.
Prostate CancerA team of MSKCC researchers — led by Kenneth Offit, Chief of the Clinical Genetics Service; Peter T. Scardino, Chair of the Department of Surgery; Howard I. Scher, Chief of the Genitourinary Oncology Service; and genetics fellow David Gallagher — reports that prostate cancer often takes an aggressive course in men who have inherited mutations in the genes BRCA1 or BRCA2, which are associated with (inherited) breast and ovarian cancer.
The investigators collected anonymous DNA samples and clinical data from close to 900 prostate cancer patients of Ashkenazi Jewish ancestry, a substantial resource that allowed them to explore the heritable compo-nents of the disease. The researchers showed
that patients who carry BRCA mutations have an increased risk of dying or having their disease recur after treatment. “We also found that tumors were of more advanced grade in BRCA2 mutation carriers,” Dr. Offit says. “These men are genetically susceptible to a form of prostate cancer that is particularly aggressive.” He and his colleagues are hope-ful that the patient group will benefit from a new class of drugs called PARP inhibitors, which are being developed for treatment of BRCA-related breast and ovarian cancer. They estimate that such therapy, if proven success-ful, could be used in treating about 2,800 men with prostate cancer and BRCA mutations in the United States yearly.
MSKCC
discovers the biological underpinnings of cancer
20 MSKCC
MSKCCinnovates treatment delivery and patient care
MSKCC 212010 ANNUAL REPORT
Today many patients receive chemotherapy over extended periods of time and often have to struggle to fit this time-consuming routine into their lives — in addition to dealing with the physical and emotional aspects of their disease and its treatment. MSKCC’s new Brooklyn Infusion Center is an innovative facility designed to meet the special needs of patients receiving chemotherapy and the caregivers who accompany them.
The site offers leading-edge chemotherapy services to current MSKCC patients who live in or near the borough — which amounts to more than 15 percent of those currently being treated in Manhattan. Many of these patients can now be spared the rigors of a commute and
receive their treatment in a setting conveniently located in downtown Brooklyn.
The facility has the capacity to accom-modate 30 patients and their visitors a day, with 12 private treatment rooms enclosing an indoor garden and adjoining library where patients may spend time both during and between treatments. Each room is equipped with a touch-screen computer, so patients may also get work or shopping done on the Internet, or make videophone calls with friends and family.
In addition to relieving space constraints at MSKCC’s Manhattan sites, the Brooklyn Infusion Center will serve as a prototype for exploring innovative cancer care models. For
example, on the day before a patient’s appoint-ment, a nurse ensures that he or she is fit for treatment by reviewing blood tests and calling the patient. The phone call initiates the process of preparing chemotherapy for the next day’s visit. This “chemo-ready” approach reduces waiting times for patients and allows for more cost-effective drug preparation. Nurses at the Brooklyn center are also trained in providing complementary therapies such as acupressure and Reiki massage.
In addition, Memorial Sloan-Kettering is piloting telemedicine visits between patients in Brooklyn and their physicians at MSKCC’s Manhattan locations.
MSKCC’s new Brooklyn Infusion Center is an innovative facility designed to meet the special needs of patients receiving chemotherapy and the caregivers who accompany them.
The Brooklyn Infusion Center is located on a tree-lined stretch of Atlantic Avenue near a major transportation hub, including subways, a Long Island Rail Road station, and several parking facilities.
Brooklyn Infusion Center Improves Patients’ Chemotherapy Experience
22 MSKCC
With the opening of its state-of-the-art Outpatient Rehabilitation Center, Memorial Sloan-Kettering greatly expanded its capacity to help patients with cancer regain physical function and a sense of well-being.
Treatments for cancer — including surgery, chemotherapy, and radiation — can interfere with the proper function of nerves and muscles. Patients may have trouble regain-ing strength and mobility after treatment and can struggle with everyday tasks such as walk-ing, dressing, cooking, bathing — and even eating or speaking clearly. To help alleviate symptoms and restore functional capacity to the fullest extent possible, MSKCC physicians refer their patients to rehabilitation specialists, who have expertise in helping patients to regain functional independence.
The new 22,500-square-foot rehabilita-tion center occupies the fourth and fifth floors of 515 Madison Avenue “and allows us to improve our quality of care and help patients maximize their physical potential,” says Teresa W. Fitzpatrick, Manager of the Outpatient Rehabilitation Center. “With more space and a larger staff, we can meet the increased demand for our services, and patients are able to recover in a beautiful environment.”
MSKCC’s physical and occupational therapists previously served inpatient and outpatient needs in Memorial Hospital. As demand for their services increased, the department needed more space and staff for outpatient therapy. A generous gift from Robert F. X. Sillerman and Laura Baudo
MSKCC Opens Outpatient Rehabilitation CenterMSKCC
innovatestreatment delivery and patient care
MSKCC 232010 ANNUAL REPORT
Sillerman through their Tomorrow Foundation enabled the building of the new outpatient center and the hiring of additional therapists.
Specialists include physiatrists (physi-cians who treat and manage neuromuscular, musculoskeletal, and cardiopulmonary disorders) as well as physical therapists (PTs) and occupational therapists (OTs), who help patients recover physical skills through a vari-ety of approaches, such as therapeutic exercise, neuromuscular training, and cardiopulmonary rehabilitation. In addition, lymphedema thera-pists help patients manage lymphedema — the swelling of an extremity that can be a side effect after surgery for some types of cancer, particularly breast cancer, in which lymph nodes may be removed for examination by pathologists.
Fifteen treatment bays enable PTs and OTs to provide hands-on care in a private setting, and three additional rooms are dedi-cated to the management of lymphedema. A spacious gymnasium resembles a full-service health club with advanced equipment. Many of the machines are wheelchair compatible or have other adaptations to accommodate people who have physical impairments. One even combines sophisticated pressure sensors with computer games, offering patients an enjoyable and effective way to build strength and coordination.
The fifth floor houses the center’s clini-cal component, including the offices of four physiatrists. The physiatrists see patients referred by their primary MSKCC physicians
and assess and treat pain and dysfunction in nerves, muscles, and bones that may be limiting mobility or causing discomfort.
After performing a thorough evaluation, the physiatrist refers the patient to an appropri-ate therapist for the necessary exercise program. Sometimes the physiatrist outfits the patient with a specialized brace to improve function and independence.
Ms. Fitzpatrick notes that the need for rehabilitative services will become more critical over the long term as new treatments trans-form cancer into a less fatal, more chronic disease. The hope is that the new center will help MSKCC’s specialists use their expertise to advance the entire field of cancer rehabilitation.
“ With more space and a larger staff, we can meet the increased demand for our services, and patients are able to recover in a beautiful environment.” – Teresa Fitzpatrick
Manager, Outpatient Rehabilitation Center
24 MSKCC
MSKCC
A New Targeted Therapy Shows Promise for Advanced Melanoma
“We have never before had a specific target in melanoma that we could attack,” says MSKCC medical oncologist Paul B. Chapman, senior author of the study. “But we now know half of melanomas depend on a mutated gene called BRAF for their growth. PLX4032 inhibits BRAF at the cellular level and shuts off these tumors. We have seen many tumors shrink rapidly, and in some patients quality of life improved dramatically.”
A phase I trial determined the maximum dose of the drug that could be given with-out adverse side effects and was followed by an extension of the trial, a phase II trial, at that recommended dose. Fifty-five patients were enrolled in the first portion of the study. Screening for BRAF mutations was not a requirement for initial entry, but as the trial progressed, an increasing percentage of patients were identified as having the muta-tion. Later, 32 patients with BRAF-mutated melanomas were added to the second phase.
In the phase I group, ten partial responses and one complete response were noted among 15 melanoma patients with BRAF mutations who were treated with mod-erate to full doses of the drug. In the extension group, two complete and 24 partial responses were seen among the 32 patients treated with a full dose of the drug. To date, 16 of 32 patients are still on the study. The side effects were minor and did not result in any patients leaving the study.
In January 2011, the phase III trial of PLX4032, which was led by Dr. Chapman, showed that the drug improved survival in patients. “Past treatments for melanoma that appeared to have a higher response rate did not lead to improved survival,” Dr. Chapman says. “This is very exciting since it is the first treatment for melanoma in which a superior response rate did indeed translate into longer survival for the patient.”
A multicenter study led by MSKCC investigators concluded that treatment with a new targeted therapy called PLX4032 resulted in significant tumor shrinkage in 80 percent of patients with advanced melanoma.
how we fight cancerMelanoma cells (in orange) with cell nuclei (in blue); normal skin cells (in green)
advances
MSKCC 252010 ANNUAL REPORT
New Technology Improves Molecular Testing of Tumors for Targeted Cancer Therapies
In 2010, MSKCC took an important step for-ward in diagnosing gene mutations in patients’ cancers on an individual basis. The Center now uses a new technology from a company called Sequenom to look for mutations in the genes EGFR, KRAS, and BRAF in biopsy samples from patients with lung, colorectal, and thyroid cancers, as well as melanoma.
In patients with certain types of cancer, the presence or absence of specific genetic mutations determines which therapies they are likely to respond to and, therefore, should receive. Knowing as much as possible about the genetic makeup of tumors helps ensure that patients get the treatments most likely to help them, while avoiding drugs that will not benefit them and the side effects that can accompany those drugs.
For example, lung cancer patients with mutations in the gene EGFR can be treated with the drug erlotinib (Tarceva®), which targets the product of the mutated EGFR gene. However, if patients instead have a mutation in the gene KRAS, they will not
respond to erlotinib. In colorectal cancer, patients with mutations in KRAS and BRAF do not respond to the drugs cetuximab (Erbitux®) and panitumumab (Vectibix®), both of which also target the EGFR protein.
MSKCC has been at the forefront of test-ing for these mutations, starting with EGFR mutation testing in lung cancers in 2004, using older DNA testing approaches.
“There’s really been an evolution in molecular diagnostics,” explains Marc Ladanyi, incumbent of the William Ruane Chair in Molecular Oncology and attending patholo-gist on the Molecular Diagnostics Service. “We are moving from tests that are very labor intensive to ones that can be done in an automated, high-throughput manner. This new testing technology can provide results more quickly, as well as look for multiple mutations at the same time, something the old tests couldn’t do.”
The new technology also is more sensitive, allowing pathologists to perform molecular testing on biopsy samples that
contain fewer tumor cells than what was required with earlier approaches. “This is important especially for patients who have already received therapy,” he explains. “Treatments can cause a lot of inflammation in the tumor, which means that immune cells and other normal cells can outnumber the actual tumor cells. It’s also important in cancers where tumor cells are infiltrating connective tissue. This sensitivity and the ability to work with smaller tumor samples should make molecular diagnostic testing possible in cases where it was not before. At the same time, we are already evaluat-ing new sequencing technologies to further expand this molecular testing in the future.”
In addition to testing for mutations in the EGFR, KRAS, and BRAF genes, the new technology enables investigators to look for mutations in other, less well-known genes that are now emerging as possible new drug targets and for physicians to enroll patients in clinical trials for new, experimental therapies.
Pathologist Marc Ladanyi with lab member Laetitia Borsu
“ We are moving from tests that are very labor intensive to ones that can be done in an automated, high-throughput manner.”
– Marc Ladanyi Pathologist
26 MSKCC
new collaborations
pioneersMSKCC
(This image) Nanotubes; (Upper right) Neural stem cellsInflammatory cells
MSKCC 272010 ANNUAL REPORT
Nanotechnology Center Combines Cutting-Edge Science with Expertise in Patient Care
Hedvig Hricak and David Scheinberg
To take advantage of the growing field of nanotechnology, MSKCC has established a Nanotechnology Center. Nanotechnology is the science of manipulating materials on an extremely small scale, based on the nanometer (one-billionth of a meter). The field began taking off in the 1980s, but it has only been in the past few years that many of the tech-nologies developed by chemists and materials scientists for other applications have begun to be applied in biomedical settings.
“The development of nanotechnology has reached a point at which many of the tools can be used in translational research to advance patient care,” says Hedvig Hricak, Chair of the Department of Radiology in Memorial Hospital. “We have a critical mass of investigators interested in translational nanoscience. The new nanocenter not only provides a forum for them to talk about their projects and their ideas, but also facilitates collaboration with other institutions and offers resources for pilot projects. It’s moving forward extremely well.”
“The reason nanoscale is of such interest is that it is the scale on which the machinery of the cell operates,” elaborates David A. Scheinberg,
Chair of the Molecular Pharmacology and Chemistry Program in the Sloan-Kettering Institute. “The proteins that make DNA, the complexes that make proteins, and the receptors that allow the cell to communicate with and receive signals from the outside world all operate at the nanoscale. Indeed, chemotherapy drugs are actually much smaller than nanoscale; hence, these nanoscale drugs can be bigger and more complex than the kinds of drugs with which we usually work, and provide us with more versatile, multifunc-tional agents for diagnosis and therapy.”
Dr. Scheinberg, who also heads MSKCC’s Experimental Therapeutics Center, is serving as the new center’s Interim Chair. Dr. Hricak is a member of the Nanotechnology Center’s executive committee, along with Nuclear Medicine Service Chief Steven M. Larson and Human Oncology and Pathogenesis Program Chair Charles L. Sawyers. (The late chemist David Y. Gin was also a founding member of the committee.)
The two main focuses of nanotechnology research at MSKCC are the development of more-specialized, targeted drugs and the devel-opment of more-accurate diagnostic agents.
On the diagnostic side, applications include both in vitro applications, such as looking for circulating tumor cells or other markers in the bloodstream, and in vivo applications, using MRI, PET, and optical imaging to study cancer in the body. Another area under devel-opment involves what are called theranostic agents, which would allow imaging of a tumor and provide treatment to the tumor at the same time.
More than a dozen investigators in both SKI and Memorial Hospital — in fields rang-ing from pathology and chemistry to surgery and radiology — are participating in the center. There also are plans to recruit research fellows who are interested in working on nanotechnology-related projects. MSKCC has also established formal collaborative agree-ments with leaders in nanotechnology from other institutions: Joseph DeSimone, of the University of North Carolina, and Ulrich Wiesner, of Cornell University, researchers who already were collaborating on projects with many investigators at MSKCC.
“ The reason nanoscale is of such interest is that it is the scale on which the machinery of the cell operates.”
– David Scheinberg Chair, Molecular Pharmacology and Chemistry Program
28 MSKCC
“ Although there were already many investigators at Memorial Sloan-Kettering who were focusing on various aspects of microbial infections, bringing these investigators together and creating new facilities to help them advance their research really made sense.”
– Eric Pamer Chief, Infectious Diseases Service
Experts estimate that as many as 30 percent of all cancers result from infection with a microbe, such as a virus or bacterium, or from the inflammation caused by an infection. Additionally, infection is one of the leading complications for patients undergoing cancer treatment.
Memorial Sloan-Kettering has created a new multidisciplinary research center that promises to shed light on the role that microbes and the body’s inflammatory and immunological responses to them play in the development of cancer.
The Lucille Castori Center for Microbes, Inflammation, and Cancer unites researchers in the areas of molecular biology, immunol-ogy, computational biology, and microbiology and members of the Infectious Diseases and Clinical Microbiology Services.
“Although there were already many investigators at Memorial Sloan-Kettering who were focusing on various aspects of microbial infections, bringing these investiga-tors together and creating new facilities to
help them advance their research really made sense,” explains Eric G. Pamer, who is leading the Castori Center. Dr. Pamer is also Chief of the Infectious Diseases Service in Memorial Hospital and a researcher in the Sloan-Kettering Institute’s Immunology Program.
The Castori Center will promote research in the development of technologies to examine the causes of infections in patients, the characterization of infections associated with cancer treatment and hospitalization, the study of how inflammation can promote the development of cancer, and the study of the relationships between specific microbes and the development or progression of cancer.
The Castori Center will take advantage of two existing facilities, the Genomics Core Laboratory and the Bioinformatics Core Laboratory, to develop leading-edge technolo-gies for studying microbes and characterizing complex microbial populations in the clinical setting. The newly established Molecular Microbiology Core Facility will provide exper-tise and resources to clinical, laboratory, and translational investigators studying infections in cancer patients.
In addition to facilitating research among established investigators and clinicians at Memorial Sloan-Kettering and offering funding for specific projects, the Castori Center will support the work of the next gen-eration of investigators interested in the field by providing grants for clinical and labora-tory-based fellows to extend their research and training. Members of the center are also organizing workshops and symposia focusing on cutting-edge approaches to characterize complex microbial populations that inhabit the human intestine, to identify microbes associated with the development of cancer, and to discover microbial molecules that limit cancer growth or prevent infections.
Establishment of the Lucille Castori Center for Microbes, Inflammation, and Cancer and the new Molecular Microbiology Core Facility was made possible with a $5 million grant from The Tow Foundation. The new center is named in honor of Lucille Castori, the sister of Claire Tow.
Lucille Castori Center for Microbes, Inflammation, and Cancer Established
MSKCC
pioneers new collaborations
MSKCC 292010 ANNUAL REPORT
The creation by the Sloan-Kettering Institute of the new Center for Stem Cell Biology (CSCB) will allow scientists to exploit recent advances in stem cell biology and the poten-tial of embryonic stem cells as well as human adult cells to produce regenerative treatments and provide insights into cancer. The virtual center, led by stem cell biologist Lorenz P. Studer, consists of a hub of several SKI labora-tories, dedicated facilities, and administrative support to foster collaborations among Center investigators working in the field.
“We’ve made important discoveries here, and this new center will allow us to capitalize on them,” says Dr. Studer. He explains that the CSCB has four main areas of interest. One involves the mechanisms of stem cell
self-renewal and pluripotency, which allows stem cells to continuously replicate while retaining their capacity to develop into various cell types. A second area focuses on how stem cells naturally differentiate into specialized cell types in order to learn how to mimic this process in the laboratory. A third area concentrates on the relationship between stem cells and cancer, particularly the study of stem-like cells within tumors, which may help explain resistance to therapy and why some cancers return after treatment. Finally, research will explore the use of induced pluripotent stem cells, a new kind of stem cell produced when a human adult cell is reprogrammed to a pluripotent state, capable of developing into any cell type.
Scientists working under the umbrella of the CSCB will collaborate with other MSKCC colleagues to develop novel tech-nologies, recruit faculty, and provide training. The CSCB will complement MSKCC’s Center for Cell Engineering (CCE), estab-lished in 2007. The CSCB investigates the basic biology of stem cells, while the CCE explores how therapies based on stem cells and other cell types could be brought to the clinic.
The CSCB, bolstered by training grants of approximately $1.86 million over five years from New York State, will support five postdoctoral fellows pursuing stem cell research. MSKCC is one of only four institu-tions in the state to secure such grants, which were awarded in September 2010.
New Center for Stem Cell Biology Launched
“ We’ve made important discoveries here, and this new center will allow us to capitalize on them.” – Lorenz Studer
Stem cell biologist
With the launch of a new Center for Health Policy and Outcomes, MSKCC is stepping up its efforts to develop policy that specifi-cally applies to cancer care. Studies will be directed at how to optimize clinical out-comes while curbing costs.
Robert E. Wittes, Physician-in-Chief of Memorial Hospital, says the new center will assemble a multidisciplinary faculty to address an eclectic menu of issues — for example, how new information technologies could help integrate the many aspects of a patient’s treatment, or how the procedures by which new therapies are tested and approved could be made more efficient. “The devel-opment of cancer-related health policy is especially crucial at a time when national
efforts to reform our healthcare system are moving into high gear,” he observes.
Many of the problems patients and hospitals grapple with confront all branches of medicine alike. But in some aspects, “cancer care is special,” says Peter B. Bach, a pulmonary and critical care physician and epidemiologist, who heads the new center. “For example, the interplay between research and clinical practice is very advanced in the area of cancer. And new guidelines are needed to better fit our care model.” And in no other area of medicine have the costs for diagnosis and treatment soared as high.
“Our most pressing issue is to help establish reforms that will lower healthcare spending without harming the quality of cancer care or interfering with innovation,” Dr. Bach notes, adding that this will require rigorous analysis and evaluation.
New Collaborative Center Addresses Policy Issues Related to Cancer Care
Peter Bach Pulmonologist and Director of the Center for Health Policy and Outcomes
MSKCC 312010 ANNUAL REPORT MSKCC 31
the next generation
educatesMSKCC
(Above) Cancer biologist Johanna Joyce (center) with research fellows Jimenez Schumacher and Leila Akkari.
(Left) Philip H. Gutin (center), Chair of the Department of Neurosurgery, makes rounds with clinical fellows and nurses.
Memorial Sloan-Kettering’s training programs prepare the next generation of physicians, scientists, and other healthcare professionals to take up leadership roles in the life sciences and medicine. In 2010 MSKCC trained 1,625 residents and clinical fellows; 545 postdoctoral research fellows, research scholars, research associates and graduate research assistants; 231 PhD candidates; 26 MD/PhD candidates;105 nursing students; and 391 medical students.
32 MSKCC
In October, postdoctoral research fellows — along with their mentors, laboratory colleagues, and other members of the MSKCC and Tri-Institutional communities — gathered in the Rockefeller Research Laboratories for the fourth annual Postdoctoral Fellow Research Symposium. The daylong event allows fellows to present their latest work in two poster sessions and interact with colleagues Center-wide, gaining insight and guidance from those who have faced similar research challenges. This year, 84 posters
were presented on topics that ranged from basic research on gene functions and immune system activities to more-applied research that addressed improving imaging technologies and potential new cancer treatments. The event culminated with a keynote address by Nick Hastie, Director of the Medical Research Council Human Genetics Unit and Institute of Genetics and Molecular Medicine in Edinburgh, Scotland.
(Counterclockwise, from top left) Nick Hastie; SKI Director Thomas Kelly; and (from left) Pengpeng (Perry) Zhang, Margie Hunt and Yingli Yang from MSKCC’s Department of Medical Physics
(Above) Medical oncologist Dana Rathkopf with clinical fellows on rounds
2010 Postdoctoral Fellow Research Symposium
Clinical Training Memorial Sloan-Kettering’s renowned clinical training programs offer rich educational opportunities. Our world-class faculty prepares physicians and nurses to take up leadership roles in medicine, both in patient care and clinical research. And our affiliation with and proximity to
NewYork-Presbyterian Hospital, Weill Cornell Medical College, and The Rockefeller University provides a unique environment for learning, allowing students to participate in one of the world’s most vibrant medical and scientific communities.
MSKCC 332010 ANNUAL REPORT
(Clockwise, from top left) Timothy Chan, Mary Baylies, students at symposium, and Craig Thompson
(Above) Biostatistician Marinela Capanu (in jacket) with GSK students Yilong Zou (in glasses) and Shefali Krishna
Major Trends in Modern Cancer Research Symposium
More than 500 people filled the Rockefeller Research Laboratories Auditorium in November 2010 for the fifth annual Major Trends in Modern Cancer Research symposium. Created to expose members of the public, especially high school students and their teachers, to cutting-edge research that is improving the understanding of cancer, the symposium was moderated by MSKCC’s new President, Craig B. Thompson, who also gave one of the evening’s three lectures. Joining him were developmental biologist Mary K. Baylies and radiation oncologist Timothy A. Chan.
MSKCC
educates the next generation
Gerstner Sloan-Kettering Graduate School of Biomedical Sciences
In 2006, the first class of six students matriculated at the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences (GSK). Currently, 42 students are enrolled in the school. Dimiter Tassev, a student from the inaugural class, was the first to complete all the require-ments for his PhD; the degree was conferred in May 2011.
GSK, established with a gift from MSKCC Board member Louis V. Gerstner, Jr., seeks to bridge basic research and real-life clinical challenges by offering its students an intensive PhD program to study the biological sciences through the lens of cancer. The faculty includes many Sloan-Kettering Institute investigators and Memorial Hospital physician-scientists, with the clinical faculty taking students directly into the clinic to expose them not only to research about cancer but to the clinical experience of the disease.
MSKCC
A cancer diagnosis puts life on hold — the life of the patient as well as the lives of his or her loved ones. At Memorial Sloan-Kettering, all the efforts of our doctors, nurses, and other healthcare professionals are focused on getting these men, women, and children back to lives interrupted by this terrible disease.
Every day, our basic researchers and physician-scientists push the boundaries of understanding about what goes wrong in cancer and work tirelessly to speed discoveries into more-effective therapies.
The stories you are about to read feature four patients who entrusted their lives to our care. We are proud to say that we have sent them back to the lives they knew before cancer…healed.
heals
MSKCC 352010 ANNUAL REPORT
CJ Postighonehigh school student and varsity hockey player / page 38
Halina Frydmanprofessor / page 36
Michael Quinlanactor / page 42
Stephanie Luedkefinancial professional / page 44
36 MSKCC
Professor NYU Stern School of Business
New York
diagnosis: Primary central nervous system lymphoma
Halina Frydman
Can a husband dance too much with his wife on New Year’s Eve?
Roman Frydman’s motives for dancing the night away with his wife, Halina — while loving — were not entirely to ensure that she would have a good time at a New Year’s party welcoming 2005. Instead, he was concerned about recent, disturbing personality changes he had observed in her — including unchar-acteristic anger toward a friend attending that night’s celebration. “My husband danced with me a lot that evening because he didn’t want me to interact with too many people,” says Dr. Frydman. “He recognized there was something wrong.”
Several days later, in her office at New York University’s Stern School of Business, where she is a professor of statistics, Dr. Frydman realized she was unable to focus on her work. Returning to her apartment, she tried to read a book. Her husband, also a
professor at NYU, asked what she was reading. “I couldn’t tell him,” Dr. Frydman recalls. “That’s when he got very upset and called a friend, a psychiatrist, who said, ‘Take Halina to the emergency room now.’ ”
At NYU Medical Center, an MRI scan of Dr. Frydman’s brain showed a tumor. Immediately admitted to the hospital, she began a course of steroids. The tumor shrank dramatically. She explains: “At first, the doc-tors suspected it was a metastasis from the breast cancer I had in 1999. But because it shrank so much and so fast, they thought, ‘This is not a solid tumor.’ ” A brain biopsy followed and finally a diagnosis: primary central nervous system (CNS) lymphoma. Dr. Frydman had been treated for breast cancer at MSKCC by medical oncologist Clifford A. Hudis (now Chief of the Breast Cancer Medicine Service) and wished to be treated at the Center again.
MSKCC 372010 ANNUAL REPORT
Halina Frydman has returned to a full life of teaching, researching, writing, and publishing. And today, she and her husband dance just for the fun of it.
Dr. Hudis referred the Frydmans to neuro-oncologist Lisa M. DeAngelis, Chair of the Department of Neurology and now Co-Executive Director of the Brain Tumor Center.
“CNS lymphoma is a rare cancer that can involve the brain, spinal cord, eyes, or the coverings of the brain and optic nerve, called the meninges,” says Dr. DeAngelis. “The designation of the disease as a lymphoma reflects the fact that the cells from which this cancer arises are lymphocytes, a type of white blood cell.”
Dr. DeAngelis enrolled Dr. Frydman in a clinical trial consisting of methotrexate — a chemotherapy drug that was given in very high doses — along with the chemotherapy drugs vincristine and procarbazine, and a monoclonal antibody called rituximab. “CNS lymphoma of the type that Dr. Frydman had used to be treated with whole-brain radiation,
which can damage normal brain structures and affect cognitive function,” explains Dr. DeAngelis. “At MSKCC, we’ve pioneered the use of chemotherapy for these tumors. Although radiation continues to play a role, we are exploring significantly reducing the doses. In patients who have received chemo-therapy and low-dose radiation we don’t see cognitive damage and the majority of them are doing extraordinarily well.”
The protocol for the trial still called for whole-brain radiation, albeit at a reduced dose. However, following chemotherapy, a scan of her brain showed no signs of cancer and Dr. Frydman decided against it. “I was worried that I wouldn’t have been able to go back to my work,” says Dr. Frydman. “I asked Dr. DeAngelis, ‘In your opinion, if I don’t do the radiation, will I put myself at a higher risk of a recurrence?’ She said no. She was very open-minded about it.”
“Dr. Frydman had gone into complete remission and had made a full clinical recovery,” says Dr. DeAngelis, “so I felt I could support her decision.” Dr. DeAngelis concludes, “What we have learned — and lymphoma is one of the best examples of this — is that underlying brain tissue is not necessarily destroyed by tumors; therefore effective treatment really can restore people to functionality.”
Halina Frydman has certainly been restored. She has returned to a full life of teaching, researching, writing, and publishing. And today, she and her husband dance just for the fun of it.
38 MSKCC
High school student
New Jersey
diagnosis: RhabdomyosarcomaCJ Postighone
MSKCC 392010 ANNUAL REPORT
The title of Carl Joseph “CJ” Postighone’s story should be Fierce Determination. The characters include a courageous and fiercely determined child. A fiercely determined, multidisciplinary, and creative medical team. And an extraordinary family, fiercely determined not only to survive an ordeal few can imagine but to emerge stronger than ever.
Pediatric oncologist Leonard H. Wexler is gentle in manner but blunt in describing CJ’s circumstances when they first met: “He was a beautiful five-year-old boy with a very bad cancer.” CJ, now 16, was diagnosed in 2000 with a rare pediatric cancer called rhab-domyosarcoma. The disease arises from cells that normally develop into skeletal muscles. It can affect almost any part of the body: the head and neck, the urinary and reproductive organs, the chest and abdomen, or, as in CJ’s case, the extremities. CJ’s rhabdomyosarcoma arose in his right buttock. “There is a common
40 MSKCC
variant called embryonal rhabdomyosarcoma,” explains Dr. Wexler, “and a less common and more virulent variant called alveolar rhabdo-myosarcoma, more typically found in tumors of the extremities. That’s what CJ had.”
It began when CJ complained that his thigh was “itchy.” Within days, his parents, Carl and Robyn — an internist and nurse respectively — noted that CJ’s thigh “had more than doubled its original size and had turned a mottled color,” Mrs. Postighone recalls. An x-ray suggested a possible injury. CJ played ice hockey. At five he was already a gifted athlete.
But an injury heals. This did not. Then, several days later, came devastating news: An MRI scan showed “that in all likelihood this was a muscle tumor consistent with a rhabdo-myosarcoma,” says Dr. Postighone. “We were in disbelief.”
Initial consultations with oncologists in New Jersey, where the family lives, convinced
the Postighones that Memorial Sloan-Kettering was the institution at which they wanted their child treated.
Treatment for rhabdomyosarcoma, then and now, consists of chemotherapy and radiation and, in selected cases, surgery. CJ was treated first with “a very intensive five-drug chemotherapy regimen not considered standard at the time,” says Dr. Wexler. It was a profoundly rigorous course. “They had to make him very, very sick to make him better,” says Dr. Postighone.
Then Michael P. La Quaglia, Chief of the Pediatric Surgical Service, and John H. Healey, Chief of the Orthopaedic Service, collaborated on surgery to remove all remain-ing disease. But even before surgery, imaging studies showed that the news was good: “After the initial 12 weeks of chemotherapy, the cancer in the lymph nodes in CJ’s pelvis and abdomen to which the disease had spread had virtually disappeared,” Dr. La Quaglia says. “And the primary tumor, in his buttock,
showed an approximately 90 percent reduc-tion in volume. I removed the lymph nodes and worked with Dr. Healey to remove the residual tumor.” But that was not the end of CJ’s time in the operating room.
To decrease the dose of external beam radiation that CJ would receive after surgery, radiation oncologist Suzanne L. Wolden collaborated with her surgical colleagues and MSKCC medical physicists to deliver a dose of intraoperative radiation to CJ’s pelvis and abdomen. “Radiotherapy works very well to help cure rhabdomyosarcoma,” says Dr. Wolden. “However, the doses needed to treat it effectively are associated with severe long-term side effects. Our challenge is to maximize effectiveness while being very creative at minimizing those side effects. This is something we’re uniquely suited to do here. Very few places in the world do intraopera-tive radiation for children.” As a result of the intraoperative radiation, Dr. Wolden was indeed able to reduce the dose of external
(Top) CJ on the ice. (Right) CJ surrounded by his Morristown-Beard Crimson teammates and coaches.
MSKCC 412010 ANNUAL REPORT
beam radiation that followed — every day for six weeks — along with six additional rounds of chemotherapy.
Asked how the family persevered, CJ’s sister, Cassandra, eight at the time of his diagnosis and now a sophomore at Villanova University, gestures at her brother: “Because of him. I remember one day our mother was cry-ing and CJ, who was still only five, went up to her and said, ‘Mommy, you have to believe.’ ”
Carl Postighone adds, “It’s also hard to imagine how we could have gotten through this without Lenny and the entire MSKCC team. They had an extraordinary ability to give us the confidence that we could get through the journey, that there was no mountain we couldn’t climb.”
“Later, after it was all over, I had these bracelets made,” CJ says. A small pile rests on the kitchen table. They are blue rubber. He sells them to raise money for the American Cancer Society. They read, simply, Believe.
Even at five years old, even through the most grueling days of treatment, CJ believed he would recover — and he remained an athlete. During numerous hospitalizations, his parents brought him his hockey stick so he could play in the hospital corridors. And when he was home and well enough, he was back on the ice — sometimes wearing a knapsack containing his chemotherapy. Today, despite his illness and the resultant loss of muscle, he plays competitive ice hockey with his high
school team, the Morristown-Beard Crimson, ranked one of the top ten high school teams in New Jersey. His position is forward. “He is lucky Number Five,” says his mother.
“I remember Dr. Wexler saying, ‘CJ’s going to be fine. I’m going to be at his high school graduation,’ ” continues Mrs. Postighone, her eyes reddening. “We’re almost there, and he will be.”
B e l i e v e .
“ It’s hard to imagine how we could have gotten through without Lenny and the MSKCC team. They had an extraordinary ability to give us the confidence that we could get through the journey, that there was no mountain we couldn’t climb.”
– Carl Postighone
(Above, left) Robyn, Cassandra, Carl, and CJ Postighone. (Above, right) CJ with another member of the Postighone family, Coco.
42 MSKCC
Michael Quinlan
Actor
New Jersey
diagnosis: Prostate cancer
MSKCC 432010 ANNUAL REPORT
After numerous consultations that included exploring the option of radiation therapy, Mr. Quinlan chose to have his pros-tate removed by robot-assisted laparoscopic surgery, an approach that allows surgeons to perform operations through a few small incisions with enhanced vision and control.
“The robot is really just a sophisticated surgical tool,” explains Dr. Laudone. Seated at a console, the surgeon uses finger, eye, and foot controls to manipulate the arms of the robot. “There are several advantages from a surgeon’s point of view. First, you can see better because the eyes of the robot — the camera — can go right down into the tissue and project a three-dimensional image, magni-fied tenfold.” In addition, the robot translates a surgeon’s hand, wrist, and finger movements into real-time movements of the surgical instruments inside the patient. “The robot takes my motions, copies them, and scales them down,” Dr. Laudone says. “If I make a one-inch movement, the robot scales it down to a quarter-inch. A quarter-inch movement is scaled down to a sixteenth of an inch. The precision is extraordinary.”
In prostate cancer surgery, precision is key. “The primary goal of any cancer opera-tion no matter how it is done is to remove
all the cancer,” Dr. Laudone asserts. “This means removing the prostate and in most cases the surrounding pelvic lymph nodes. Not removing the lymph nodes in men with more-aggressive prostate cancer runs the risk of leaving cancer behind. The second consideration is to preserve urinary and sexual function. In properly selected patients, robot-assisted surgery can achieve exceptional curative and functional outcomes. However, as helpful as the robot is with the operation, it doesn’t replace the need for good surgical judgment, experience, and skill.”
In April 2010, Dr. Laudone removed Mr. Quinlan’s prostate and 18 lymph nodes. Final pathology revealed that all 18 nodes were negative for cancer and, following surgery, Mr. Quinlan’s PSA level was zero. Subsequent PSA levels have remained undetectable, and no further treatment has been necessary. Mr. Quinlan also says that his functional outcomes have been excellent.
“I think of what happened as good news,” Mr. Quinlan remarks. “It was caught in time and Dr. Laudone was able to do something about it. Friends ask, ‘So how are you feeling?’ And I reply, ‘About what?’ And then I remem-ber. Oh! That. To be back at work, back in my life, and actually able to forget is a great gift.”
Michael Quinlan is a working actor. His credits include Broadway revivals of Death of a Salesman and The Caine Mutiny Court-Martial; television shows such as Law and Order; commercials, voiceovers, and industrial films. He also coaches executives in giving effective speeches and presentations. But in 2009, his career was interrupted when, after a routine physical, “my internist called to say that my PSA [prostate-specific antigen] level was a little higher than he’d like. He suggested I see a urologist.”
Mr. Quinlan followed his internist’s recom-mendation. And on December 23, after a prostate biopsy, the urologist called with the results: Of 12 tissue samples removed from Mr. Quinlan’s prostate, six were positive for cancer. “So there was my Merry Christmas present,” Mr. Quinlan smiles dryly.
“The first thing we do when we meet a patient is reassure him that prostate cancer is a very treatable disease and then try to find out all we can about his cancer,” says Mr. Quinlan’s physician, urologic surgeon Vincent P. Laudone, Co-Director of Minimally Invasive Surgery for Robotics at Memorial Sloan-Kettering. “Some patients we don’t have to treat because their cancers are nonag-gressive and are unlikely to cause a problem for them during their lifetime. However, more-aggressive cancers must be treated.”
Preoperative predictors for Mr. Quinlan, including his elevated PSA and a Gleason score of 7 in one area of the prostate and 6 in another, indicated that treatment was neces-sary. (The Gleason grading system, which runs from 2 to 10, is used to characterize the aggressiveness of prostate cancer and provides an estimate of how likely a prostate cancer is to spread to other parts of the body.)
44 MSKCC
Stephanie LuedkeFinancial professional
Connecticut
diagnosis: Cervical cancer
MSKCC 452010 ANNUAL REPORT
“ I’ll never forget the sound,” says Stephanie Luedke, her eyes welling with tears as she describes hearing the cries of her son, Jackson Thomas Luedke, moments after his birth. It is not unusual for a mother to weep when recalling the birth of her child. But for Ms. Luedke, Jackson’s cries are an especially joyful memory. Her journey to that day was anything but routine.
46 MSKCC
“ I don’t wish that any woman go through this, but if anyone does, I would want her to be with Dr. Abu-Rustum. He is a surgeon, a husband, a father, and a real human being. He’s remarkable.” – Stephanie Luedke
In the fall of 2008, Ms. Luedke had received a diagnosis of stage 1-B-1 cervical cancer. Just a decade earlier, the only option available to her would have been a radi-cal hysterectomy. And for a woman still in her childbearing years who wished to have children, the news would have been doubly devastating: You have cancer — and you will never bear a child.
However, for Ms. Luedke and other women in similar straits, there is now a procedure called a radical trachelectomy that can preserve fertility in patients with early-stage cervical cancer. Gynecologic surgeon Nadeem R. Abu-Rustum, Director of Minimally Invasive Surgery for Memorial
Sloan-Kettering’s Gynecology Service, and his colleagues have been performing and perfect-ing the operation since 2001. “We have done more than 100 cases and have proven that this is an excellent choice for certain patients,” says Dr. Abu-Rustum. Of the approximately 105 women who have had radical trachelectomies at MSKCC, 19 have given birth to healthy babies and several more are now pregnant.
In a radical trachelectomy, surgeons remove the cervix and several pelvic lymph nodes. During surgery, a pathologist deter-mines if the margins of the cervical tissue removed are free of cancer cells. If they are, surgeons can spare the healthy uterus. The remaining portion of the uterus is
sutured to the vagina, creating a new cervix. The operation can be performed laparo-scopically — which is a minimally invasive procedure — or as a traditional open surgery. The choice depends on the size of the tumor and other considerations. “Laparoscopy is good for very small cancers,” explains Dr. Abu-Rustum. “But if we are doing a more complex case or if it is a larger, more high-risk tumor, we will choose the open approach.”
“Our cure rate is outstanding,” he adds. “The reason is that we select patients very carefully and study them preoperatively. This includes a review of their biopsy sample with our pathologists and an evaluation of women using pelvic MRI and full-body PET scans to
MSKCC 472010 ANNUAL REPORT
rule out any spread of cancer.” Dr. Abu-Rustum says that this meticulous preoperative planning has allowed MSKCC surgeons to broaden the inclusion criteria. “In the beginning, we were choosing only extremely small tumors. However as we have gained experience we’ve been able to operate on slightly larger lesions and more-advanced stages of disease, and so can offer this option to more women.”
Ms. Luedke, a senior-level executive of an investment management firm, had surgery with Dr. Abu-Rustum in mid-February 2009 and became pregnant in November. Her pregnancy was high risk and was not without its difficult moments. “But Dr. Abu-Rustum stayed in complete communication with
my obstetrician, which gave me tremendous peace of mind,” says Ms. Luedke. “I don’t wish for any woman to go through this, but if anyone does, I would want her to be with Dr. Abu-Rustum. He is a surgeon, a husband, a father, and a real human being. He’s remarkable.”
At 33 weeks into her pregnancy, on July 2, 2010, Stephanie Luedke and her husband, Fritz, welcomed Jackson into the world. He weighed five pounds, three ounces — “one perfect, beautiful little boy,” says his mother.
Fritz, Jackson, and Stephanie Luedke
48 MSKCC
excellence
pursuesMSKCC
The pursuit of excellence occupies all of us, every day. Excellence is an attitude, not a skill. We strive to be better today than we were yesterday. We have a passion to innovate. We embrace change. These are the drivers of excellence. And at Memorial Sloan-Kettering excellence is what we do best.
2010year in review
50 MSKCC
PATIENT CARE 2006 2007 2008 2009 2010
Patient Admissions: Adults 19,626 20,195 21,039 21,932 22,852
Patient Admissions: Children 1,553 1,673 1,650 1,537 1,494
Total Admissions 21,179 21,868 22,689 23,469 24,346
Total Patient Days 136,920 137,787 139,847 140,224 143,532
Average Patient Stay (days) 6.5 6.3 6.2 6.0 5.9
Bed Occupancy Rate (1) 88.1% 87.4% 88% 88.5% 83.7%
Outpatient MD Visits: Manhattan 363,458 368,200 384,889 406,024 418,410
Outpatient MD Visits: Regional Network 67,702 75,631 81,995 94,293 97,425
Total Outpatient MD Visits 431,160 443,831 466,884 500,317 515,835
Screening Visits 31,198 30,200 28,888 27,369 23,373
Surgical Cases 16,329 16,951 18,035 19,233 19,362
Radiation Treatments and Implants: Manhattan 59,369 57,307 58,494 57,856 59,223
Radiation Treatments and Implants:
Regional Network 44,175 44,615 43,550 47,987 47,926
Total Radiation Treatments and Implants 103,544 101,922 102,044 105,843 107,149
X-ray Examinations and Special Procedures 305,404 329,329 346,157 358,052 362,609
Clinical Investigation Protocols (2) 460 493 522 507 552
(1) Based on adjusted bed count(2) Excludes studies closed to accrual
STATISTICAL PROFILE
MSKCC 512010 ANNUAL REPORT
STAFF 2006 2007 2008 2009 2010
Center (1) (2) 798 766 826 873 911
Hospital Attending Staff 713 672 727 768 804
Sloan-Kettering Institute Members(2) 122 128 133 140 142
Registered Nurses 1,504 1,615 1,734 1,845 1,946
Total Employees (3) 9,309 9,917 10,505 11,039 11,474
Volunteers 895 848 871 917 942
(1) All Hospital Attendings and Institute Members hold appointments in the Center; in 2010, 35 staff members held appointments in both the Institute and the Hospital(2) Includes professional support staff appointments(3) Includes all clinicians, scientists, nurses, other health professionals, and support staff
EDUCATION 2006 2007 2008 2009 2010
Residents and Clinical Fellows — Positions 412 419 418 436 447
Residents and Clinical Fellows — Annual Total 1,421 1,687 1,609 1,651 1,625
Research Fellows 400 404 254 303 295
Research Scholars — — 140 121 132
Research Associates 62 63 87 90 94
Graduate Research Assistants — — — — 23
Frank A. Howard Scholars 1 1 1 1 1
PhD Candidates 163 195 232 227 231
MD/PhD Candidates 23 24 29 28 26
Registrants in Continuing
Medical Education Programs 2,140 2,035 2,115 2,395 2,554
Medical Observers 534 522 561 572 541
Medical Students 332 368 358 399 391
Nursing Students 71 61 72 109 105
Social Work Students 6 6 6 6 6
Radiation Oncology Technology Students 16 16 15 15 14
Cytotechnology Students 3 4 3 3 2
Physical Therapy Students 4 3 3 3 3
Occupational Therapy Students 2 1 5 4 3
STATISTICAL PROFILE
52 MSKCC
OPERATING REVENUES AND EXPENSES (in thousands) 2006 2007 2008 2009 2010
OPERATING REVENUES
Patient Care Revenue $ 1,398,393 $ 1,531,639 $ 1,606,989 $ 1,723,313 $ 1,854,776
Grants and Contracts 129,693 149,275 163,352 167,495 186,327
Contributions Allocated to Operations 83,538 95,481 108,844 126,250 117,323
Royalty Income 44,558 38,302 94,131 62,232 68,663
Other Income 39,439 39,902 41,963 43,144 44,874
Investment Return Allocated to Operations 116,143 113,131 116,546 103,998 100,389
Transfer of Board-Designated
Annual Royalty Annuitization 26,083 29,440 33,122 37,158 41,578
Total Operating Revenues 1,837,847 1,997,170 2,164,947 2,263,590 2,413,930
OPERATING EXPENSES
Compensation and Fringe Benefits 966,034 1,061,946 1,164,155 1,286,536 1,361,032
Purchased Supplies and Services 594,671 659,488 684,872 757,863 772,968
Provision for Bad Debts and Assessments 41,978 13,387 6,823 10,881 11,046
Depreciation and Amortization 139,402 157,494 175,870 171,806 175,494
Interest Expense 45,463 54,872 59,023 64,997 47,931
Less Fund Raising Expenses Transferred to
Non-Operating Income (Expenses) (28,390) (33,523) (36,048) (40,320) (43,926)
Total Operating Expenses 1,759,158 1,913,664 2,054,695 2,251,763 2,324,545
Income from Operations $ 78,689 $ 83,506 $ 110,252 $ 11,827 $ 89,385
PHILANTHROPY (in thousands)
Philanthropy $ 298,728 $ 239,020 $ 279,103 $ 166,247 $ 237,666
CAPITAL SPENDING (in thousands)
Capital Spending $ 309,524 $ 273,944 $ 345,135 $ 226,049 $ 262,371
BALANCE SHEET SUMMARY (in thousands)
Assets $ 5,740,721 $ 6,143,433 $ 5,578,522 $ 6,068,707 $ 6,448,415
Liabilities 2,098,245 2,098,776 2,354,618 2,467,135 2,550,889
Net Assets $ 3,642,476 $ 4,044,657 $ 3,223,904 $ 3,601,572 $ 3,897,526
FINANCIAL SUMMARY
MSKCC 532010 ANNUAL REPORT
Douglas A. Warner IIIChairman
James D. Robinson IIIHonorary Chairman
Richard I. BeattieVice Chairman of Boards;Chairman, Board of Managers, Memorial Hospital
Clifton S. RobbinsTreasurer
Louis V. Gerstner, Jr.Vice Chairman of Boards;Chairman, Board of Managers, Sloan-Kettering Institute
Norman C. SelbySecretary
Craig B. Thompson, MDPresident and Chief Executive Officer
Frederick R. AdlerRichard I. BeattieMrs. Edwin M. BurkeMrs. John J. ByrneMrs. Joseph A. Califano, Jr. Stanley F. DruckenmillerAnthony B. EvninRoger W. Ferguson, Jr.Steve ForbesWilliam E. FordRichard N. FosterStephen FriedmanEllen V. FutterPhilip H. Geier, Jr.Louis V. Gerstner, Jr.Jonathan N. GrayerJohn R. GunnBette-Ann GwathmeyWilliam B. Harrison, Jr.Jane D. Hartley
Benjamin W. Heineman, Jr.Mrs. Ann Dibble Jordan David H. KochMarie-Josée KravisMrs. Evelyn H. LauderMrs. Thomas V. LeedsMrs. Jean Remmel LittleMrs. John L. MarionPaul A. Marks, MDDonald B. MarronJamie C. NichollsJames G. NivenHutham S. OlayanE. Stanley O’NealBruce C. RatnerClifton S. RobbinsJames D. Robinson IIIVirginia M. RomettyBenjamin M. RosenDavid M. Rubenstein
Jack RudinLewis A. SandersFayez S. SarofimNorman C. SelbyStephen C. SherrillPeter J. SolomonWilliam C. Steere, Jr.J. McLain StewartScott M. StuartCraig B. Thompson, MDLucy R. Waletzky, MDDouglas A. Warner IIISanford I. WeillPeter A. WeinbergJon WinkelriedDeborah C. WrightJeff ZuckerMortimer B. Zuckerman
Board of Overseers Emeriti
Mrs. Elmer H. BobstPeter O. Crisp
Richard M. FurlaudJames W. Kinnear
Elizabeth J. McCormack, PhDMrs. Arnold Schwartz
Board of Scientific Consultants
Frederick R. Appelbaum, MDRichard Axel, MDPhilip A. Cole, MD, PhDNancy E. Davidson, MDTitia de Lange, PhD James R. Downing, MD
Laurie Glimcher, MDJoseph L. Goldstein, MDGregory Hannon, PhD Barnett S. Kramer, MD, MPHArthur Levinson, PhDPaul Nurse, PhD, FRS
Stanley R. Riddell, MD William R. Sellers, MDGregory L. Verdine, PhDRalph Weissleder, MD, PhDIrving L. Weissman, MD
BOARDS OF OVERSEERS AND MANAGERSMEMORIAL SLOAN-KETTERING CANCER CENTER
54 MSKCC
Murray F. Brennan, MDVice President for International Programs and Director, Bobst International Center
Eric M. Cottington, PhDVice President, Research and Technology Management
Dennis Dowdell, Jr.Vice President, Human Resources
Michael P. GutnickSenior Vice President, Financeand Assistant Treasurer
Jason KleinVice President and Chief Investment Officer
Kathy LewisVice President, Public Affairs
Edward J. MahoneyVice President,Facilities Management
Kathryn MartinSenior Vice President andHospital Administrator
Richard K. NaumVice President, Development
Roger N. Parker, JDSenior Vice President andGeneral Counsel
Patricia C. SkarulisVice President, Information Systems and Chief Information Officer
Ellen Miller SonetVice President, Marketing
Paul A. Marks, MDPresident Emeritus
Harold Varmus, MDPresident Emeritus
For a listing of the members of the professional staffof Memorial Hospital and the Sloan-Kettering Institute,please visit www.mskcc.org/annualreport2010.
Craig B. Thompson, MD President and Chief Executive Officer, Memorial Sloan-Kettering Cancer Center
John R. GunnExecutive Vice President
Robert E. Wittes, MDPhysician-in-Chief, Memorial Hospital
Larry Norton, MDDeputy Physician-in-Chief,Breast Cancer Programs, Memorial Hospital
Thomas J. Kelly, MD, PhDDirector, Sloan-Kettering Institute
Maureen Killackey, MDDeputy Physician-in-Chief and Medical Director, MSKCC Regional Care Network
PRINCIPAL OFFICERSMEMORIAL SLOAN-KETTERING CANCER CENTER
MSKCC 54A2010 ANNUAL REPORT
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR
Robert E. Wittes, MD
Vincent Astor Chair of Clinical Research
David R. Artz, MD
Gay Bailey, RN
Boris C. Bastian, MD, PhD
Colin B. Begg, PhD
George J. Bosl, MD
Arthur E. Brown, MD
Kevin Browne, RN
Michelle Burke, RN
Lisa M. DeAngelis, MD
Joseph O. Deasy, PhD
Dawn P. Desiderio, MD
Mary Dowling, RN
Martin Fleisher, PhD
Hans Gerdes, MD
John R. Gunn
Philip H. Gutin, MD
William Hoskins, MD
Hedvig Hricak, MD, PhD
William R. Jarnagin, MD
Lewis J. Kampel, MD
Thomas J. Kelly, MD, PhD
Maureen Killackey, MD
Aileen Killen, PhD, RN
David W. Kissane, MD
Charles D. Lucarelli, RPh
Kathryn Martin
Mary Jane Massie, MD
Mary McCabe, RN
Elizabeth Nelkin McCormick, MSN, RN
Larry Norton, MD
Eileen M. O’Reilly, MB, BCh, BAO
Richard J. O’Reilly, MD
David G. Pfister, MD
Simon N. Powell, MD, PhD
Paul J. Sabbatini, MD
Leonard B. Saltz, MD
Charles L. Sawyers, MD
Peter T. Scardino, MD
Craig B. Thompson, MD
Roger S. Wilson, MD
CHAIR AND ATTENDING
Martin Fleisher, PhD
ATTENDINGS
Ann M. Dnistrian, PhD
Bo Dupont, MD, DSc
Hans G. Lilja, MD, PhD
Peter Maslak, MD
Eric Pamer, MD
Enid A. Haupt Chair in Clinical Investigation
Lilian M. Reich, MD, PhD
Gerald A. Soff, MD
David L. Wuest, MD
ASSOCIATE ATTENDINGS
Renier J. Brentjens, MD, PhD
Vincent F. LaRussa, PhD
Celia J. Menendez-Botet, PhD
Rekha Parameswaran, MBBS
Trudy Nan Small, MD
ASSISTANT ATTENDINGS
Maria Eugenia Arcila, MD
Ngolela Esther Babady, PhD
Laura K. Bechtel, PhD
Kazunori Murata, PhD
Christopher Yongchul Park, MD, PhD
Larry J. Smith, PhD
CHAIR AND ATTENDING
Roger S. Wilson, MD
Founder’s Chair
ATTENDINGS
David Amar, MD
Lisa R. Barr, MD
Ruth A. Borchardt, MD
Dawn P. Desiderio, MD
Mary Ellen Fischer, MD
Florence J. Grant, MD
Jeffrey Groeger, MD
Neil A. Halpern, MD
Paul M. Heerdt, MD, PhD
Anne C. Kolker, MD
Ronald A. Kross, MD
William L. Marx, MD
Stephen M. Pastores, MD
Diane E. Stover, MD
Alisa C. Thorne, MD
Robert A. Veselis, MD
ASSOCIATE ATTENDINGS
Kenneth H. Cubert, MD
Paul H. Dalecki, MD
Jamie A. Fortunoff, MD
Alan L. Kotin, MD
Vivek T. Malhotra, MD, MPH
Roger E. Padilla, MD
ASSISTANT ATTENDINGS
Kara Michelle Barnett, MD
Clara Broad, MD
Mohit Chawla, MD
Sanjay Chawla, MD
Anahita Dabo, MD
Oscar E. Del Valle, MD
Rodney H. Garcia, MD
Amitabh Gulati, MD
Eric R. Kelhoffer, MD
Amy Lu, MD, MPH
Jennifer Mascarenhas, MD
Eileen P. McAleer, MD
Leslie S. Ojea, MD
Alessia C. Pedoto, MD
Kane O. Pryor, MBBS
Vinay Ganesh Puttanniah, MD
Nina D. Raoof, MD
Elizabeth Fay Rieth, MD
Luis E. Tollinche, MD
Louis P. Voigt, MD
Cindy Beng-Imm Yeoh, MD
INSTRUCTORS
Diba Daneshrad, MD, MPH
Kaye E. Hale, MD
MEDICAL BOARD
DEPARTMENT OF ANESTHESIOLOGY AND CRITICAL CARE MEDICINE
DEPARTMENT OF CLINICAL LABORATORIES
54B MSKCC
CHAIR AND ATTENDING
Colin B. Begg, PhD
Eugene W. Kettering Chair
ATTENDINGS
Peter B. Bach, MD
Jonine L. Bernstein, PhD
Glenn Heller, PhD
Malcolm C. Pike, PhD
Chris Sander, PhD
Venkatraman E. Seshan, PhD
ASSOCIATE ATTENDINGS
Lawrence S. Engel, PhD
Mithat Gonen, PhD
Irene Orlow, PhD
Katherine S. Panageas, DrPH
Jaya M. Satagopan, PhD
Howard T. Thaler, PhD
Andrew J. Vickers, DPhil
Ann G. Zauber, PhD
ASSISTANT ATTENDINGS
Ethan M. Basch, MD
Victoria S. Blinder, MD
Marinela Capanu, PhD
Elena B. Elkin, PhD
Anna Helena Furberg-Barnes, PhD
Shari Goldfarb, MD
Alexia E. Iasonos, PhD
Yuelin Li, PhD
Chaya S. Moskowitz, PhD
Susan Oliveria, ScD, MPH
Sara H. Olson, PhD
Irina Ostrovnaya, PhD
Sujata Patil, PhD
Li-Xuan Qin, PhD
Talya Salz, PhD
Ronglai Shen, PhD
Camelia S. Sima, MD
Zhigang Zhang, PhD
CHAIR AND ATTENDING
Joseph O. Deasy, PhD
Enid A. Haupt Chair of Medical Physics
ATTENDINGS
Howard I. Amols, PhD
Chandra M. Burman, PhD
John L. Humm, PhD
Peter Kijewski, PhD
Jason A. Koutcher, MD, PhD
Gloria C. Li, PhD
C. Clifton Ling, PhD
Thomas J. LoSasso, PhD
Gikas S. Mageras, PhD
Jean M. St. Germain, MS
Ellen D. Yorke, PhD
Marco Zaider, PhD
Pat Zanzonico, PhD
ASSOCIATE ATTENDINGS
Douglas J. Ballon, PhD
Maria F. Chan, PhD
Yusuf E. Erdi, DSc
Doracy P. Fontenla, PhD
Y. C. David Huang, PhD
Margie A. Hunt, MS
Andrew Jackson, PhD
Assen S. Kirov, PhD
Dale M. Lovelock, PhD
James G. Mechalakos, PhD
Sadek Nehmeh, PhD
Ceferino H. Obcemea, PhD
Joseph A. O’Donoghue, PhD
Kristen L. Zakian, PhD
ASSISTANT ATTENDINGS
Ase M. Ballangrud-Popovic, PhD
Lawrence T. Dauer, PhD
Amita Dave, PhD
Cesar Della Biancia, PhD
Paul Frisch, PhD
David H. Gultekin, PhD
Hongbiao Carl Le, PhD
Guang (George) Li, PhD
Jingdong Li, PhD
Ruimei Ma, PhD
Yousef Mazaheri, PhD
Kyung K. Peck, PhD
Charles R. Schmidtlein, PhD
Yulin Song, PhD
Sunitha B. Thakur, PhD
Weijun Xiong, PhD
Guozhen (Jenny) Yang, PhD
Pengpeng Zhang, PhD
Qinghui Zhang, PhD
INSTRUCTORS
Ellen Ackerstaff, PhD
Jazmin Schwartz, PhD
DEPARTMENT OF EPIDEMIOLOGY AND BIOSTATISTICS
DEPARTMENT OF MEDICAL PHYSICS
DEPARTMENTS OF MEMORIAL HOSPITAL
MSKCC 54C2010 ANNUAL REPORT
CHAIR AND ATTENDING
George J. Bosl, MD
The Patrick M. Byrne Chair in Clinical Oncology
DIVISION HEADS AND ATTENDINGS
Ephraim S. Casper, MD
Division of Network Medicine Services
David R. Spriggs, MD
Division of Solid Tumor Oncology; Winthrop Rockefeller Chair in Medical Oncology
Diane E. Stover, MD
Division of General Medicine
Marcel R. M. van den Brink, MD, PhD
Division of Hematologic Oncology; Alan N. Houghton Chair
SENIOR ATTENDING
Bayard D. Clarkson, MD
Enid A. Haupt Chair of Therapeutic Research
ATTENDINGS
James P. Allison, PhD
David H. Koch Chair in Immuno-logic Studies; Howard Hughes Medical Institute Investigator
Peter Bach, MD
Dean F. Bajorin, MD
Michael S. Baum, MD
Ellin Berman, MD
William S. Breitbart, MD
Murray F. Brennan, MD
Benno C. Schmidt Chair in Clinical Oncology
Arthur E. Brown, MD
Philip C. Caron, MD, PhD
Albert R. Casazza, MD
Barrie R. Cassileth, PhD
Laurance S. Rockefeller Chair in Integrative Medicine
Hugo R. Castro-Malaspina, MD
Raju S.K. Chaganti, PhD
William E. Snee Chair
Paul B. Chapman, MD
Bo Dupont, MD, DSc
James A. Fagin, MD
Carlos D. Flombaum, MD
Kathleen M. Foley, MD
Society of Memorial Sloan- Kettering Cancer Center Chair
Francesca M. Gany, MD
Hans Gerdes, MD
Teresa Ann Gilewski, MD
Sergio A. Giralt, MD
Paul A. Glare, MBBS
Michael S. Glickman, MD
Richard D. Granstein, MD
Jeffrey S. Groeger, MD
José G. Guillem, MD
Allan C. Halpern, MD
Neil A. Halpern, MD
Brian Harper, MD, MPH
Alan N. Houghton, MD
Virginia and Daniel K. Ludwig Clinical Chair
Clifford A. Hudis, MD
David H. Ilson, MD, PhD
Suresh C. Jhanwar, PhD
Lewis J. Kampel, MD
David Paul Kelsen, MD Edward S. Gordon Chair in Medical Oncology
Nancy E. Kemeny, MD
Richard N. Kolesnick, MD
Jason A. Koutcher, MD, PhD
Mark G. Kris, MD
William and Joy Ruane Chair in Thoracic Oncology
Robert C. Kurtz, MD
Diana E. Lake, MD
Steven M. Larson, MD
Donna and Benjamin M. Rosen Chair in Radiology
Stuart M. Lichtman, MD
Hans G. Lilja, MD
Philip O. Livingston, MD
Michael D. Lockshin, MD
Steven K. Magid, MD
Joseph A. Markenson, MD
Paul A. Marks, MD
Steven C. Martin, MD
Peter G. Maslak, MD
Vincent A. Miller, MD
Nancy E. Mills, MD
Malcolm A. S. Moore, DPhil
Enid A. Haupt Chair of Cell Biology
Robert J. Motzer, MD
Patricia L. Myskowski, MD
Stephen D. Nimer, MD
Alfred P. Sloan Chair
Larry Norton, MD
Norna S. Sarofim Chair in Clinical Oncology
Kevin Oeffinger, MD
Herbert F. Oettgen, MD
Kenneth Offit, MD
Richard J. O’Reilly, MD
Claire L. Tow Chair in Pediatric Oncology Research
Stephen A. Paget, MD
Eric G. Pamer, MD
Enid A. Haupt Chair in Clinical Investigation
Esperanza B. Papadopoulos, MD
Gavril W. Pasternak, MD, PhD
Anne Burnett Tandy Chair of Neurology
Stephen Pastores, MD
David G. Pfister, MD
Carol S. Portlock, MD
Lilian M. Reich, MD, PhD
Isabel C. Rivière, PhD
Nancy Roistacher, MD
Neal Rosen, MD, PhD
Enid A. Haupt Chair in Medical Oncology
Michel Sadelain, MD, PhD
Stephen and Barbara Friedman Chair
Leonard B. Saltz, MD
Jean T. Santamauro, MD
Charles L. Sawyers, MD
Marie-Josèe and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Howard Hughes Medical Institite Investigator
David A. Scheinberg, MD, PhD
Vincent Astor Chair
Howard I. Scher, MD
D. Wayne Calloway Chair in Urologic Oncology
William J. Schneider, MD
Philip Schulman, MD
Gary K. Schwartz, MD
Andrew D. Seidman, MD
Kent A. Sepkowitz, MD
Moshe Shike, MD
Stewart Shuman, MD, PhD
Simon H. Rifkind Chair
Nancy T. Sklarin, MD
DEPARTMENT OF MEDICINE
DEPARTMENTS OF MEMORIAL HOSPITAL
54D MSKCC
DEPARTMENTS OF MEMORIAL HOSPITAL
Gerald A. Soff, MD
Richard M. Steingart, MD
David J. Straus, MD
Steven M. Sugarman, MD
Martin S. Tallman, MD
Maria Theodoulou, MD
Craig B. Thompson, MD
R. Michael Tuttle, MD
Nicholas Jon Vander Els, MD
Stephen R. Veach, MD
Carolyn Wasserheit, MD
Sidney J. Winawer, MD
Paul Sherlock Chair
Robert E. Wittes, MD
Vincent Astor Chair of Clinical Research
David L. Wuest, MD
Han Xiao, MD
James W. Young, MD
ASSOCIATE ATTENDINGS
Carol Aghajanian, MD
David R. Artz, MD
Juliet Barker, MBBS
Anne R. Bass, MD
Renier J. Brentjens, MD, PhD
Jacqueline F. Bromberg, MD, PhD
Alan C. Carver, MD
Chih-Shan Jason Chen, MD, PhD
Gabriella M. D’Andrea, MD
Gary E. Deng, MD, PhD
Maura N. Dickler, MD
Pamela R. Drullinsky, MD
Alan L. Engelberg, MD
Theodore R. Fields, MD
John J. Fiore, MD
Stephanie A. Fish, MD
Venera Grasso, MD
Audrey M. Hamilton, MD
Hani Hassoun, MD
Mark L. Heaney, MD, PhD
Martee L. Hensley, MD
James Hsieh, MD, PhD
Katharine C. Hsu, MD, PhD
Ann A. Jakubowski, MD, PhD
Michelle N. Johnson, MD
Joseph G. Jurcic, MD
Marcia F. Kalin, MD
Noah D. Kauff, MD
Mary L. Keohan, MD
Jeffrey A. Knauf, PhD
Beatriz Korç-Grodzicki, MD, PhD
Lee M. Krug, MD
Mario E. Lacouture, MD
Sheron Latcha, MD
Jennifer E. Liu, MD
C. Ronald. MacKenzie, MD
Vivek T. Malhotra, MD, MPH
Ashfaq A. Marghoob, MD
Arnold J. Markowitz, MD
Franklin Marsh, Jr., MD
Michael R. McDevitt, PhD
Craig H. Moskowitz, MD
Mary E. Moynahan, MD
Kishwer S. Nehal, MD
Deena J. Nelson, MD
Kenneth K. Ng, MD
Ariela Noy, MD
Eileen M. O’Reilly, MB, BCh, BAO
Genovefa A. Papanicolaou, MD
Rekha Parameswaran, MBBS
Govindaswami Ragupathi, PhD
Milind Rajadhyaksha, PhD
Naiyer A. Rizvi, MD
Mark E. Robson, MD
Paul J. Sabbatini, MD
Mona Sabra, MD
Lisa R. Sammaritano, MD
Mark A. Schattner, MD
Sergio Schwartzman, MD
Susan K. Seo, MD
Susan F. Slovin, MD, PhD
Robert F. Spiera, MD
Richard Stern, MD
Andrew J. VIckers, PhD
Howard Weinstein, MD
Jedd D. Wolchok, MD, PhD
Ann G. Zauber, PhD
Andrew D. Zelenetz, MD, PhD
ASSISTANT ATTENDINGS
Ghassan K. Abou-Alfa, MD
Juliet B. Aizer, MD
Arlyn Apollo, MD
Abraham Aragones, MD
Dalit Ashany, MD
Christopher G. Azzoli, MD
Ethan M. Basch, MD
Katherine M. Bell-McGuinn, MD, PhD
Stefan Berger, MD
Jessica R. Berman, MD
Victoria S. Blinder, MD
Michelle S. Boyar, MD
Richard D. Carvajal, MD
Kathleen N. S. Cathcart, MD
Andrea Cercek, MD
Sarat Chandarlapaty, MD, PhD
Mohit Chawla, MD
Sanjay Chawla, MD
Carol L. Chen, MD
Gabriela Chiosis, PhD
Frederick R. Adler Chair for Junior Faculty
Dana M. Cutzu, MD
David R. D’Adamo, MD, PhD
Chau T. Dang, MD
Jennifer L. DeFazio, MD
Liang Deng, MD, PhD
Madhuri Devabhaktuni, MBBS
Mark A. Dickson, MD
Christopher J. DiMaio, MD
Stephen J. DiMartino, MD, PhD
Barbara C. Egan, MD
Doruk Erkan, MD
Azeez Farooki, MD
Julie Fasano, MD
Marc B. Feinstein, MD
Darren R. Feldman, MD
Monica N. Fornier, MD
Mark G. Frattini, MD, PhD
Matthew G. Fury, MD, PhD
John F. Gerecitano, MD, PhD
Monica Girotra, MD
Ilya G. Glezerman, MD
Jenna Goldberg, MD
Zoe Goldberg, MD
Shari Goldfarb, MD
Stephanie M. Goodman, DO
Susan M. Goodman, MD
Mila Gorsky, MD
Deena M. Atieh Graham, MD
Polly D. Gregor, PhD
Yvona Griffo, MD
Rebecca D. S. Guest, MD
Shellie L. Gumbs, MD
Paul A. Hamlin, MD
Alan Loh Ho, MD, PhD
Steven M. Horwitz, MD
Yelena Y. Janjigian, MD
Robert Jenq, MD
Erik K. Johnson, MD
Anna Kaitsas, MD
Mini Kamboj, MBBS
Rana Kaplan, MD
Amsale Ketema, MD
Magi M. Khalil, MD, PhD
Tomas Kirchhoff, PhD
Kyriakos A. Kirou, MD, DSc
Virginia M. Klimek, MD
Adam D. Klotz, MD
Guenther Koehne, MD, PhD
Jason A. Konner, MD
Nicole Lamanna, MD
Heather J. Landau, MD
Erica H. Lee, MD
Robert P. Lee, MD
Nikoletta Lendvai, MD, PhD
Jenifer C. F. Leng, MD, MPH
Ross Levine, MD
Geoffrey Beene Junior Faculty Chair
Emmy Ludwig, MD
Vicky Makker, MD
Lisa A. Mandl, MD
Debra Mangino, DO
Anna R. Marcelli, MD
Matthew J. Matasar, MD
Eileen P. McAleer, MD
Heather L. McArthur, MD
Charis Fan-Hui Meng, MD
Raymond D. Meng, MD, PhD
Taha Merghoub, PhD
Matthew I. Milowsky, MD
Shanu Modi, MD
Patricia and James Cayne Chair for Junior Faculty
Ana M. Molina, MD
Michael J. Morris, MD
Natalie Moryl, MD
Alison J. Moskowitz, MD
Michelle K. Nowak, MD
Roisin E. O’Cearbhaill, MB, Bch, BAO
Susan A. Oliveria, ScD, MPH
Barbara O’Sullivan, MD
Maria Lia A. P. Palomba, MD
Edward J. Parrish, MD
Miguel-Angel Perales, MD
Maria C. Pietanza, MD
Ian G. Pinto, MBBS
Doris Ponce, MD
Elizabeth A. Quigley, MD
Dragos Rancea, MD
MSKCC 54E2010 ANNUAL REPORT
DEPARTMENTS OF MEMORIAL HOSPITAL
Nina D. Raoof, MD
Dana E. Rathkopf, MD
Diane L. Reidy, MD
Gregory J. Riely, MD, PhD
Todd L. Rosenblat, MD
Marina Rozenberg, MD
Linda A. Russell, MD
Mabel M. Ryder, MD
Cori Salvit, MD
Craig S. Sauter, MD
Wendy L. Schaffer, MD, PhD
Neil H. Segal, MD, PhD
Manish A. Shah, MD
Monika Shah, MD
Marni Sheren-Manoff, MD
Eric J. Sherman, MD
Stephanie Smith-Marrone, MD
David B. Solit, MD
Elizabeth and Felix Rohatyn Chair for Junior Faculty
Philip S. Spencer, MD
Zsofia K. Stadler, MD
Sung Wu Sun, MD
Sohail F. Tavazoie, MD, PhD
William P. Tew, MD
Dharmarao Thapi, PhD
Roma Tickoo, MD. MPH
Emily S. Tonorezos, MD, MPH
Tiffany A. Traina, MD
Tiffany Troso-Sandoval, MD
Lisa C. Vasanth, MD
Adrienne Vincenzino, MD
Louis P. Voigt, MD
Steven Q. Wang, MD
Kathleen M. Wesa, MD
Arthur M. F. Yee, MD, PhD
Diana A. Yens, MD
Joseph P. Yoe, MBBS
Kenneth Ho-Ming Yu, MD
INSTRUCTORS
Amina Abdeldaim, MD
Omar I. Abdel-Wahab, MD
Christina Hafermalz Adaniel, MD
Teimuraz Apridonidze, MD
Daniel Barkan, MD
Samarth Beri, MD
David Chung, MD, PhD
Lisa M. Czanko, MD
Daniel C. Danila, MD
Lauren Elena Ferrante, MD
Kaye E. Hale, MD
Douglas Koo, MD, MPH
Yelena Kopyltsova, MD
Chhavi Kumar, MD
James M. Lebret, MD
Alexander M. Lesokhin, MD
Jyoti Malhotra, MBBS, MPH
Anuj B. Mehta, MD
Devi Navamani, DO
Demetrios N. Panagiotou, MD
Shilen N. Patel, MD
Nelson F. Sanchez, MD
Jonathan H. Schatz, MD
Stacy Marie Stabler, MD, PhD
Ying Taur, MD, MPH
Frank Tsai, MD
George K. Wang, MD, PhD
Gulrukh Z. Zaidi, MBBS
CHAIR AND ATTENDING
Lisa M. DeAngelis, MD
Lillian Rojtman Berkman Chair in Honor of Jerome B. Posner
ATTENDINGS
Ronald G. Blasberg, MD
Robert B. Darnell, MD, PhD
Kathleen M. Foley, MD
The Society of Memorial Sloan-Kettering Cancer Center Chair
Paul A. Glare, MBBS
Eric Holland, MD, PhD
Emily Tow Jackson Chair in Oncology
Gavril W. Pasternak, MD, PhD
Anne Burnett Tandy Chair of Neurology
Jerome B. Posner, MD
American Cancer Society Clinical Research Professor; George C. Cotzias Chair of Neuro-Oncology
Neal Rosen, MD, PhD
Enid A. Haupt Chair in Medical Oncology
Jonathan D. Victor, MD, PhD
ASSOCIATE ATTENDINGS
Alan C. Carver, MD
Xi Chen, MD, PhD
Denise D. Correa, PhD
Adrian Cristian, MD
Ying-Xian Pan, PhD
ASSISTANT ATTENDINGS
Edward K. Avila, DO
Christian M. Custodio, MD
Igor T. Gavrilovic, MD
Yvona Griffo, MD
Adilia M. V. Hormigo, MD, PhD
Thomas Kaley, MD
Yasmin Khakoo, MD
Erik J. Kobylarz, MD, PhD
Andrew B. Lassman, MD
Ingo K. Mellinghoff, MD
Natalie Moryl, MD
Craig P. Nolan, MD
Antonio M. P. Omuro, MD
Sonia K. Sandhu, DO
Jonas M. Sokolof, DO
Michael D. Stubblefield, MD
Roma Tickoo, MD, MPH
Kaleb H. Yohay, MD
INSTRUCTORS
Milan Chheda, MD
Kevin C. De Braganca, MD
DEPARTMENT OF NEUROLOGY
CHAIR AND ATTENDING
Philip H. Gutin, MD
Fred Lebow Chair in Neuro-Oncology
ATTENDINGS
Mark H. Bilsky, MD
Eric C. Holland, MD, PhD
Emily Tow Jackson Chair in Oncology
Samuel H. Selesnick, MD
Philip E. Stieg, MD, PhD
Lorenz P. Studer, MD
ASSOCIATE ATTENDINGS
Michael Kaplitt, MD, PhD
Mark M. Souweidane, MD
Viviane S. Tabar, MD
ASSISTANT ATTENDINGS
Cameron W. Brennan, MD
Jeffrey P. Greenfield, MD, PhD
DEPARTMENT OF NEUROSURGERY
54F MSKCC
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR AND ATTENDING
Richard J. O’Reilly, MD
Claire L. Tow Chair in Pediatric Oncology Research
ATTENDINGS
David H. Abramson, MD
Nai-Kong V. Cheung, MD, PhD
Enid A. Haupt Chair in Pediatric Oncology
Patricia J. Giardina, MD
Nancy A. Kernan, MD
Brian H. Kushner, MD
Michael P. La Quaglia, MD
Joseph H. Burchenal Chair in Pediatrics
Paul A. Meyers, MD
Kevin C. Oeffinger, MD
Michel Sadelain, MD, PhD
Stephen and Barbara Friedman Chair
Charles A. Sklar, MD
Laurel J. Steinherz, MD
Peter G. Steinherz, MD
ASSOCIATE ATTENDINGS
Farid Boulad, MD
James B. Bussel, MD
Ira J. Dunkel, MD
Bruce M. Greenwald, MD
Kim Kramer, MD
Shakeel Modak, MBBS
Trudy Nan Small, MD
Tanya M. Trippett, MD
Maria G. Vogiatzi, MD
Leonard H. Wexler, MD
ASSISTANT ATTENDINGS
Abraham Bartell, MD
Naomi B. Bishop, MD
Sheila J. Carroll, MD
Alexander Ja-Ho Chou, MD
Jennifer S. Ford, PhD
Aisha N. Hasan, MBBS
Joy D. Howell, MD
Deyin Doreen Hsing, MD
Rosandra N. Kaplan, MD
Yasmin Khakoo, MD
Martha C. Kutko, MD
David C. Lyden, MD, PhD
Steven Pon, MD
Christine A. Pratilas, MD
Susan E. Prockop, MD
Peter M. C. Savard, MD
Chani Traube, MD
Kaleb H. Yohay, MD
INSTRUCTORS
Ellen M. Basu, MD, PhD
Kevin C. De Braganca, MD
Stephen W. Gilheeney, MD
Julia A. Kearney, MD
Rachel Kobos, MD
Heather Magnan, MD
Pamela Merola, MD
Thomas M. Renaud, MD
Neerav Shukla, MD
DEPARTMENT OF PEDIATRICS
CHAIR AND ATTENDING
Boris C. Bastian, MD, PhD
James Ewing Alumni Chair of Pathology
ATTENDINGS
Klaus J. Busam, MD
Daniel A. Filippa, MD
Meera R. Hameed, MBBS
Suresh C. Jhanwar, PhD
David S. Klimstra, MD
Marc Ladanyi, MD
William J. Ruane Chair in Molecular Oncology
Victor E. Reuter, MD
Marc K. Rosenblum, MD
Founder’s Chair
Robert A. Soslow, MD
Satish K. Tickoo, MD
William D. Travis, MD
Maureen F. Zakowski, MD
ASSOCIATE ATTENDINGS
Cristina Antonescu, MD
Edi Brogi, MD, PhD
Emily Cheng, MD, PhD
Ronald A. Ghossein, MD
Dilip D. Giri, MD
Oscar Lin, MD
André L. Moreira, MD, PhD
Khedoudja Nafa, PhD
Jinru Shia, MD
Lee K. Tan, MD
Julie Teruya-Feldstein, MD
Christina E. Vallejo, MD
ASSISTANT ATTENDINGS
Hikmat A. Al-Ahmadie, MD
Maria E. Arcila, MD
Michael F. Berger, PhD
Yingbei Chen, MD, PhD
Adriana Dionigi Corben, MD
Marcia Edelweiss, MD
Samson W. Fine, MD
Karuna Garg, MBBS
Anuradha Gopalan, MBBS
Cyrus V. Hedvat, MD, PhD
Jason T. Huse, MD, PhD
Nora Katabi, MD
Melissa Murray, DO
Christopher Y. Park, MD, PhD
Kay J. Park, MD
Melissa P. Pulitzer, MD
Natasha Rekhtman, MD, PhD
Laura H. Tang, MD, PhD
Efsevia Vakiani, MD, PhD
Lu Wang, MD, PhD
Yong Hannah Wen, MD, PhD
Liying Zhang, MD, PhD
INSTRUCTORS
Deborah F. DeLair, MD
Carlie Selbo Sigel, MD
DEPARTMENT OF PATHOLOGY
MSKCC 54G2010 ANNUAL REPORT
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR AND ATTENDING
David W. Kissane, MBBS
Jimmie C. Holland Chair
ATTENDINGS
Timothy A. Ahles, PhD
Philip A. Bialer, MD
William S. Breitbart, MD
Francesca M. Gany, MD
Jimmie C. Holland, MD
Wayne E. Chapman Chair of Psychiatric Oncology
Marguerite S. Lederberg, MD
Mary Jane Massie, MD
Andrew J. Roth, MD
ASSOCIATE ATTENDINGS
Carma L. Bylund, PhD
Katherine N. DuHamel, PhD
Jennifer L. Hay, PhD
Jamie S. Ostroff, PhD
ASSISTANT ATTENDINGS
Abraham Aragones, MD
Thomas M. Atkinson, PhD
Abraham S. Bartell, MD
Smith Banerjee, PhD
Jack E. Burkhalter, PhD
Jeanne Carter, PhD
Jennifer S. Ford, PhD
Miriam M. Friedlander, MD
Jenifer C. F. Leng, MD
Tomer T. Levin, MBBS
Yuelin Li, PhD
Christian J. Nelson, PhD
James C. Root, PhD
Elizabeth L. Ryan, PhD
INSTRUCTORS
Julia A. Kearney, MD
Wendy G. Lichtenthal, PhD
Taia I. Zaider, PhD
DEPARTMENT OF PSYCHIATRY AND BEHAVIORAL SCIENCES
CHAIR AND ATTENDING
Simon N. Powell, MD, PhD
Enid A. Haupt Chair in Radiation Oncology
ATTENDINGS
David H. Abramson, MD
Adriana Haimovitz-Friedman, PhD
Gloria C. Li, PhD
Beryl McCormick, MD
Karen D. Schupak, MD
Joachim Yahalom, MD
Michael J. Zelefsky, MD
ASSOCIATE ATTENDINGS
Kaled M. Alektiar, MD
Daphna Y. Gelblum, MD
Nancy Lee, MD
Borys R. Mychalczak, MD
Suzanne L. Wolden, MD
Yoshiya Yamada, MD
ASSISTANT ATTENDINGS
Kathryn F. Beal, MD
Karen Borofsky, MD
Timothy A. Chan, MD, PhD
Brett Wayne Cox, MD
Pinaki R. Dutta, MD, PhD
Richard M. Gewanter, MD
Karyn A. Goodman, MD
Alice Yoosun Ho, MD
Marisa A. Kollmeier, MD
James E. Lee, MD
Boris Mueller, MD
Preeti K. Parhar, MD
Shyam S. D. Rao, MD, PhD
Melissa R. Remis, MD
Andreas Rimner, MD
Helen L. Sidebotham, MD
Abraham Jing-Ching Wu, MD
DEPARTMENT OF RADIATION ONCOLOGY
54H MSKCC
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR AND ATTENDING
Hedvig Hricak, MD, PhD
Carroll and Milton Petrie Chair
ATTENDINGS
Andrea F. Abramson, MD
Sara J. Abramson, MD
Ariadne M. Bach, MD
Michael S. Baum, MD
Ronald G. Blasberg, MD
Mark J. Bluth, MD
Karen T. Brown, MD
James F. Caravelli, MD
Jorge A. Carrasquillo, MD
Christopher E. Comstock, MD
D. David Dershaw, MD
Yuman Fong, MD
Murray F. Brennan Chair in Surgery
George I. Getrajdman, MD
Robert T. Heelan, MD
Andrei I. Holodny, MD
John L. Humm, PhD
Peter K. Kijewski, PhD
Jason A. Koutcher, MD, PhD
George Krol, MD
Steven M. Larson, MD
Donna and Benjamin M. Rosen Chair in Radiology
Carol H. Lee, MD
Jason S. Lewis, PhD
Laura Liberman, MD
Elizabeth A. Morris, MD
David M. Panicek, MD
Anita P. Friedman Price, MD
Stephen B. Solomon, MD
Richard M. Steingart, MD
H. William Strauss, MD
Jerrold B. Teitcher, MD
Pat B. Zanzonico, PhD
Robert D. Zimmerman, MD
ASSOCIATE ATTENDINGS
Linda R. Aboody, MD
Orguz Akin, MD
Douglas J. Ballon, PhD
Lynn A. Brody, MD
Betty A. Caravella, MD
Anne M. Covey, MD
Otilia-Liana Dumitrescu, MD
Arthur A. Fruauff, MD
Scott R. Gerst, MD
Michelle S. Ginsberg, MD
Marc J. Gollub, MD
Linda A. Heier, MD
Tunç A. Iyriboz, MD
Stefanie S. Jacobs, MD
Maxine S. Jochelson, MD
Karen B. Karlson, MD
Delia M. Keating, MD
Robert A. Lefkowitz, MD
Eric Lis, MD
Michael R. McDevitt, PhD
Sadek Nehmeh, PhD
Neeta Pandit-Taskar, MBBS
Harpreet K. Pannu, MD
Jurgen Rademaker, MD
Heiko Schöder, MD
Marc Z. Simmons, MD
Constantinos T. Sofocleous, MD, PhD
Hilda E. Stambuk, MD
Jean M. Torrisi, MD
Barbara Wajsbrot-Kandel, MD
Corinne B. Winston, MD
Kristen L. Zakian, PhD
Jingbo Zhang, MD
ASSISTANT ATTENDINGS
William Alago, Jr., MD
Michelle S. Bradbury, MD, PhD
Sandra Brennan, MB, BCh, BAO
Sean D. Carlin, PhD
Joshua L. Chaim, DO
Donna D. D’Alessio, MD
Amita Dave, PhD
Kinh Gian Do, MD, PhD
Mark Phillip S. Dunphy, DO
Joseph P. Erinjeri, MD, PhD
Kimberly N. Feigin, MD
Stephen E. Fleming, Jr., MD
Josef J. Fox, MD
James L. Fuqua III, MD
Athanasios P. Glekas, PhD
Ravinder K. Grewal, MD
Jan Grimm, MD, PhD
David H. Gultekin, PhD
Sofia S. Haque, MD
Valos Hatzoglou, MD
Mary C. Hughes, MD
Sinchun Hwang, MD
Sandra Joo, MD
Jennifer B. Kaplan, MD
Sasan Karimi, MD
Seth S. Katz, MD, PhD
Valencia King, MD
Moritz F. Kircher, MD
Yuliya Lakhman, MD
Jonathan Landa, DO
Duan Li, MD
John K. Lyo, MD
Weining Ma, MD
Majid Maybody, MD
Yousef Mazaheri, PhD
Svetlana Mironov, MD
Kyung Peck, PhD
Nagavarakishore Pillarsetty, PhD
Vladimir Ponomarev, MD, PhD
Elmer B. Santos, MD, PhD
Debra M. Sarasohn, MD
Rajesh Pravin Shah, MD
Robert Siegelbaum, MD
Janice S. Sung, MD
Sunitha Bai Thakur, PhD
Raymond H. Thornton, MD
Gary A. Ulaner, MD, PhD
Darren R. Veach, PhD
Robert J. Young, MD
DEPARTMENT OF RADIOLOGY
MSKCC 54I2010 ANNUAL REPORT
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR AND ATTENDING
Peter T. Scardino, MD
David H. Koch Chair
DIVISION HEAD AND ATTENDING
Ronald P. DeMatteo, MD
Division of General Surgical Oncology; Leslie H. Blumgart Chair in Surgery
ATTENDINGS
David H. Abramson, MD
Nadeem R. Abu-Rustum, MD
Manjit S. Bains, MD
Neil H. Bander, MD
Richard R. Barakat, MD
Ronald O. Perelman Chair in Gynecologic Surgery
Leslie H. Blumgart, MD
Bernard H. Bochner, MD
Patrick J. Boland, MD
Murray F. Brennan, MD
Benno C. Schmidt Chair in Clinical Oncology
Mercedes Castiel, MD
Dennis S. Chi, MD
Hiram S. Cody, III, MD
Daniel G. Coit, MD
Peter G. Cordeiro, MD
Guido Dalbagni, MD
Joseph J. Disa, MD
S. Machele Donat, MD
Robert J. Downey, MD
James A. Eastham, MD
Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology
Mahmoud El-Tamer, MD
Yuman Fong, MD
Murray F. Brennan Chair in Surgery
Harold P. Freeman, MD
José G. Guillem, MD
John H. Healey, MD
Harry W. Herr, MD
William J. Hoskins, MD
Joseph M. Huryn, DDS
William R. Jarnagin, MD
Enid A. Haupt Chair in Surgery
Maureen Killackey, MD
Dennis H. Kraus, MD
Michael P. La Quaglia, MD
Joseph H. Burchenal Chair in Pediatrics
Hans G. Lilja, MD
Monica Morrow, MD
Anne Burnett Windfohr Chair of Clinical Oncology
John P. Mulhall, MB, BCh, BAO
Raul O. Parra, MD
Philip B. Paty, MD
Valerie W. Rusch, MD
Miner Family Chair in Intrathoracic Cancers
Paul Russo, MD
Virgilio Sacchini, MD
Lisa M. Sclafani, MD
Jatin P. Shah, MD
Elliot W. Strong Chair in Head and Neck Oncology
Ashok R. Shaha, MD
Jatin P. Shah Chair in Head and Neck Surgery and Oncology
Joel Sheinfeld, MD
William G. Cahan Chair in Surgery
Samuel Singer, MD
Pramod C. Sogani, MD
Diane E. Stover, MD
Kimberly J. Van Zee, MD
E. Darracott Vaughan, MD
W. Douglas Wong, MD (deceased 1/20/2011)
ASSOCIATE ATTENDINGS
Peter J. Allen, MD
Edward A. Athanasian, MD
Oheneba Boachie-Adjei, MD
Jay O. Boyle, MD
Mary S. Brady, MD
Carol L. Brown, MD
Deborah M. Capko, MD
Michael D’Angelica, MD
Cherry L. Estilo, DMD
Mary L. Gemignani, MD
Henry G. Godfrey, MD
Deborah J. Goldfrank, MD
Alexandra S. Heerdt, MD
Murk-Hein Heinemann, MD
Noah Kauff, MD
Tari King, MD
Jeanne A. Petrek Junior Faculty Chair
Vincent Laudone, MD
Mario M. Leitao Jr., MD
Douglas A. Levine, MD
Ross T. Lyon, MD
Babak J. Mehrara, MD
Carol D. Morris, MD
Snehal G. Patel, MBBS
Sitaram Pillarisetty, MD
Andrea L. Pusic, MD
Glenn L. Schattman, MD
Bhuvanesh Singh, MD
Yukio Sonoda, MD
Vivian E. Strong, MD
Larissa K. F. Temple, MD
Martin R. Weiser, MD
Richard J. Wong, MD
ASSISTANT ATTENDINGS
Prasad S. Adusumilli, MBBS
Charlotte Eielson Ariyan, MD, PhD
George C. Bohle III, DDS
Jeanne Carter, PhD
Brett S. Carver, MD
Mohit Chawla, MD
Jonathan A. Coleman, MD
Aimee M. Crago, MD, PhD
David J. Finley, MD
Ian Ganly, MB, ChB, PhD
Ginger J. Gardner, MD
Leonard N. Girardi, MD
Allan D. Greenberg, DMD, PhD
Jerry L. Halpern, DDS
James Huang, MD
Elizabeth L. Jewell, MD
John Karwowski, MD
T. Peter Kingham, MD
John P. Lyden, MD
Charles A. Mack III, MD
Debra A. Mangino, DO
Brian P. Marr, MD
Evan Matros, MD
Colleen M. McCarthy, MD
Garrett M. Nash, MD
Nabil Rizk, MD
Jaspreet S. Sandhu, MD
Nitsana A. Spigland, MD
Inderpal Singh Sarkaria, MD
Karim A. Touijer, MD
Steven J. Tunick, DMD
Zhaoshi Zeng, MD, MPH
DEPARTMENT OF SURGERY
54J MSKCC
DEPARTMENTS OF MEMORIAL HOSPITAL
CHAIR AND ATTENDING
Charles L. Sawyers, MD
Marie-Josée and Henry R. Kravis Chair in Human Oncology and Pathogenesis; Howard Hughes Medical Institute Investigator
ATTENDINGS
Boris C. Bastian, MD, PhD
James Ewing Alumni Chair of Pathology
James A. Fagin, MD
Marc Ladanyi, MD
William J. Ruane Chair in Molecular Oncology
ASSOCIATE ATTENDING
Emily H. Cheng, MD, PhD
Adriana Heguy, PhD
James Hsieh, MD, PhD
ASSISTANT ATTENDINGS
Cameron Brennan, MD
Timothy A. Chan, MD, PhD
Ross L. Levine, MD
Geoffrey Beene Junior Faculty Chair
Ingo K. Mellinghoff, MD
Christopher Y. Park, MD, PhD
David B. Solit, MD
Elizabeth and Felix Rohatyn Chair for Junior Faculty
HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM
CHIEF NURSING OFFICER
Elizabeth Nelkin McCormick, RN
Enid A. Haupt Chair of Nursing
DIRECTORS
Gay Bailey, RN
Kevin P. Browne, RN
Michelle Burke, RN,
MaryAnn Connor, RN
Mary E. Dowling, RN
Dennis Graham, DNSc, ANP, RN
Nancy Kline, PhD, ANP, CPNP, RN
Josephine Nappi, RN
R. David Rice, PhD, AOCNP, RN
Donna Schick, RN
NURSE LEADERS, MANAGERS, CLINICAL COORDINATORS
Abigail Baldwin, RN
Patricia Brosnan, RN
Jacquelyn Burns, RN
Carole M. Cass, RN
Kristin Cawley, RN
Stacie Corcoran, RN
Karen Cullum, RN
Susan L. Dosil-Loiacono, RN
Mary M. Eagan, RN
Susan Filshie, RN
Jeanine Gordon, RN
Judy M. Graham, RN
Barbara G. Hennessey, RN
Nancy G. Houlihan, RN
Catherine Hydzik, RN
Matthew Kennedy, RN
Stephanie Kennedy, RN
Michele Kranz, RN
Viviane Leveille, RN
Catherine T. Licitra, RN
Sulin Low, RN
Suzanne V. Maier, CPNP, RN
Annmarie Mazzella-Ebstein, RN
Shelley W. McKay, RN
Lorraine K. McEvoy, RN
Patricia A. McTague-Allen, RN
Donna Miale-Mayer, RN
Altagracia I. Mota, RN
Maryellen O’Sullivan, RN
Diane Paolilli, RN
Elizabeth S. Rodriguez, RN
Jane A. Sallustro, RN
Rori Salvaggio, RN
Robert Schley, RN
Anna M. Schloms, RN
Rosemary O. Semler, RN
Lenore Smykowski, RN
Patricia Spellman, RN
Lystra M. Swift, RN
Blanca M. Vasquez-Clarfield, RN
Keri Jean Wagner, RN
Marianne Wallace, RN
Maribeth Wooldridge-King, RN
CLINICAL NURSE SUPERVISORS
Nancy M. Borzain, RN
Marie E. Cox, RN
Barbara K. Hutton, RN
Susan LaBombardi, RN
Christine E. Lantier, RN
Katleen Maher, RN
Esther M. Ruiz, RN
NURSE EDUCATORS
Gretchen A. Copeland, EdD, RN
Kristy Dunleavy, RN
Wendy Facey, RN
Lisa Kennedy, RN
Joan E. McKerrow, RN
Marjorie E. Mosley, RN
Janice R. Reid, RN
Beth Sferrazza, RN
Hrafn Oli Sigurdsson, RN
Shaneka D. Storey, RN
Inderani M. Walia, RN
CLINICAL NURSE SPECIALISTS
Jean Adelhardt, RN
Angela A. Adjetey, RN
Rose Ali, RN
Roberta H. Baron, RN
Lisa Bazos, RN
Beth Marie Boseski, RN
Gloria Coffey, RN
Suzanne Costello, RN
Maureen F. Cunningham, RN
Mary Elizabeth Davis, RN
Nkechi Fearon, RN
AnneMarie Flaherty, RN
Ruth Ford, RN
Michele L. Frank, RN
Elizabeth R. Grahn, RN
Cathyann M. Hanson-Heath, RN
Melanie Harold, RN
Sandra E. James, RN
Noelene A. Johnson, RN
Joyce E. Kane, RN
Nancy Karon, RN
Joanne F. Kelvin, RN
Janine Kennedy, RN
Mary Lakaszawski, RN
Ethel Beeling Law, RN
Beth Dee Licht, RN
Vashti Livingston, RN
Diane M. Llerandi, RN
Nora A. Love, RN
Nancy McEntee, RN
Kim Mertens, RN
Linda Muller, RN
Maureen G. O’Brien, RN
Wayne Alec Quashie, RN
Natasha Ramrup, RN
Debra Rodrigue, RN
Wanda Rodriguez, RN
Patricia Schaindlin, RN
Kathleen Short, RN
Joanne M. Taylor, RN
Elisabeth M. Wall, RN
Eileen M. Walsh, RN
Cecilia Watson, RN
Donna J. Wilson, RN
DEPARTMENT OF NURSING
MSKCC 54K2010 ANNUAL REPORT
DEPARTMENTS OF MEMORIAL HOSPITAL
NURSE PRACTITIONERS, NP COORDINATORS
Megan P. Abate, ANP, RN
Lynn Adams, ANP, RN
Linda Ahn, ANP, RN
Karen V. Allison, CPNP, RN
Lorraine E. Anderson, ANP, RN
Latasha Anderson-Dunkley, ANP, RN
Ramadevi Arcot, ANP, RN
Laurie Augello, AHNP,RN
Nadine Auguste, ACNP, RN
Jennifer Aviado-Langer, FNP, RN
Cheryl D. Barnes, FNP ,RN
Rana Bazzi, ACNP, RN
Alison Berkowitz, ANP, RN
Kimberly A. Berry, ANP, RN
Margaret H. Boelke, FNP, RN
Ayelet Brenner, NP, RN
Devika Brijlall, PNP, RN
Laurie Brusco, ANP, RN
Tara Buchholz, ACNP, RN
Bernice E. Burford, ANP, RN
Regina Byrne, ANP, RN
Maura E. Byrnes-Casey, CPNP, RN
Maureen Caban, ANP, RN
Joanne Lee Candela, ANP, RN
Lisa Canecchia, NP, RN
Maria Elena C. Cantos, ANP, ACNP, RN
Maryann Carousso, FNP, AOCNP, RN
Erin K. Carr, FNP, RN
Anne Regan Casson, CPNP, RN
Kristen Cavanaugh, NP, RN
Mei Ling Chan, NP, RN
Ewa Chauvin, ANP, RN
Cynthia Ciaschi, NP, RN
Laura Ciavolino, ANP, RN
Jennifer Ciminiello. ANP, RN
Keith A. Clement, ANP, RN
Twilight Cofield, ACNP, RN
Kimberly Colantuono, ANP, RN
Nancy Collado, ANP, RN
Mercedes M. Condy, ANP, RN
Erin Ann Conlon, FNP, RN
Catherine Copeland, ACNP, RN
Lenny Coraci, ANP, RN
Rosemarie Corless, CPNP, RN
Zana Correa, ANP, RN
Marissa Corti, ANP, RN
Alison Costalas, ACNP, RN
Margaret Courtney, AOCNP, RN
Nessa M. Coyle, ANP, RN
Joanne Cregg, ANP, RN
Catherine C. Cruz, ANP, RN
Bernadette M. Cuello, ANP, RN
Kristen M. Cullen, AOCNP, RN
Laryn M. Cullen, NP, RN
Rhonda D’Agostino, ACNP, RN
Rebecca G. D’Amore, CPNP, RN
Linda D’Andrea, PNP, RN
Ester C. Dantis, PNP, RN
Dorothea A. Dashiell, CPNP, RN
Denise Dasti, ANP, RN
Deeann M. Davidson, ACNP, RN
Anthony De La Cruz, ANP, RN
Jenny Delaleu, FNP, RN
Susan Derby, GNP, RN
Amy Rose Devigne, FNP, RN
Kleoniki Diamantis, FNP, RN
Deborah Diotallevi, CPNP, RN
Stephanie Dlugacz, ACNP, RN
Maria Donzelli, CPNP, RN
Melissa P. Doyle, CPNP, RN
Lauren Drysdale, ANP, RN
Jane M. Duffy-Weisser, ANP, RN
Megan Dunne, ANP, RN
Christina Durney, CPNP, RN
Nancy E. Edmonds, ANP, RN
Carlene Edwards, FNP, RN
Catherine Ellenberger, ANP, RN
Glenda Espinosa, ANP, RN
Julie Ewy, CPNP, RN
Catherine Ann Featherstone, FNP, RN
Zulay E. Fernandez, ANP, RN
Christine Ferrari, ANP, RN
Cheryl M. Fischer, CPNP, RN
Cristy B. Fitzpatrick, ANP, RN
Deborah A. Fleischer, ACNP, RN
Idania Flete-Olmeda, ANP, RN
Jennifer A. Flood, ANP, RN
Karen A. Flynn, ACNP, RN
Anjelina M. Forbes, CPNP, RN
Crystal Freise, NP, RN
Erin Fusco, FNP, RN
Patricia Gabriel, ANP, RN
Ruth Gargan-Klinger, ANP, RN
Alison Gilgan, FNP, RN
Maryanne M. Giuliante, ANP, RN
Winsome L. Grant, WHCNP, RN
Randolph E. Gross, WHCNP, RN
Michelle Hall, ANP, RN
Elizabeth F. Halton, ANP, RN
Joan M. Hartnett, ANP, RN
Kate Healy, ACNP, RN
Courtney E. Hennelly, FNP, RN
Evlyn L. Hinds, FNP, RN
Maria Hinton, ANP, RN
Ashley Hole, FNP, RN
Karen E. Holritz, ANP, RN
Mi Young Hong, NP, RN
Aletha R. Huckins, FNP, RN
Solange D. Inglis, ANP, RN
Christine Scura Iovino, FNP, RN
Lorraine Jackson, ACNP, RN
Mindy Jaffe, CPNP, RN
Laura A. James, ANP, RN
Jeanine Jerro-Doody, ANP, RN
Latisha A. Jones, ANP, RN
Stacey L. Kaufman, ANP, RN
Sheila Keaveney, ANP, RN
Kathleen J. Keenan, ANP, RN
Elizabeth Kelliher, ANP, GNP, RN
Paulette M. Kelly, FNP, RN
Sheila A. Kenny, FNP, RN
Denise M. Kessel, ANP, RN
Karen Kestenbaum, ANP, RN
Kathleen Kilroy, NP, RN
Jean M. Korycki, CPNP, RN
Nicole Kowalewski, NP, RN
David R. Kraft, ANP, RN
Lauren Kushner, PNP, RN
Kenny M. Lacossiere, ANP, RN
Liza Lee Lagdamen, NP, RN
Patricia Lakin, WHCNP, RN
Mary Layman-Goldstein, ANP, RN
Alexis Leitenberger, NP, RN
Angela Lentini-Rivera, CPNP, RN
Nicole R. Leonhart, ANP, RN
Nicole LeStrange, ANP, RN
Erica G. Levinson, ANP, RN
Isobel M. Lewis, FNP, RN
Christine A. Liebertz, ANP, RN
Yi-Chih Lin, CPNP, RN
Camille L. Lineberry, ACNP, RN
Chhiu-Mei Liu, ANP, RN
Marie-Helene Lofland, ANP, RN
Amy E. Logue, GNP, RN
Helen M. Loumeau, ANP, RN
Andria D. Lyn, ACNP, RN
Peggy Lynch, ANP, RN
Noelia Maamouri, ACNP, RN
Kelly M. Magee, FNP, RN
Jibran Majeed, NP, RN
Jennifer L. Maloney, NP, RN
Melissa A. Manning, ACNP, RN
Denise Margiotta, NP, RN
Marie Kathlyn Marte, ANP, RN
Andrea Martelli, FNP, RN
Leslie V. Matthews, ANP, RN
Shirley Mauzoul, ANP, RN
Susan McCall, NP, RN
Emily J. McCullagh, FNP, RN
Christine McGrade, ANP, RN
Kateri McGuire, CPNP, RN
Julie Ellen Mcmahon, CPNP, RN
Julianne McNamara, FNP, RN
Margaret McSweeney, ACNP, RN
Carol Ann Milazzo-Kiedaisch, FNP, RN
Aida Milcetic, FNP, RN
Mary Montefusco, ACNP, RN
Joanna J. Moulton, CPNP, RN
Kara Ann Muhr, ANP, RN
Yvette Murillo, FNP, RN
Eibhlis Murray, FNP, RN
Joseph B. Narus, GNP, RN
Rachel O. Nebab, ACNP, RN
Katherine G. O’Connor, ANP, RN
MaryAnn P. O’Connor, FNP, RN
Shannon O’Keefe, NP, RN
Marykate O’Rourke, ACNP, RN
Kristen Ohagan, ANP, APRN, RN
Robert U. Okolie, NP, RN
Claudia M. Ortiz, WHNP, RN
Rosemary Ortiz, FNP, RN
Maria Pacis, ANP, RN
Brima Padlan, ANP, RN
Meighan Palazzo, NP, RN
Lauren Panico, NP, RN
Alichia L. Paton, ACNP, RN
Purnima Persaud, NP, RN
Mary C. Petriccione, CPNP, RN
Sandra D. Pezzulli, AOCNP, RN
Bobbi Pino-y-Torres, ANP, RN
Mary Plakovic, FNP, RN
Joan M. Pope, ANP, RN
Paula Portelli, NP, RN
Elaine M. Pottenger, CPNP, RN
Nana Prempeh-Kete Ku, ANP, RN
Erin Punturieri, ANP, RN
Avery Putterman, CPNP, RN
Hilda Quintanilla, ANP, AOCNP, RN
Robin Rawlins-Duell, ANP, RN
Sarah Rebal, NP, RN
Tara A. Reilly, ACNP, RN
Rebecca W. Repetti, ANP, RN
54L MSKCC
DEPARTMENTS OF MEMORIAL HOSPITAL
Martha Rodriguez, ANP, RN
Carol Rossetto, CPNP, RN
Rose Ann Ruddy, ACNP, RN
Mary Rudzewick, ANP, RN
Julianne Ruggiero, CPNP, RN
Tara Russo, FNP, RN
Erin Ryan, NP, RN
Lina Saab, FNP, RN
Joseph Santarpia, NP, RN
Anita Schabel, FNP, RN
Mary A. Schoen, ANP, RN
Sharlene Seecharran, ANP, RN
Jody Selzer, FNP, RN
Yelena Shames, ACNP, RN
Rosanne Sharp, ANP, RN
Caroline Shirzadi, NP, RN
Ana Sjoberg, ANP, RN
Zeta Smikle-Hamilton, ANP, RN
Tammy Son, ACNP, RN
Celeste M. Springer, ANP, RN
Rebecca Steed, WHCNP, RN
Christine Stefanski, FNP, RN
Deborah E. Stein, NP, RN
Rebecca Sturm, NP, RN
Dyana K. Sumner, CRNP, RN
Miho Suzuki, NP, RN
Yekaterina D. Tayban, ACNP, RN
Jennifer Tempesta, NP, RN
Janice Terlizzi, NP, RN
Ursula McPeak Tomlinson, CPNP, RN
Joanne E. Torok-Castanza, CPNP, RN
Kathleen A. Trotta, ANP, RN
Roseann Tucci, CPNP, RN
Leslie Tyson, ANP, RN
Jennifer Valdellon, NP, RN
Jill M. Vanak, ACNP, RN
Nelly Vega-Woo, NP, RN
Stephanie Vitolano, CPNP, RN
Kelly Vuksanaj, ANP, RN
Emily R. Walsh, FNP, RN
Christine D. Waters-Clayton, FNP, RN
Richard Weiner, ANP, RN
Joanne M. Wells, ANP, RN
Elizabeth H. Whittam, FNP, RN
Kerry Williams, ANP, RN
Gloria Y. Wong, ACNP, RN
Christina M. Wray-Asaro, ACNP, RN
Fengxin Wu, ACNP, RN
Jane Yoffe, FNP, RN
Joanna Yohannes-Tomicich, NP, RN
Heidi M. Yulico, GNP, RN
Nicole Zakak, CPNP, RN
Joan M. Zatcky, ACNP, RN
Rebecca Zeuren, ANP, RN
DIRECTOR
Charles D. Lucarelli, RPh
ASSOCIATE DIRECTORS
Stella Lee Eng, RPh
Scott Freeswick, RPh
Raymond J. Muller, RPh
Priti Patel, RPh
SUPERVISORS
Jerry Chow, RPh
Jacqueline Gomes, RPh
Susan Murillo, RPh
Donald Murphy, RPh
Gerald O’Neill, RPh
Marie Ryan, RPh
Faina Shenderov, RPh
Dolores Sleiman, RPh
John Timoney, RPh
Jodi Wald, RPh
Elaine Yam, RPh
Karen Yeung, RPh
CLINICAL MANAGERS
Nelly Adel, RPh
David Gregornik, RPh
CLINICAL COORDINATORS
Stern Bereth, RPh
Manpreet Boparai, RPh
Amelia Chan, RPh
Florina Chuy, RPh
Douglas Deritis, RPh
Joseph Galgano, RPh
Dennis Grossano, RPh
Peter Ho, RPh
Ellie Kashani-Massoumi, RPh
Michael Kellick, RPh
Mark Klang, RPh
Caroline Lau, RPh
Melissa Lee-Teh, RPh
Diane Leone, RPh
Donna McGuffy, RPh
Vivian Park, RPh
Barbara Simon, RPh
Pofan Sin, RPh
Gregory Stelzer, RPh
James Sumka, RPh
Frank Surita, RPh
Edward Tyler, RPh
Frank Zappa, RPh
Anthony Zinga, RPh
CLINICAL SPECIALISTS
Nina Cohen, RPh
Stephen Harnicar, RPh
Sherry Mathew, RPh
Jeanna Miller, RPh
Russell Moore, RPh
Alia Paskovaty, RPh
Melissa Pozotrigo, RPh
Richard Tizon, RPh
Bhatt Valkal, RPh
Daniel Van Meter, RPh
DIVISION OF PHARMACY SERVICES
DIRECTOR
Jane Bowling, DSW, LCSW
SOCIAL WORK SENIOR STAFF
Diane Iannuzzi, LCSW
Rosalind Kleban, LCSW
Anne Martin, PhD, LCSW
POST-TREATMENT RESOURCE PROGRAM
Penny Damaskos, LCSW
DIVISION OF SOCIAL WORK
MSKCC 54M2010 ANNUAL REPORT
PROGRAMS OF THE SLOAN-KETTERING INSTITUTE
DIRECTOR
Thomas J. Kelly, MD, PhD
Benno C. Schmidt Chair of Cancer Research
James P. Allison, PhD
Kathryn V. Anderson, PhD
Eric M. Cottington, PhD
John R. Gunn
Alan Hall, PhD
Kenneth J. Marians, PhD
Joan Massagué, PhD
Nikola P. Pavletich, PhD
Chris Sander, PhD
David A. Scheinberg, MD, PhD
Craig B. Thompson, MD (ex officio)
STEERING COMMITTEE
CHAIR AND MEMBER
Joan Massagué, PhD
Alfred P. Sloan Chair; Howard Hughes Medical Institute Investigator
MEMBERS
Robert Benezra, PhD
Eric C. Holland, MD, PhD
Emily Tow Jackson Chair in Oncology
Craig B. Thompson, MD
ASSOCIATE MEMBER
Johanna A. Joyce, PhD
Geoffrey Beene Junior Faculty Chair
ASSISTANT MEMBERS
Robert J. Klein, PhD
Christine Mayr, MD, PhD
Andrea Ventura, MD, PhD
Geoffrey Beene Junior Faculty Chair
Hans G. Wendel, MD
Professional Support Staff
LABORATORY MEMBERS
Neil S. Lipman, VMD
Felix R. Wolf, DVM, PhD
ASSOCIATE LABORATORY MEMBERS
Linda K. Johnson, DVM
Andrew C. Nicholson, DVM, PhD
ASSISTANT LABORATORY MEMBERS
Paula Paula C. Ezell, DVM
Christine Lieggi, DVM
Sebastien Monette, DVM
Rodolfo J. Ricart-Arbona, DVM
JOINT APPOINTMENT
Kenneth Offit, MD
CANCER BIOLOGY AND GENETICS PROGRAM
CHAIR AND MEMBER
Alan Hall, PhD
Alfred P. Sloan Chair
MEMBERS
Raju S.K. Chaganti, PhD
William E. Snee Chair
Filippo G. Giancotti, MD, PhD
Paul A. Marks, MD
Malcolm A. S. Moore, DPhil
Enid A. Haupt Chair of Cell Biology
Marilyn D. Resh, PhD
Urs Rutishauser, PhD
ASSOCIATE MEMBER
Xuejun Jiang, PhD
ASSISTANT MEMBERS
Cole M. Haynes, PhD
Jidong Liu, PhD
Philipp M. Niethammer, PhD
Michael H. Overholtzer, PhD
Meng-Fu Bryan Tsou, PhD
Professional Support Staff
ASSOCIATE LABORATORY MEMBER
Margaret A. Leversha, PhD
At The Rockefeller University
ASSISTANT MEMBER (AFFILIATE)
Hironori Funabiki, PhD
At Weill Cornell Medical College
MEMBER (AFFILIATE)
Timothy A. Ryan, PhD
CELL BIOLOGY PROGRAM
CHAIR AND MEMBER
Chris Sander, PhD
Tri-Institutional Professor
ASSISTANT MEMBERS
Gregoire Altan-Bonnet, PhD
Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair
Christina S. Leslie, PhD
Joao de Bivar Xavier, PhD
Professional Support Staff
LABORATORY MEMBER
Alex E. Lash, MD
ASSOCIATE LABORATORY MEMBERS
Nicholas D. Socci, PhD
ASSISTANT LABORATORY MEMBERS
Raya Khanin, PhD
At Weill Cornell Medical College
MEMBER (AFFILIATE)
Harel Weinstein, DSc
COMPUTATIONAL BIOLOGY PROGRAM
54N MSKCC
PROGRAMS OF THE SLOAN-KETTERING INSTITUTE
CHAIR AND MEMBER
Kathryn V. Anderson, PhD
Enid A. Haupt Chair in Developmental Biology
MEMBERS
Mary K. Baylies, PhD
Peter Besmer, PhD
Maria Jasin, PhD
William E. Snee Chair
Alexandra L. Joyner, PhD
Courtney Steel Chair in Pediatric Cancer Research
Elizabeth H. Lacy, PhD
Lorenz P. Studer, MD
ASSOCIATE MEMBERS
Anna-Katerina Hadjantonakis, PhD
Eric C. Lai, PhD
Jennifer A. Zallen, PhD
Howard Hughes Medical Institute Early Career Scientist
ASSISTANT MEMBERS
Zhirong Bao, PhD
Mary G. Goll, PhD
Danwie Huangfu, PhD
Julia A. Kaltschmidt, PhD
Song-Hai Shi, PhD
Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chair
Professional Support Staff
LABORATORY MEMBERS
Katia O. Manova-Todorova, PhD
Willie H. Mark, PhD
ASSISTANT LABORATORY MEMBER
Mark J. Tomishima, PhD
Frank A. Howard Scholar
Nicholas Tolwinski, PhD
DEVELOPMENTAL BIOLOGY PROGRAM
CHAIR AND MEMBER
James P. Allison, PhD
David H. Koch Chair in Immunologic Studies; Howard Hughes Medical Institute Investigator
MEMBERS
Bo Dupont, MD, DSc
Michael S. Glickman, MD
Ulrich G. Hämmerling, PhD
Alan N. Houghton, MD
Virginia and Daniel K. Ludwig Clinical Chair
Herbert F. Oettgen, MD
Lloyd J. Old, MD
William E. Snee Chair of Cancer Immunology; Director, New York Branch, Ludwig Institute for Cancer Research
Richard J. O’Reilly, MD
Claire L. Tow Chair in Pediatric Oncology Research
Eric G. Pamer, MD
Enid A. Haupt Chair in Clinical Investigation
Alexander Y. Rudensky, PhD
Marcel R. M. van den Brink, MD, PhD
Alan N. Houghton Chair
ASSOCIATE MEMBERS
Lisa K. Denzin, PhD
Derek B. Sant’Angelo, PhD
ASSISTANT MEMBERS
Jayanta Chaudhuri, PhD
Frederick R. Adler Chair for Junior Faculty
Morgan Huse, PhD
Ming Li, PhD
Joseph C. Sun, PhD
Professional Support Staff
LABORATORY MEMBER
Tulia Lindsten, MD, PhD
ASSOCIATE LABORATORY MEMBERS
P. Jan Hendrikx, PhD
Frances Weis-Garcia, PhD
ASSISTANT LABORATORY MEMBERS
Annamalai Selvakumar, PhD
Jianda Yuan, MD, PhD
Joint Appointments
Ronald P. DeMatteo, MD
Leslie H. Blumgart Chair in Surgery
Katharine C. Hsu, MD, PhD
Jedd D. Wolchok, MD, PhD
James W. Young, MD
IMMUNOLOGY PROGRAM
CHAIR AND MEMBER
Kenneth J. Marians, PhD
William E. Snee Chair
MEMBERS
Jerard Hurwitz, PhD
Scott N. Keeney, PhD
Howard Hughes Medical Institute Investigator
Thomas J. Kelly, MD, PhD
Benno C. Schmidt Chair of Cancer Research
Andrew Koff, PhD
John H. J. Petrini, PhD
Paul A. Marks Chair in Molecular Cell Biology
Mark S. Ptashne, PhD
Virginia and Daniel K. Ludwig Chair
Stewart Shuman, MD, PhD
Simon H. Rifkind Chair
Paul Tempst, PhD
ASSOCIATE MEMBER
Prasad V. Jallepalli, MD, PhD
ASSISTANT MEMBERS
Dirk Remus, PhD
Iestyn Whitehouse, PhD
Xiaolan Zhao, PhD
Professional Support Staff
LABORATORY MEMBERS
Hediye Erdjument Bromage, PhD
Agnès Viale, PhD
ASSOCIATE LABORATORY MEMBER
Ricardo Toledo-Crow, PhD
ASSISTANT LABORATORY MEMBER
Mariana M. Yaneva, PhD
At The Rockefeller University
MEMBER (AFFILIATE)
C. David Allis, PhD
Joint Appointment
Simon N. Powell, MD, PhD
Enid A. Haupt Chair in Radiation Oncology
MOLECULAR BIOLOGY PROGRAM
MSKCC 54O2010 ANNUAL REPORT
PROGRAMS OF THE SLOAN-KETTERING INSTITUTE
CHAIR AND MEMBER
David A. Scheinberg, MD, PhD
Vincent Astor Chair
MEMBERS
Colin B. Begg, PhD
Eugene W. Kettering Chair
Ronald G. Blasberg, MD
Murray F. Brennan, MD
Benno C. Schmidt Chair in Clinical Oncology
Bayard D. Clarkson, MD
Enid A. Haupt Chair of Therapeutic Research
Samuel J. Danishefsky, PhD
Eugene W. Kettering Chair
Zvi Fuks, MD
Alfred P. Sloan Chair
David Y. Gin, PhD (deceased 3/21/2011)
Hedvig Hricak, MD, PhD
Carroll and Milton Petrie Chair
Richard N. Kolesnick, MD
Steven M. Larson, MD
Donna and Benjamin M. Rosen Chair in Radiology
C. Clifton Ling, PhD
Stephen D. Nimer, MD
Alfred P. Sloan Chair
Gavril W. Pasternak, MD, PhD
Anne Burnett Tandy Chair of Neurology
Jerome B. Posner, MD
American Cancer Society Clinical Research Professor; George C. Cotzias Chair of Neuro-Oncology
Neal Rosen, MD, PhD
Enid A. Haupt Chair in Medical Oncology
Michel Sadelain, MD, PhD
Stephen and Barbara Friedman Chair
Peter T. Scardino, MD
David H. Koch Chair
ASSOCIATE MEMBERS
Yueming Li, PhD
Derek S. Tan, PhD
ASSISTANT MEMBERS
Luca Cartegni, PhD
Gabriela Chiosis, PhD
Jan Grimm, MD, PhD
Minkui Luo, PhD
Professional Support Staff
LABORATORY MEMBERS
Ting-Chao Chou, PhD
Hakim Djaballah, PhD
Isabelle Rivière, PhD
ASSOCIATE LABORATORY MEMBERS
Elisa de Stanchina, PhD
Ouathek Ouerfelli, PhD
George D. Sukenick, PhD
Nian Wu, PhD
ASSISTANT LABORATORY MEMBERS
Christophe Antczak, PhD
Ying-Xian Pan, PhD
Maria K. Spassova, PhD
At Cornell University
ASSISTANT MEMBER (AFFILIATE)
Hening Lin, PhD
At The Rockefeller University
ASSISTANT MEMBER (AFFILIATE)
Sean Brady, PhD
Joint Appointments
Renier J. Brentjens, MD, PhD
Jason A. Koutcher, MD, PhD
Jason S. Lewis, PhD
MOLECULAR PHARMACOLOGY AND CHEMISTRY PROGRAM
CHAIR AND MEMBER
Nikola P. Pavletich, PhD
Stephen and Barbara Friedman Chair; Howard Hughes Medical Institute Investigator
MEMBERS
Jonathan D. Goldberg, PhD
Stephen and Barbara Friedman Chair; Howard Hughes Medical Institute Investigator
Christopher D. Lima, PhD
Dimitar B. Nikolov, PhD
Dinshaw Patel, PhD
Abby Rockefeller Mauzé Chair of Experimental Therapeutics
ASSISTANT MEMBERS
Stephen B. Long, PhD
Alexandros Pertsinidis, PhD
Professional Support Staff
ASSOCIATE LABORATORY MEMBERS
Yehuda Goldgur, PhD
David M. Zuckerman, BSEE
STRUCTURAL BIOLOGY PROGRAM
54P MSKCC
MEMBERS EMERITIMEMORIAL SLOAN-KETTERING CANCER CENTER
Lowell L. Anderson, PhD
Donald Armstrong, MD
June L. Biedler, PhD
Ronald A. Castellino, MD
E. Eugene Covington, MD
Thomas J. Fahey, Jr, MD
Joseph H. Galicich, Jr., MD
Robert B. Golbey, MD
Susan E. Krown, MD
Walter B. Jones, MD
John L. Lewis, Jr., MD
Philip H. Lieberman, MD
Kenneth O. Lloyd, PhD
Klaus Mayer, MD
Myron R. Melamed, MD
W. P. Laird Myers, MD
Manuel Ochoa Jr., MD
Stuart H. Q. Quan, MD
Richard A. Rifkind, MD
Lawrence N. Rothenberg, PhD
F. Kingsley Sanders, DPhil
Morton K. Schwartz, PhD
Maurice E. Shils, MD, ScD
Francis M. Sirotnak, PhD
Martin Sonenberg, MD, PhD
Maus W. Stearns, MD
Stephen S. Sternberg, MD
C. Chester Stock, PhD
Elliot W. Strong, MD
Osias Stutman, MD
Alan D. Turnbull, MD
Norma Wollner, MD
James M. Woodruff, MD
Samuel D. J. Yeh, MD, ScD
MSKCC 552010 ANNUAL REPORT
LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES MEMORIAL SLOAN-KETTERING CANCER CENTER
SLOAN-KETTERING DIVISIONWEILL CORNELL GRADUATE SCHOOL OF MEDICAL SCIENCES
Chairman of the BoardLouis V. Gerstner, Jr.
President Craig B. Thompson, MD
Provost Thomas J. Kelly, MD, PhD
Treasurer John R. Gunn
DeanKenneth J. Marians, PhD
Assistant TreasurerMichael P. Gutnick
Secretary Carolyn Bonheur (through April 2011)
Trustees Richard I. BeattieRichard N. FosterStephen Friedman Ellen V. Futter
Louis V. Gerstner, Jr.Jonathan N. GrayerDavid H. KochHutham S. Olayan
Benjamin M. RosenNorman C. SelbyCraig B. Thompson, MDDouglas A. Warner III
DirectorThomas J. Kelly, MD, PhD
Director, Graduate StudiesKenneth J. Marians, PhD
Graduate ProgramCo-Chairs
Biochemistry and Structural Biology Unit Nikola P. Pavletich, PhD
Molecular Biology UnitStewart Shuman, MD, PhD
Cell Biology and Genetics UnitAlan Hall, PhD
Pharmacology UnitDavid A. Scheinberg, MD, PhD
Immunology and Microbial Pathogenesis UnitJames P. Allison, PhD
56 MSKCC
For the second year in a row, the Center received more than one million gifts, with the total of 1,022,400 donations in 2010 marking an all-time high. Reflecting the ongoing generosity of its supporters, Memorial Sloan-Kettering recorded $208,719,583 in cash receipts during the course of the year. And, at a time when the Center underwent a transition in leadership that culminated in the appointment of Craig B. Thompson as President and CEO, the Campaign benefited enormously from the steady guidance of its co-chairs, Douglas A. Warner III and Louis V. Gerstner, Jr.
Of the many gifts received during the year, the following exemplified the commit-ment to making a difference that is shared by all Memorial Sloan-Kettering’s donors:
• A contribution of $5 million from the Peserga International Foundation will provide timely support for advanced research into cancer.
• Charlotte and William E. Ford III made a commitment of $5 million to create the Theresa Feng Initiative in the Brain Tumor Center, including the endowment
of the Theresa Feng Professorship in Neurosurgery.
• The Commonwealth Foundation for Cancer Research is providing an addi-tional $5 million on behalf of Alice and William H. Goodwin, Jr., to support special initiatives in the Experimental Therapeutics Center. The gift brings the Foundation’s total giving for the ETC to $45 million.
• A gift of more than $3.5 million from the Trust of Philip R. Mallory is being used to establish The Mildred Courtney Mallory Fund for Cancer Research.
• New contributions totaling $3.5 million from Board member David H. Koch bring his total giving during the Campaign to more than $52 million. Among the initiatives established through his support are the David H. Koch Center for the Immunologic Control of Cancer and the David H. Koch Chair.
Memorial Sloan-Kettering also benefited enormously from the dedication of volun-teers who took part in athletic events and community fundraising activities to support
innovation in research and treatment. On November 7, the 2010 ING New York City Marathon brought out thousands of athletes, including 725 who ran on behalf of the Center as members of Fred’s Team. Through their participation in that marathon and other events during the course of the year, Fred’s Team members generated $4.5 million for an array of research initiatives — the highest one-year total in the history of the program.
Some 4,500 people participated in the most recent Cycle for Survival indoor cycling events, raising a total of $4.6 million to support research into rare cancers at Memorial Sloan-Kettering. Since its founding in 2007, Cycle for Survival has grown to include high-profile gatherings in New York City and Chicago, and on Long Island, with satellite teams joining in from as far away as London and Hong Kong.
At every level of support, the generosity shown by Memorial Sloan-Kettering’s bene-factors serves to fuel the latest advances in understanding and treating cancer. Their gifts, both large and small, offer a source of immedi-ate encouragement while laying the groundwork for even greater progress in years to come.
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
(Top) Emily Dodd and Peggy Conlon run the ING New York City Marathon with Fred’s Team
(Bottom) A New York City Cycle for Survival event
The Campaign for Memorial Sloan-Kettering continued to make steady progress in 2010, with gifts and pledges as of December 31 totaling more than $2.224 billion.
MSKCC 56A2010 ANNUAL REPORT
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
$100,000,000 or More
The Estate of Geoffrey Beene
Mortimer B. Zuckerman
$50,000,000 — $99,999,999
David H. Koch
The Leonard and Evelyn Lauder Foundation
Virginia and D. K. Ludwig Fund for Cancer Research
The Starr Foundation
$25,000,000 — $49,999,999
The Atlantic Philanthropies
Mr. and Mrs. Jack Byrne
The Louis V. Gerstner, Jr. Foundation, Inc.
Mr. and Mrs. William H. Goodwin, Jr., and the Commonwealth Foundation for Cancer Research
The Sidney Kimmel Foundation
The Tow Foundation
$20,000,000 — $24,999,999
Anonymous
Stanley F. and Fiona Druckenmiller
$10,000,000 — $19,999,999
Trust of Burton Abrams
The Elmer and Mamdouha Bobst Foundation
The Breast Cancer Research Foundation
The Stephen and Barbara Friedman Foundation
The Arnold and Arlene Goldstein Family Foundation
The Donald B. and Catherine C. Marron Foundation
Prostate Cancer Foundation
Robertson Foundation
Laurance S. Rockefeller
Robert F. X. Sillerman and Laura Baudo Sillerman through their Tomorrow Foundation
The Simons Foundation
Mr. and Mrs. Douglas A. Warner III
$5,000,000 — $9,999,999
Anonymous
Bristol-Myers Squibb Company
The Carson Family Charitable Trust
The Steven A. and Alexandra M. Cohen Foundation, Inc.
Charlotte and Bill Ford III
Mr. and Mrs. Frederic B. Garonzik
Mr. and Mrs. Philip H. Geier, Jr.
Alan and Sandra Gerry
Estate of Sherlock Hibbs
The Robert J. Kleberg, Jr., and Helen C. Kleberg Foundation
Trust of L. H. P. Klotz
John W. Kluge
The Lebensfeld Foundation
Estate of Tse Kyung Lee
Martin S. and Sheila Major and Family
The Robert and Kate Niehaus Foundation
Peserga International Foundation
Mr. and Mrs. John S. Reed
Laurance S. Rockefeller Fund
Dorothy Rose and Dr. Milton Rose
Donna and Benjamin Rosen
Allan H. Selig
The Peter Jay Sharp Foundation
Mr. and Mrs. Richard Siegal
The Society of MSKCC Thrift Shop
Estate of Margaret McCormack Sokol
The William and Lynda Steere Foundation
Stop & Shop Supermarket Company, Inc.
UBS
Sue and Edgar Wachenheim III
Michael A. and Zena Wiener
$2,500,000 — $4,999,999
Anonymous
Mr. and Mrs. Bruce Adam
The Allbritton Foundation
Bethany Allen
Lance Armstrong Foundation
Estate of Eleanor Backer
Band of Parents Foundation
The Arthur & Rochelle Belfer Foundation
Estate of Lillian R. Berkman
The James E. and Diane W. Burke Foundation, Inc.
Mrs. D. Wayne Calloway
Iris and B. Gerald Cantor Foundation
The Kristen Ann Carr Fund
James D. Carter
The Irma L. and Abram S. Croll Charitable Trust
Estate of Elizabeth M. Frelinghuysen
Estate of Francis Gonzalez
Mr. and Mrs. Jonathan N. Grayer
William Randolph Hearst Foundations
Estate of Irma A. Howard
ICAP
W. M. Keck Foundation
Estate of Martin C. Kessler
F. M. Kirby Foundation, Inc.
Susan G. Komen for the Cure
Henry and Marie-Josée Kravis
The Lymphoma Foundation
The Leon Lowenstein Foundation, Inc., and Robert and John Bendheim
Trust of Philip R. Mallory
The T. J. Martell Foundation for Leukemia, Cancer and AIDS Research
Estate of Charles J. Mauro
The Abby R. Mauzé Charitable Trust
Melanoma Research Alliance Foundation
Florence Miner
Gloria Miner
The Naddisy Foundation
The Samuel I. Newhouse Foundation
Ronald O. Perelman
Estate of Catherine R. Price
Frederick Henry Prince Memorial Fund
Bruce C. Ratner
The Robbins Family Foundation
Estate of Marilyn L. Schaefer
Estate of Grace A. Shapro
The Joachim Silbermann Family
Paul E. Singer
Joan and Joel Smilow
Stand Up to Cancer
Swim Across America, Inc.
The Joseph and Arlene Taub Foundation
Trust of Jane Toplitt
Margaretta J. Taylor
TOSA Foundation
$1,000,000 — $2,499,999
Anonymous
Mr. and Mrs. Andrew B. Abramson
Mr. and Mrs. Frederick R. Adler
Mr. and Mrs. Fred M. Alger III
Alliance for Cancer Gene Therapy
Stephen and Madeline Anbinder
John M. Angelo and Judy Hart Angelo
The Award of Courage Corporation
The Batishwa Fellowship
Trust of Edgar D. Baumgartner
Estate of Mary Ann Benjamin
Mr. and Mrs. Daniel C. Benton
Allen and Joan Bildner
The Anita and Leonard Boxer Family Foundation
Breast Cancer Alliance, Inc.
Estate of Helen Brown
Trust of Emil A. Buelens
Estate of Diane B. Burkhart
Estate of Nizza Burstyn
The Burnett Foundation
Cancer Research Institute
Estate of Marion B. Carstairs
Robert B. Catell
John and Michael Chandris
Pei-Yuan Chia and the Chia Family Foundation
Trust of Charles P. Ciaffone
Trust of George Clegg
The Comer Science and Education Foundation
Trust of James J. Corbalis, Jr.
Countess Moira Foundation
Mr. and Mrs. Peter O. Crisp
Cure Breast Cancer Foundation, Inc.
Estate of Helen M. Curry
Trust of Margaret E. Dahm
Dennis D. Dammerman
Estate of Charles E. Dillman
Gloria DiPietro-Cooper
The Doris Duke Charitable Foundation
Entertainment Industry Foundation
The Eunice Foundation
Estate of Harry Fagen
Farmer Family Foundation
Trust of Harold Farrington
Estate of Barbara D. Finberg
The Jerome and Anne C. Fisher Charitable Foundation
56B MSKCC
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
Flight Attendant Medical Research Institute
The Stephanie and Lawrence Flinn, Jr. Charitable Trust
Estate of Harry N. Forman
Lorraine Friedman
Estate of Jeanette R. Fulham
Fund for Ophthalmic Knowledge
Estate of Frank H. Gabriel
Gabrielle’s Angel Foundation
Sara Gadd
Estate of Thomas Gardiner
Trust of Virginia L. Garrison
Trust of Florence K. Geffen
The Lawrence M. Gelb Foundation, Inc.
Richard L. Gelb
Genentech
General Electric Company
Eileen Genet Fund for Ovarian Cancer Research and Prevention
Trust of Josephine A. Gilmore
Estate of Anna H. Gleason
Miriam and Alan Goldberg
Golfers Against Cancer Foundation
The Gordon Fund
Trust of Jane H. Gordon
Grass Family Foundation
The Marion and Louis Grossman Foundation
Mr. and Mrs. Robert Grossman
Trust of Helen Guerin
Hackers for Hope
Mr. and Mrs. James J. Hagan
Mr. and Mrs. John J. Hannan
Estate of Margaret H. Hanson
Stephen P. Hanson
Jamie and Jeffrey Harris
Mr. and Mrs. Lloyd Hascoe
The Lita Annenberg Hazen Foundation
Hazen Polsky Foundation
The Heckscher Foundation for Children
Mr. and Mrs. Benjamin W. Heineman, Jr.
Marie B. Hilliard
The Charles and Marjorie Holloway Foundation, Inc.
Estate of Harriet Huber
Estate of Dorris Hutchison
Trust of Harry C. Jaecker, Jr.
Estate of Clarence W. Johnson
Estate of Wilda Johnson
Trust of Marion Kahn
Estate of Mary B. Ketcham
Mr. and Mrs. Matania Kochavi
Estate of Rosemarie Krulish
The Thomas G. Labrecque Foundation
Trust of Grace Fay Lamb
Philippe Laub
Estate of Wilhelmina LeJeune
Leon Levy Foundation
Estate of Ada Leventhal
Dr. Nancy Alpern Levin
The LisaBeth Foundation
The Litwin Foundation
Robert S. Ludwig and Gwenyth E. Rankin
Lydian Asset Management, LP
The Maloris Foundation
Trust of Estelle A. Manning
Margaux’s Miracle Foundation
Mr. and Mrs. Joseph L. Martino
The G. Harold & Leila Mathers Foundation
Mrs. William L. Matheson
Merrill Lynch & Co. Foundation, Inc.
Fred and Marie-Noelle Meyer
Estate of Robert C. Mitchell
Trust of Douglas C. Mohl
Estate of Warren A. Montel
Mushett Family Foundation, Inc.
Stavros S. Niarchos Foundation
Nonna’s Garden Foundation
The Olayan Group
Estate of Frederick Pelda
John and Francie Pepper
Perry Capital LLC
Estate of Jeanne Poli
Laura and Christopher A. Pucillo
Mrs. Katharine J. Rayner
Charles H. Revson Foundation
Estate of Edith Roberts
The Jim & Linda Robinson Foundation
The Felix and Elizabeth Rohatyn Foundation
The Laura Rosenberg Foundation, Inc.
Estate of Lillian E. Rosenmerkel
Juliet Rosenthal Foundation, Inc.
Jack Rudin
The Louis & Rachel Rudin Foundation
The May & Samuel Rudin Family Foundation
The Peter M. Sacerdote Foundation
Lewis A. Sanders
Fayez Sarofim & Co.
Estate of Margaret W. Schafer
Mr. and Mrs. Norman C. Selby
Dr. David E. and Beth Kobliner Shaw
Trust of Henry H. Shepard
Mr. and Mrs. H. Virgil Sherrill
Mr. and Mrs. Stephen C. Sherrill
Alfred J. and Stephanie Shuman through the Windmill Lane Foundation
Mr. and Mrs. Herbert J. Siegel
M. Steven and S. David Silbermann
The Rosanne H. Silbermann Foundation
Mary Ann and Arthur M. Siskind through the Siskind Family Sarcoma Fund
The Skirball Foundation
Trust of William Kirkland Smith
Trust of Emily V. Smyth
Trust of Clemance and Edwin Snyder
The Society of MSKCC Special Projects Committee
Ira Sohn Conference Foundation, Inc.
Peter J. Solomon Family Foundation
The Society of MSKCC
The Sontag Foundation
Sportsmen for Charity
Estate of Stanley R. Stones
Mr. and Mrs. David K. Storrs
George Strawbridge, Jr.
The Margaret Dorrance Strawbridge Foundation of PA
The Jeffrey Steiner Family Foundation
The Sussman Family Fund
Trust of M. Allen Swift
Tarnopol Family Foundation
Estate of Lillian Tomek
Anthony and Carole Trapani
The Trump Group
Universal Network Television
The V Foundation for Cancer Research
Trust of Edward W. Vollintine
Joan and Sanford I. Weill
Louis and Jane Weinstock
The Lillian S. Wells Foundation, Inc.
Mr. and Mrs. Clay T. Whitehead
Estate of Carolyn H. Wilson
Winterburn Foundation
Diana S. Wister
The Wolfensohn Family Foundation
Mr. and Mrs. Robert Wright
Zev’s Fund Inc.
$500,000 — $999,999
Estate of Marguerite Abrams
Alex’s Lemonade Stand
Allen & Company, Inc.
American Skin Association
Anonymous
Roland Arthur
Aventis Pharmaceuticals, Inc.
Mr. and Mrs. Robert C. Baker Family Foundation
Estate of Eileen W. Bamberger
The Arnold and Mabel Beckman Foundation
Trust of William T. Benitt
The Besen Family
Jamie Nicholls & Fran Biondi Charitable Trust
Betty, James, and Thomas Blake (The Thomas Blake, Sr. Memorial Fund)
The Blue Dot Foundation
Trust of Ethelvida Boehme
Estate of William Boehme
Mr. and Mrs. David Boies
Trust of Frederick W. Bonacker, Jr.
Estate of Adele Bozio
Trust of Nancy J. Bradford
Mr. and Mrs. Peter Bren
The Andrea and Charles Bronfman Philanthropies, Inc.
Mrs. Edwin M. Burke
The Cancer Research Foundation of America
The Richard E. Capri Foundation on behalf of the Wolf Family
Estate of Richard B. Carman
The Tina and Richard V. Carolan Foundation
James & Patricia Cayne Charitable Trust
Trust of Betty R. Ciaffone
Citigroup
The Simon & Eve Colin Foundation
Estate of Harry J. Colish
The Connecticut Sports Foundation
Constant Convocation Center
The Elaine Terner Cooper Foundation
Trust of Faye Copeland
Estate of Leonard Corso
Estate of Helen M. Cramer
The Dana Foundation
Mr. and Mrs. Marvin H. Davidson
Davis Enterprises
Estate of Sandra Newman Dawson
MSKCC 56C2010 ANNUAL REPORT
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
The Thompson Dean Family Foundation
The DeGroot Family Foundation
Annette and Oscar de la Renta
Deutsche Bank Securities Inc.
Trust of James Douglas
Estate of Louis Duenweg
The Emerald Foundation
Mr. and Mrs. David Epstein
Arthur Falcone
Estate of Beatrice Feinstein
Estate of Alice H. Ficht
Trust of Alice D. Fiedler
Trust of Marie Finch
Trust of Ira S. French
The Michael J. Fox Foundation
Estate of Joseph G. Gaumont
Estate of Lillian B. George
The Gerber Foundation
Estate of Thelma Gish
GIST Cancer Research Fund
Mr. and Mrs. Robert S. Goldberg
Goldman Sachs & Company
The Horace W. Goldsmith Foundation
Peter M. Guggenheimer
The Marc Haas Foundation
Mr. and Mrs. William W. Haerther, Jr.
Estate of Ethel V. Haldeman
Evelyn A. J. Hall Charitable Trust
Mr. and Mrs. William B. Harrison, Jr.
Estate of Ruth H. Hewlett
Marie B. Hilliard
The Patricia M. Hynes and Roy L. Reardon Foundation
IBM Corporation
Deanne and Arthur Indursky
Mrs. H. Anthony Ittelson
Johnson & Johnson
Estate of Horace A. Jones
Fritz and Adelaide Kauffmann Foundation
Kinetics Foundation
Estate of Joan E. Kinley
Estate of Hazel V. Knapp
Estate of Ruth Koch
The Koodish Family Charitable Trust
The Jacob & Valeria Langeloth Foundation
Trust of Charles T. Larus
Lazard Capital Markets
Harold F. Levinson
Life Raft Group
Trust of Martin C. and Margaret V. Lohsen
Trust of Louis J. Lombardi
Earle I. Mack Foundation
Estate of Lucille Knowles
Freedman Mann
Trust of John C. McCormick
Estate of Ralph Melson
Estate of Ruth Vitow Messias
Wilma S. Mills
The Ambrose Monell Foundation
J. P. Morgan Chase
The Norman M. Morris Foundation
The William T. Morris Foundation
Trust of Paula Moss
Mr. and Mrs. Charles H. Mott
Trust of Saul Nathonsohn
News Corporation
The New York Community Trust
The New York Yankees Foundation
Trust of Melba M. O’Connell
The Sylvan and Ann Oestreicher Foundation
Trust of Jo Anne H. Olmsted
E. Stanley O’Neal
Estate of Beatrice P. K. Palestin
Elsa U. Pardee Foundation
The Pediatric Cancer Foundation
The Perelman Family Foundation
Trust of Elizabeth L. Perkins
Pfizer Inc.
Estate of Lucie Picard
Margot Rosenberg Pulitzer Foundation
The Mitchell P. Rales Family Foundation
John Bradbury Reed
Trust of Irene Dorothy Reel
Estate of Agnes Rezler
Drs. Helena and David Rodbard
Alexander J. Roepers
Shafi Roepers
Trust of William C. Rogers
The Arthur Ross Foundation, Inc.
Trust of Edward G. Ryder
Joseph J. Santry
Estate of George W. Schneider III
Estate of Alana M. Schuster
The Beatrice & Samuel A. Seaver Foundation
The Seraph Foundation
The Shen Family Foundation
Trust of William and Isabelle Sherlock
Evelyn R. Simmers Charitable Trust
Trust of Barbara K. Snader
The Society of MSKCC Associates Committee
Estate of Katherine R. Sonneman
Spin4Survival
St. Baldrick’s Foundation
The John R. and Inge P. Stafford Foundation
Estate of Helen E. Steadman
Bonnie and Steven E. Stern
The Mel Stottlemyre Myeloma Foundation
Mr. and Mrs. Paul A. Street
Trust of James Strobridge
The Michael Sweig Foundation
The Craig D. Tifford Foundation, Inc.
Barbara Davies Troisi Foundation
Estate of Stanley F. Tucker
Tudor Investment Corporation
Daniel P. and Grace I. Tully Foundation
Turner Construction Company
United Way of Tri-State
Uniting Against Lung Cancer
Trust of Ward M. Vanderpool
Variety – The Children’s Charity
Richard C. Vergobbi
Estate of Christine Villano
Lucy R. Waletzky, MD
Trust of Thomas J. Watson, Jr.
Estate of Ruth C. Weismann
Trust of Reamer W. Wigle
Mr. and Mrs. Sam Wilderman
The Meryl and Charles Witmer Charitable Foundation
Trust of Richard A. Yudkin
Estate of Anna M. Zavatt
Ronald Zung
$250,000 — $499,999
Trust of George Aaron
Accelerate Brain Cancer Cure (ABC2) Foundation
Estate of John D. Adams, Jr.
The Louis & Bessie Adler Foundation
The Rita Allen Foundation
The Alliance Against ASPS Foundation
American Brain Tumor Foundation
American Health Assistance Foundation
The Ametek Foundation, Inc.
Dorothy A. Anderson
Trust of Eileen Alpert
Anonymous
Estate of Anita S. Appel
Mr. and Mrs. Frank W. Appleton, Jr.
Arms Wide Open Childhood Cancer Foundation
Joyce Ashley
Estate of Rose Ashton-Irvine
Aventis Pharmaceutical
Avon Foundation
Estate of William C. Bahn, Jr.
The Banbury Fund
Estate of Marcia Batten
Betsy L. Battle
Richard I. Beattie
Estate of Ethel A. Bell
Trust of Virginia Poole Benjamin
The Bie Family Foundation
The Lisa E. Bilotti Foundation
The Nancy and Robert S. Blank Foundation
Albert and Betty Bodian
The Bondi Foundation
Trust of Lillian Borchardt
The Louis L. Borick Foundation
The Albert C. Bostwick Foundation
Trust of Alice M. Branch
The Braver Foundation
Estate of Paul P. Brieloff
Trust of Dorothy Fielder Brown
Estate of Madalyn B. Bryant
The Bugas Fund
Hilary and Joseph A. Califano, Jr.
Cancer Support Services, Inc.
Estate of Georgia M. Catrini
Trust of Ruth C. Celarek
Estate of Burdette G. Chamberlin
The Y. C. Ho/Helen and Michael Chiang Foundation
Joan Chorney
CIBC World Markets Corporation
Estate of Dorothy L. Cobb
Trust of Joan F. Cobb
Frances B. Cohen
Mr. and Mrs. John K. Colgate, Jr.
The Community Foundation for Northern Virginia – Hanlon Family Fund
Estate of Robert I. Conley
Estate of Lillian Copperman
Carlos A. Cordeiro Foundation
Estate of Leonard Cossack
The Cowles Charitable Trust
Chandler Cox Foundation
Estate of Mary O. Craft
Estate of Edna W. Curl
Trust of DeWitt S. Davidson
Trust of Richard L. Davies
Estate of Frederick W. Davis
Trust of Marion E. Dean
Trust of Carolyn B. Denney
Hester Diamond Foundation
56D MSKCC
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
The Dickson Foundation
The DiMenna Foundation, Inc.
Elizabeth K. Dollard Charitable Trust
The Walter S. and Lucienne B. Driskill Foundation
Mr. and Mrs. Barclay Ehrler
The Mitzi and Warren Eisenberg Foundation
Eli Lilly & Co.
Rita H. Schaefer Elliott
The Charles Engelhard Foundation
Trust of June K. Evans
Trust of Lillian Evans
Lord Evans of Watford
Anthony B. Evnin
Trust of Sarah W. Ewing
Mr. and Mrs. Barton Faber
Estate of Giuliana Fantini
Trust of Mary E. Farrell
The Feinstein Family Foundation
Paul Felzen
The Fibrolamellar Cancer Foundation
Estate of Selma Fine
The Grace J. Fippinger Foundation, Inc.
Jeanne Donovan Fisher
The Jodi Spiegel Fisher Cancer Foundation
Aaron I. Fleischman Foundation
The Floren Family Foundation
Fondazione Italiana
Leonardo Giambrone
For the Love of Life
The Terry Fox Run for Cancer Research
The Evan Frankel Foundation
Mr. and Mrs. Lewis Frankfort
The Edna R. Fredel Charitable
Lead Annuity Trust
Estate of Frank O. Fredericks
The Fribourg Foundation
Estate of Gerard M. Friedman
Estate of Regina M. Gallichio
Estate of Norman D. Galloway
Trust of Esther B. Garnsey
Estate of Mildred B. Gehrke
Joe and Ellen Gellert
Genzyme
The Aaron and Betty Gilman Family Foundation
The Albert and Pearl Ginsberg Foundation
The Joyce & Irving Goldman Family Foundation
Alfred G. & Hope P. Goldstein Fund
Granary Associates
Mr. and Mrs. Alan I. Greene
Virginia and Howard Groombridge
Mr. and Mrs. Martin D. Gross
Robert C. Halboth
Mrs. Melville W. Hall
Mr. and Mrs. Stephen L. Hammerman
Gladys and Roland Harriman Foundation
Susanne and Shelley Harrison
Trust of Abraham Hases
Estate of Irma Hayes
Mr. and Mrs. Charles Heimbold, Jr.
Estate of Judith B. Helfant
Heyman-Merrin Family Foundation
The Catie Hoch Foundation
Estate of Laverne Hodges
Estate of Martha Holloway
Mr. and Mrs. D. Gregory Horrigan
Estate of Karen L. Hudson
William Lawrence & Blanche Hughes Foundation
Edith M. Hunter
IBM International Foundation
Bruce H. Jacobs
Trust of Clyde H. Jacobs
The Rona Jaffe Foundation
Janssen Pharmaceutica Products LP
Estate of Mira Jelin
The Jewish Communal Fund
The Robert Wood Johnson Foundation
Estate of Al Jolson
Estate of Robert L. Jones
Max Kade Foundation, Inc.
Mr. and Mrs. Robert B. Kay
Estate of Helen Keena
Trust of Fenton O. Keister
Mr. and Mrs. John R. Kennedy
Trust of Paul and Fran Knight
Joel Koschitzky
Mr. and Mrs. Marvin H. Koslow
The Fred W. Kramer Charitable Trust
Cheryl Gordon Krongard
Estate of Harriette H. Kussin
Estate of Sidney Lacher
Mr. and Mrs. Joseph M. La Motta
Estate of Harriet L. Lampert
Vivian F. Laube
Lavelle Fund for the Blind, Inc.
Betty Reid Lawson
Trust of Joseph Lebednik
The Lerner Foundation
Estate of Donald LeRoy
Mr. and Mrs. Allan L. Levey
Trust of Leona Levy
The Anne Boyd Lichtenstein Foundation
Estate of John E. Liebmann
Pauline H. Lin
Live4Life Foundation
Estate of Marian J. Looser
Mr. and Mrs. Edward Lundy
The Lustgarten Foundation for Pancreatic Research
Lymphoma Research Foundation
Estate of Julian Malkiel
Manhasset Women’s Coalition Against Breast Cancer
The Lois H. Mann Charitable Foundation
Estate of Albert Manning
Estate of Marvin Margolies
Mrs. John L. Marion
The Marmot Foundation
Estate of Edith Lipphardt Martens
Estate of Elizabeth Martin
Trust of Richard and Betty Martin
Estate of Ann L. Martinez
Trust of Anthony J. Masard
The Lucille and Paul Maslin Foundation
Trust of Cecelia Matarazzo
Estate of Harry H. Maus
Max Cure Foundation
The Mayday Fund
Mr. and Mrs. Louis V. Mazzella
MBNA America Bank
The MBNA Education Foundation
Donald J. McCarraher
Mary Jane McCarthy
The Michael W. McCarthy Foundation
The James S. McDonnell Foundation
Estate of Charles McGreevy
Estate of Alan McMaster
MeadWestvaco Corporation
The Merck Company Foundation
Estate of Despina Messinesi
Trust of Russell H. Michel
Mrs. Minot K. Milliken
Young Ae Lim and Joonsikk Moon
Estate of Dorothea K. Money
Morgan Stanley
Trust of Edmund L. Murray
The National Brain Tumor Society
National Childhood Cancer Foundation
Carole and Raymond Neag
Trust of Louise F. Neely
Estate of Ann M. Nelson
Muriel Neumann
New York Workers’ Compensation Bar Association
James G. Niven
Occidental Petroleum Corporation
Grace Oughton Cancer Foundation
Eileen and James A. Paduano
PepsiCo Foundation, Inc.
The Perkin Fund
Estate of Ann Perkins
Estate of Claude E. Petruzzi
Mr. and Mrs. Jeroen Henk L. Pit
Jean D. Pitcher
Josephine K. Poling
Polo Ralph Lauren Corporation
Estate of Elizabeth Polotaye
Trust of Helen M. Price
Estate of Seymour Price
Project A.L.S.
Prudential Financial, Inc.
Mrs. Jenice Pulver
Purdue Pharma LP
Leslie C. Quick and Regina A. Quick Charitable Trust
Trust of Anne Ressner
The Andréa Rizzo Dance Therapy Fund
Trust of Lillian Robbins
Estate of Sandra Sheppard Rodgers
Estate of Nathan Rothstein
Estate of Wilhelmina T. Rouget
The Selma and Lawrence Ruben Foundation
David Mark Rubenstein
Mrs. Orhan I. Sadik-Khan
Mrs. Edmond J. Safra
Dr. Nathan E. Saint-Amand
Mr. and Mrs. Herbert E. Saks
Mara and Ricky Sandler
Trust of Erika Saphier
Trust of Edwin & Grace Sayers
Estate of Christine C. Scanlan
Trusts of Anabel M. Scarborough and Walter L. Scarborough
The Milton Schamach Foundation, Inc.
Trust of Jennie C. Schneider
Trust of Crystal Schull
Estate of Bertha Schulman
The Schultz Foundation
The Nina and Ivan Selin Family Foundation
Estate of Gladys N. Severud
MSKCC 56E2010 ANNUAL REPORT
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
The Shanken Family Foundation
Estate of Odette Sharow
Trust of Minnie M. Shaw
Hope Sheridan Foundation
Nancy Shevell
Renee and Irwin Shishko
Estate of Lillian M. Siemionko
Leonard and Donna Simon
Trust of Angie S. Skinner
The Gordon H. and Norma Smith Family Foundation
Estate of Robert A. Smith
Roberta A. Smith
Estate of William E. Snee
Ms. Beryl Snyder
The Seth Sprague Educational and Charitable Foundation
The Robert Steel Foundation for Pediatric Cancer Research
Trust of Frederick T. Steinberg
Trust of Charles M. Stevenson
Estate of Sonia Stolin-Moresco
The Daniel P. Sullivan Clinical Fellowship Fund
Ping Y. Tai Foundation
Frank N. Tedesco
Estate of Ida Tepper
Trust of Annette M. Terdina
Estate of Stella R. Thater
Thrasher Research Fund
Mr. and Mrs. Carl W. Timpson, Jr.
Estate of Michael Z. Toman
Mr. Steven Trost
United Hospital Fund of New York
United Leukemia Fund Inc.
United Way of New York City
Estate of Eleanor B. Vogel
The Wasily Family Foundation
Estate of Ingeborg K. Watson
The Scott Weingard Memorial Fund
Effie Wells-Lonning
Mr. and Mrs. Harold S. Wertheimer
Trust of Ida Wharton
Whitehall Foundation
John C. Whitehead
Estate of Ruth Whitfield
Mr. and Mrs. Frank C. Whittelsey III
The Jesse R. Wike Charitable Trust
Mr. and Mrs. Sam Wilderman
Kendrick R. Wilson, III
Trust of Vincent J. Zappolo
Deborah A. Zoullas
Nicholas B. Zoullas
$100,000 — $249,999
A & P Foundation
The Louis & Anne Abrons Foundation, Inc.
Mr. and Mrs. Laszlo Adam
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
The Francis X. Ahearn, Sr. Foundation
Daniel G. Alexander
Robert and Elaine Allen
Mr. and Mrs. Robert I. Alpern
The Amaturo Foundation, Inc.
The American Ireland Fund
The American Italian Cancer Foundation
Amgen, Inc.
Estate of Maurice Amzalak
Mr. and Mrs. Harold F. Anderson
Warren and Lillian Anderson
Anonymous
Mr. and Mrs. Jerome V. Ansel
Estate of Mark J. Anton
Mr. and Mrs. Rand V. Araskog
Mr. and Mrs. William J. Armfield IV
Kym S. Arnone
The Aronson Family Foundation
Mary Kay Ash Charitable Foundation
Autism Speaks
B*Cured
Trust of Maureen E. Bacchi
Dr. Joseph J. Bailey
Elliot A. Baines
The Baird Family Fund
Estate of Harold P. Bannister
Mr. and Mrs. Robert L. Barbanell
Trust of James R. Barber
Trust of Margaret D. Barber
Trust of Grace M. Barry
Estate of Kaethe F. Barry
Estate of Patricia A. Barry
Trust of Eileen L. Batten
Estate of Thelma Beatty
Trust of Gertrude E. Beck
Rosalie Becker
Estate of Charles R. Beechler
Estate of Robert D. Bennett
Corinne Berezuk and Michael Stieber
Bergstein Family Foundation
Rita S. and Bernard S. Berkowitz
Estate of Tony P. Bernabich
The Bill Bernbach Foundation
Robert Berne
Mrs. Louis Bernstein
Bid-Service LLC
Jill and Darius Bikoff Foundation
Estate of Margaret L. Bingman
Biomet
BJ’s Charitable Foundation
Alexander Blass
Bill Blass Licensing Company, Inc.
Mr. and Mrs. James A. Block
Estate of Vivian K. Blonder
The Walter & Adi Blum Foundation, Inc.
Trust of Eli Blumenfeld
Harold and Adele Blumenkrantz
Estate of Simon P. Blustone
Bruce Bocina
Estate of Marti A. Boden
Estate of Marjorie R. Boselly
Mr. and Mrs. Kevin A. Bousquette
Alan F. Bovee
William R. Boyle
Estate of Mary C. Brabson
Estate of Elsie L. Bradford
Brahman Capital
Brain Tumor Funders’ Collaborative
Anna M. and Mark R. Brann
Milton Brenner
Estate of Mae Bridewell
Bridgemill Foundation
Trust of Marie H. Brock
Terri Brodeur Breast Cancer Foundation
Estate of Edna Brodie
Randall Brooks
Carl and Nickey Brown
Catherine D. Brown
Trust of Ruth Ann Brown
Estate of Vernon Brunelle
Elizabeth Bucher
Janna Bullock
Trust of Florence Bunn
Tory Burch
Mr. and Mrs. Franz H. Burda
Estate of Louise V. Burnett
Mr. and Mrs. Harold Busch
The Paul Nabil Bustany Foundation
Gilbert and Ildiko Butler Family Foundation, Inc.
Estate of Lillian A. Byman
Mr. and Mrs. Bruce L. Calhoun
Trust of Marilyn Campbell
Cancer Research & Treatment Fund
Leah Rush Cann
Estate of Edward A. Cantor
The Paul Robert Carey Foundation
Caring for Carcinoid Foundation
Mr. and Mrs. Kenneth Carmel
Estate of William K. Carson
Colon B. Carter
Trust of Winifred T. Carter
Estate of Elsie Cartotto
Joan (Perkowski) Cashin Foundation
Casual Male Corp.
The Cayuga Foundation
Estate of Charlotte A. Celian
Trust of George F. Chagnot
Margaret Anne Chappell
Estate of Franklin Chenenky
Estate of Camille Chericone
Child Neurology Foundation
Childhood Brain Tumor Foundation
The Children’s Brain Tumor Foundation
Children’s Neuroblastoma Cancer Foundation
Mr. and Mrs. Allen Chipman
Florence Chu, MD
Estate of Lyman W. Clardy
The Clark Foundation
Cleveland Clinic Health System
Clarence L. Coleman Jr. and Lillian S. Coleman Foundation
James J. Coleman, Jr.
Estate of Gertrude T. Coles
Robert and Maryann Collin
Arthur R. Collins
Estate of Lila V. Collins
Terry S. Collins
The Julien Collot Foundation, Inc.
Consolidated Edison Company of New York
Dudley P. Cook
Mr. and Mrs. Errol M. Cook
Mrs. William B. Cook
Cookies for Kids’ Cancer
E. Gerald Cooper
Sharon Levine Corzine
Estate of G. R. Couch
Courtesy Associates, Inc.
Estate of Edith C. Cox
Trust of Franklin C. Craig
Trust of Louise Crites
Bruce Crystal
Cure Childhood Cancer
Custom Design Communications, Inc.
56F MSKCC56F MSKCC
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
Filomen M. D’Agostino Foundation Corp.
Rosetta B. Damilano
Estate of Richard Daniels
The Gloria and Sidney Danziger Foundation, Inc.
The E. S. P. Das Foundation
The Arthur Vining Davis Foundations
The Ellen and Gary Davis Foundation
Mrs. Roger J. Davis
Roxana V. Dawson
Estate of Jean Decker
Estate of Libiro DeFilippis
The Lawrence and Florence DeGeorge Charitable Trust
Lynn DeGregorio
Anthony Del Bove
Estate of Helen Demitriades
The De Rosa Foundation for Colon Cancer Research and Prevention
Ernst and Paula Deutsch Foundation
The DeWitt Wallace Fund
Mr. and Mrs. Anthony Diaco
The Miriam & Arthur Diamond Charitable Trust
The Ernest & Jeanette Dicker Foundation
Estate of Richard I. Diennor
Estate of Maurice A. Donovan
John R. Doss
Michael Douglas and Catherine Zeta-Jones
Percy S. Douglas
The William C. Dowling Foundation
Susie M. Downing
Jane Clausen Drorbaugh
Dr. Scholl Foundation
Dr. Jeffrey Duban
Trust of Patricia P. Duffy
Estate of Doris M. Dunham
The Durst Organization, Inc.
Estate of Laura D. Eastman
The Eberstadt-Kuffner Fund Inc.
Doris M. Edwards
E. E. Cruz Company
Mr. and Mrs. Blair W. Effron
Trust of Raymond Ehrlich
Estate of Elinor Ehrman
Estate of Estelle Eisenstat
Martin Elk League for Cancer Research
Trust of Arnold B. and Joan S. Elkind
Mr. and Mrs. Richard S. Emmet
Empire Blue Cross & Blue Shield
Andrew J. Entwistle
Estate of Lillian Epps
Rafael Etzion
The Evslin Family Foundation
Trust of James D. Ezzell
Family Reach Foundation
Mr. and Mrs. Alfonso Fanjul, Jr.
Mr. and Mrs. James T. Fantaci
Estate of Marion E. Feigenbaum
Gretchen V. and Samuel M. Feldman
The Corinne Feller Memorial Fund
Trust of Thelma F. Fernandez
Hilary Carla Feshbach
Fetzer Institute
Mrs. Frederick Fialkow
Gloria S. Fine
First Quality Enterprises, Inc.
Randee and Howard Fischer
Estate of James K. Fisher
Estate of William and Frederica Fissell
Trust of Loretta B. Fitzgerald
Mr. and Mrs. Thomas M. Fitzgerald III
The Francis Florio Fund of the New York Community Trust
Steve Forbes
Trust of William Forbes
Richard N. Foster
Four Seasons Hotel – New York
Claire and Meyer W. Frank and Leann Frank Charitable Foundation
Trust of Irene R. Frank
Helen Frankenthaler Foundation
Mr. and Mrs. David Lee Frankfurt
Trust of Jill and Jayne Franklin
Gloria Freed
Frey Family Foundation, Inc.
Knawm Friedman
Richard M. Furlaud
Mr. and Mrs. Thomas J. Gahan
Trust of Ralph W. Gaines
Estate of Anne Gallagher
Mr. and Mrs. Robert M. Gardiner
Trust of William G. Genner, Sr.
Panayotis Gerolymatos
Estate of Theresa A. Ghiringhello
Marlene and Alan Gilbert
Liane Ginsberg
Mr. and Mrs. William H. Girvan
The Glades Foundation
Mr. and Mrs. Eugene J. Glaser
Glenwood Management Corporation
Trust of Glenn R. Gobble
Mr. and Mrs. Bradley Goldberg
Leslie H. Goldberg
Trust of Marc S. Goldberg
The Goldhirsh Foundation
Estate of Elizabeth B. Golding
Daniel S. Goldman
The Barbara L. Goldsmith Foundation
Susan Wallack Goldstein
Trust of Manuel and Anne Goodman
The Gordon Family Foundation, Inc.
Mr. and Mrs. Sheldon M. Gordon
Arthur A. Gosnell
Trust of Louise S. Gosse
Marietta A. Goulandris
Julie Gould Fund for Medical Research
Estate of Richard P. Gould
Felice M. Grad
Graff Diamonds
Grantham Mayo Van Otterloo & Co.
The Grateful Foundation, Inc.
Estate of Harvey R. Graveline
Susan Zises Green
Brigadier General and Mrs. William S. Greenberg
Estate of Edythe Griffinger
Trust of William C. Griffith, Jr.
Trust of Vernon H. Grigg
Estate of Evelyn Gross
Estate of J. Stanley Gross
Trust of Lambert J. Gross
Trust of William Gross
Estate of Anthony Grosso
Allen J. Grubman
Audrey and Martin Gruss Foundation
Estate of Wanda Grzymala
Guardsmark, LLC
Marilyn B. Gula Mountains of Hope Foundation
Trust of Elizabeth Guon
Estate of Gloria E. Gurney
Gurney Foundation
Hachette Filipacchi Media U.S.
Jayma Meyer Hack and Bruce L. Hack
The Hagedorn Fund
The Laverna Hahn Trust
Estate of Margaret S. Hahn
Estate of Elizabeth W. Hall
Estate of Mazie J. Hall
Estate of Helen Sue Hameetman
Trust of Florence M. Hammer
Milton and Miriam Handler Foundation
Estate of Marion K. Hardwicke
Dorothy Harlow
Estate of Mary Jane Harrington
Perry Harten
Laura Hartenbaum Breast Cancer Foundation
Mr. and Mrs. William R. Hartong
Have A Chance, Inc.
Morris A. Hazan Family Foundation
The Colon Cancer Foundation
Trust of Lonie G. Hearn
Hecht & Company Philanthropic Foundation
Trust of Shirley S. Heiligman
Mr. and Mrs. Robert M. Hendrickson
Mr. and Mrs. John Hennessy
The Maxine R. and Richard L. Henry Trust
Estate of Robert Hensel, Jr.
Carolina Herrera, Ltd.
Trust of Leon Hershaft
Trust of Marie Hesselbach
Estate of Manny Hilfman
The Hillcrest Foundation
Hillenbrand Family Foundation
Trust of Myfanwy Hinkle
Estate of Vladimir Hladik
Estate of Edward B. Hodge
Estate of Marion Hoffman
Estate of Ruth M. Hoffman
Trust of Steward B. Hoffman, Sr.
Hoffman-La Roche Inc.
Deborah H. and Sigmar K. Hofmann
Mrs. Carolyn T. Holden
Estate of Lillian E. Holdren
Estate of Herman L. Hoops
Hope Funds for Cancer Research
Alfred Samson Hou
Robert Howard Family Foundation
Evelyn Huber
The Howard Hughes Medical Institute
Nancy Hughes
Edna Hunt
Carol Hunter
MSKCC 56G2010 ANNUAL REPORT
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
James B. Hunter
Syde Hurdus Foundation, Inc.
Mr. and Mrs. David W. Ichel
Estate of Priscilla T. Iden
Inamed Corporation
Incyte Corporation
The Interpublic Group of Companies
Irish Society of Medical Oncology
It Figures LLC
Harry A. Jacobs, Jr.
Mr. and Mrs. Stanley R. Jaffe
Trust of Ann E. Jennings
The Jewish Communal Fund
The JMB Hope Foundation
The Samuel C. Johnson Trust
The Kahn Charitable Foundation
Trust of Frank J. Kahn
Kallan’s Klan
Jane Kalmus
Harry P. Kamen Family Foundation
Trust of Mildred Kaminsky
Estate of Eleanor Kane
Estate of Bernard Kantor
Steve and Meghan Kanzer
Marie H. Karger
The Karma Foundation
Trust of Jerry Katz
Trust of Toby Katz
Edward M. Kaufman
Trust of John Kaufmann, Jr.
Mr. and Mrs. Robert M. Kavner
Thomas F. Kearns
Mr. and Mrs. Brian G. Kelly
Estate of Ruth C. Kelly
Mrs. Ann Kelman and the late Dr. Charles D. Kelman
Eleanora and Michael Kennedy
J. Kevin Kenny
John A. Kent
Estate of Herman Kerner
The Glenn D. Kesselhaut Children’s Joy Fund
Estate of Mary F. Kessler
Mr. and Mrs. Peter A. Kessler
The Kettering Family Foundation
Estate of Henri Khouri
Doris and Floyd Kimble Foundation
Pamela and Dwaine Kimmet
The King Family Charitable Lead Trust
Mr. James W. Kinnear II
Patricia A. Kirby
David L. Klein, Jr. Foundation
Robert D. Klemme
The Esther and Joseph Klingenstein Fund
Trust of Estelle Knapp
Fernand Koch
Estate of Gale K. Kokubu
Emanuel Kondoleon
The Koppelman Family Foundation
The Gwen L. Kosinski Foundation
Robert A. Kotick
Mr. and Mrs. Jerome I. Kroll
Mr. and Mrs. Jeffrey W. Kronthal
Mr. and Mrs. William L. Kronthal
Trust of Grace E. Kruse
The Lakeside Foundation
Estate of Schubert L. Lamb
Estate of Marvadene B. LaMonica
The Edward & Kinga Lampert Foundation
Emma Landau
Mr. and Mrs. Barry Lang
Estate of Annie Langen
Estate of Anne Lanigan
J. Clair and Pamela Lanning
Dr. Gerald D. Laubach
Mrs. Lois H. Lazaro
Trust of Edwin S. Lee, Jr.
Mr. and Mrs. Thomas V. Leeds
The Lefkofsky Family Foundation
The Richard S. and Karen LeFrak Charitable Foundation
Lehman Brothers Inc.
Karen and James Lehrburger
Mr. and Mrs. Lewis E. Lehrman
Trust of Martha B. Leigh
In memory of Stacey Leondis
The Leukemia & Lymphoma Society
Leukemia Research Foundation
Estate of Dina Levinsky
Estate of Erna T. Lewine
Linda Lipay
Trust of Wilhelmina I. Lipfert
Ira A. Lipman
Lisa’s Heart Kids’ Cancer Research Fund
The Harold I. & Faye B. Liss Foundation
Mr. and Mrs. Martin Liss
Julia Little
Demarest Lloyd, Jr. Foundation
Harry J. Lloyd Charitable Trust
Estate of Margaret S. Longwell
Estate of Anthony Lopez
Milton Lowenstein
James J. and Marianne B. Lowrey
The Lucerne Foundation
Lung Cancer Research Foundation
Mr. and Mrs. Alexander P. Lynch
Trust of John F. Lynch
Estate of Kathleen E. Lynch
Estate of Charles S. Lyons
Estate of Melvin E. Lyons
The M and N Fund in Community Funds, Inc.
MacDonald-Peterson Foundation
Josiah Macy, Jr. Foundation
Mr. and Mrs. Duncan MacMillan
The Arthur and Holly Magill Foundation
Estate of Margaret E. Maihl
Estate of Margaret H. Mairs
The Maguy Foundation
Mr. and Mrs. Irving H. Malitson
Elissa Caterfino Mandel
Estate of Harry Marder
Estate of Ida Mae Margolis
Trust of Carlton G. Marie
Mr. and Mrs. Bernard Marin
Edward J. Marino
Susan and Morris Mark
Jerome S. and Maria Markowitz
Trust of Sarah Marks
Estate of Benjamin Marmer
The Christina & Paul Martin Foundation
Dorothy Marx
Estate of Rita B. Masse
James Mathos
The Hale Matthews Foundation
Trust of Walter J. Matthews
The Matt’s Promise Foundation
Maverick Capital Charities
Maynard Childhood Cancer Foundation
The Helen & William Mazer Foundation
Mr. Michael Mazzucca
Estate of Ann C. McBride
Mr. and Mrs. Thomas McCullough
Mr. and Mrs. Jeffrey A. McDermott
McDonald Financial Group
Ralph McDonough
The Dextra Baldwin McGonagle Foundation
The McKnight Endowment Fund for Neuroscience
Estate of Geoffrey McLoughlin
Estate of Mary E. McMaster
Mr. and Mrs. David B. McQueary
The Meckler Foundation
Melanoma Research Foundation
Estate of Dorris M. Mendelsohn
Estate of Irving M. Mendelson
Estate of Lorraine Mensing
The Reuven Merker Charitable Foundation, Inc.
Estate of Amy Joan Meskin
Mesothelioma Applied Research Fund
Mr. Robert A. Metzler
Estate of Abby E. Meyer
Mrs. Sidney Michael
Trust of William M. Michaelson
Trust of Florence B. Mickels
The Mike and Steve Foundation
The Millbank Foundation for Rehabilitation
Elaine P. Miles
Eleanor F. Miley
Carolyn Rosen Miller Family Foundation
Mr. and Mrs. Matthew Miller
Mrs. Mary E. S. Milligan
Mr. and Mrs. James W. Milton
Melissa and Robert Mittman
Estate of Catherine Mohan
Estate of Irene Mokrzycki
Trust of Celestine Elizabeth Moloney
Estate of William Monaghan
Arthur R. Montgomery
John and Hee-Jung Moon
Estate of Pauline Moor
Trust of Anny S. Moore
Mr. and Mrs. Charles V. Moore
Estate of Percy W. Moore
Estate of Barbara B. Morgan
Melissa and Chappy Morris
Alfred L. and Annette S. Morse Foundation
Manuel and Mercedes Mosteiro
Virginia M. Mueller
Estate of Irving Mulde
Mr. and Mrs. Thomas W. Murphy III
Ernest Muth
Edith L. Nathanson
The National Genetics Foundation, Inc.
NBC Universal
Estate of Leslie A. Nelkin
Trust of Jerome Nerenberg
56H MSKCC
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
New York City District Council of Carpenters Relief and Charity Fund
Gerald L. Nichols and Jacqueline W. Nichols Foundation
Trust of Robert F. Novak
NYS Fraternal Order of Police Foundation
The Michael A. O’Bannon Foundation
Estate of Ernestine A. O’Connell
Mr. and Mrs. Jeremiah O’Connor
Trust of Emily C. O’Grady
Estate of Grace O’Hare
Oki Data Americas, Inc.
The Okonite Company
Mr. and Mrs. John D. Opie
Optiscan
Estate of Elaine Orbach
Otis Elevator Company
The William & Jane Overman Foundation
Parfums de Coeur Ltd.
The Parnassus Foundation
Trust of Edith Pattison
Estate of Herman L. Paul, Jr.
Mr. and Mrs. Kenneth Pearlman
Pediatric Brain Tumor Foundation
Pells-Mayton Foundation
Trust of James A. Pemberton
Mort Perlroth
Pershing Square Foundation
Estate of Frederick D. Petrie
The Pew Charitable Trusts
Samantha and Ernst Pfenninger
Trust of Peter H. Pflugk
Trust of Charles V. Pickup
Estate of Irene Pickup
Mr. Alessandro Pinto
Estate of Beatrice Pockrass
Cherie Henderson and David Poppe
Janis Z. Porch
Trust of Ann C. Porterfield
Estate of Edna G. Potter
Trust of Ruth S. Prall
Prevent Cancer Foundation
Rita Price
Estate of Ardys M. and Harold I. Proctor
The Proctor & Gamble Company
The William H. Prusoff Foundation
Dr. and Mrs. Mark Ptashne
Robert Pufahl
Richard I. Purnell Fund
Estate of Richard I. Purnell
Roselyn Flaum Radcliffe
Stewart Rahr
Muriel Rains
Mary L. Ralph Philanthropic Fund
John H. Rassweiler
Abigail T. Reardon
Estate of Phyllis E. Redmerski
Elenore Reed
Estate of Martha Cuneo Reed
Samuel P. Reed
The Beatrice Renfield Foundation
Mr. and Mrs. Ira L. Rennert
Olivier and Yosun Reza
Estate of Roland S. Rhode
The Rice Family Foundation
Martin Rich
Anne S. Richardson Fund
Trust of A. Leslie Richardson
Dee Dee Ricks
Estate of Harry Rinehimer
Estate of Elizabeth M. Ringo
Trust of Victoria Rinius
The Fannie E. Rippel Foundation
Estate of Norma Risman
The Ritter Family Foundation
Irene Ritter Foundation
Abigail Rittmeyer
The RMF Family Fund, Inc.
Mr. and Mrs. Stephen Robert
Bernard and Elaine Roberts
Estate of Floyd B. Roberts
Vivien Rock
Rodale, Inc.
Estate of Maria Rolfe
Vittorina Rolfo
Sheldon Rose
Taryn Rose International
Estate of Sylvia Rosenberg
Trust of Ilsa Rosenblum
Trust of Evelyn Rosenstein
Estate of Sylvia Ross
Estate of Eva L. Rothberg
Mr. and Mrs. Eric A. Rothfeld
Estate of Geraldine E. Rove
Denise Rover
Estate of Pearl Rubin
Mr. and Mrs. Mitchell E. Rudin
Estate of Maria Stella Ruggirello
Estate of Eileen B. Ruthrauff
The Derald H. Ruttenberg Foundation
The Raymond & Beverly Sackler Fund for the Arts and Sciences
The Saibel Foundation
Estate of V. Edward Salamon
Mr. and Mrs. Eugene L. Salem
Mr. and Mrs. William R. Salomon
Trust of Sidney Samuels
Henry Sanborn
The Sandler Family
Mrs. Barbara Santangelo
The Saw Island Foundation
Trust of Paul C. Sawyer
Estate of Ida M. Scagliarini
Scalamandré Silks
Didi and Oscar S. Schafer
Peter L. Schaffer
Estate of Richard Scharff
Estate of Josephine L. Schiff
Estate of Billie Schneider
The Schneider-Kaufmann Foundation, Inc.
Mrs. Silvia A. Schnur
Mr. and Mrs. Paul C. Schorr IV
Trust of Lola Schug
Estate of Harold B. Schwartz
Estate of Rosalind Schwartzbach
Trust of Paul J. Schwarz
Mrs. Arline Schwarzman
Trust of Robert E. Schwenk
Mr. and Mrs. John W. Scully
Estate of Jewel C. Seab
The Jean & Charles Segal Foundation
Mr. David Sekiguchi
The Select Equity Group Foundation
R. B. Sellars Foundation
The Jacqueline Seroussi Memorial Foundation
Seventh District Association, Inc.
L. J. Sevin
Harold Shames
Estate of Reuben Shane
Estate of Saul Shapiro
The Sharma Foundation
Estate of Bernice Baruch Shawl
William R. Sheldon
Estate of Alice Sherwin
Estate of Leo A. Shifrin, MD
Mr. and Mrs. Stanley B. Shopkorn
Mr. and Mrs. William Shulevitz
Mr. and Mrs. Steven J. Sidewater
The Muriel F. Siebert Foundation
Estate of Ruth Siegmann
Estate of Mary Siekert
Trust of Walter Silberfarb
The Grace, George, and Judith Silverburgh Foundation
The Seymour Simon Charitable Trust
Marilyn M. Simpson Charitable Trust
Simpson Thacher & Bartlett
Trust of Otto K. & Harriet J. Singer
Estate of Shirley Singer
Estate of Madeline Sisia
Estate of Evelyn M. Skolnick
Estate of Alvin F. Sloan
Suse Smetana
The Randall and Kathryn Smith Foundation
Estate of Woodrow Q. Smith
Estate of Dorothy Smolen
Catherine M. Smolich
Trust of Robert J. Smutny
Mr. and Mrs. Jay T. Snyder
The Harry & Estelle Soicher Foundation
Trust of Robert Solnick
Professor and Mrs. C. Alan Soons
Soros Fund Charitable Foundation
Sotheby’s
The Roy M. Speer Foundation
Estate of Regina W. Spence
Estate of DeAnne Spencer
Estate of Agnes Spillmer
The Seth Sprague Educational and Charitable Foundation
The St. Giles Foundation
Ronald Stafford Cancer Support Foundation, Inc.
Estate of Sanford L. Steelman
Estate of Dennis Stein
The Fred & Sharon Stein Foundation
Mrs. Nancy Steinfeld
The Ernest E. Stempel Foundation
Mr. and Mrs. Howard Stern
Estate of Irene Stern
Estate of Winona H. Stevens
The Guy M. Stewart Cancer Fund
J. McLain Stewart
Estate of Rebecca Stohl
Mr. and Mrs. Norman L. Stone
Estate of Clair B. Stough
Trust of May Strang
Estate of Herta Strauss
Geraldine Stutz Trust Inc.
MSKCC 56I2010 ANNUAL REPORT
THE CAMPAIGN FOR MEMORIAL SLOAN-KETTERING CANCER CENTER
Trust of Mary R. Suchanski
Mr. and Mrs. Robert J. Sullivan
Timothy P. Sullivan Charitable Lead Trust
Estate of Sandra Syms
Dorothy D. Taggart Trust
J. T. Tai & Co. Foundation, Inc.
Trust of Andrew Taras
Trust of Joyce A. Taras
Edward Tarby
Estate of Ruth N. Taub
Tay-bandz, Inc.
Estate of Florence G. Taylor
Estate of Gertrude S. Taylor
Team Luke vs. Neuroblastoma
Telethon Italy – US Foundation
Estate of Walter G. Terwedow
Mr. and Mrs. Andrew S. Thomas
Estate of Robert P. Thome
Trust of Vernon Thompson
Thrill Hill Productions
Estate of Margaret R. Tomas
Estate of Milton Topolsky
Estate of John J. Tormey
The Tortuga Foundation
Trust of Angelina Ann Tovar
Jill Tracey
Estate of Rita L. Tracey
Trust of Helen A. Trahin
Trust of Dorothy B. Traufield
Beatrice Travis-Cole
The Robert Mize & Isa White Trimble Family Foundation
The W. James & Jane K. Truettner Foundation
Thomas N. Tryforos
Estate of Ina Tuckman
Estate of R. Read Tull
Lucien L. and Shirley Turk
The Tyler Foundation
Ahavas Tzedek Foundation
David V. Uihlein, Sr.
Trust of Irwin C. Unger
Mr. and Mrs. Mark D. Unger
The Lucy & Eleanor S. Upton Charitable Foundation
The Valley Foundation
Valley of the Sun United Way
Vanguard Charitable Endowment Fund
The Varnum DeRose Trust
The Vasey Foundation
The Victoria’s Smile Foundation
Trust of Eva Vida
The Family of Maria Elena Villanueva
Estate of Dorothy Voelker
Trust of Anna L. Vogel
Estate of Gertrude Vogel
Trust of Beverly Wachtel
Wachtell, Lipton, Rosen & Katz
The Paul E. and Mary Wagner Trust
Estate of Lillie M. Waldon
Mr. and Mrs. Paul D. Walsh
Estate of Frances M. Wanek
Warren/Soden/Hopkins Family Foundation
The Washington Post Company
Mr. and Mrs. Bruce Wasserstein
Estate of Shirley F. Watkins
Jesse and Doris Weaver
Mr. and Mrs. Bradford G. Weekes II
Mr. and Mrs. John G. Weiger
Mrs. John L. Weinberg
Danny M. Weinheim
The Isak & Rose Weinman Foundation, Inc.
Mr. and Mrs. Michael Weisberg
Estate of Gertrude Weiss
John A. Weissenbach and Ann Southworth
Trust of Gertrude Wellisch
The Nina W. Werblow Charitable Trust
Estate of E. Olga Wesner
Mrs. Elizabeth G. Weymouth
Estate of Frank A. Widenski
Mr. and Mrs. Gene Wilder
The Wilf Family Foundation
Williams Trading LLC
Trust of Helen A. Wilson
James B. Wittrock
The Henry Wolf Foundation
Estate of Gordon Wootton
Estate of Bernadette Wyrough
Alfred D. Youngwood
The Patricia J. and Edward W. Zeh Charitable Foundation
The Zickler Family Foundation
The Isaac Ziegler Charitable Trust
Stanley Shalom Zielony Foundation
Ziff Brothers Investment, LLC
Martha E. Zimmer
Larry and Anne Zimmerman
2010 ANNUAL REPORT MSKCC 57
THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER
Courtney ArnotMuffie Potter AstonMrs. Alan J. BlinkenMrs. Andrew M. BlumTory BurchMrs. Bryan J. CareyMrs. Michael CarrNancy CoffeyDianne G. CraryJennifer CreelMrs. Michael J. A. DarlingMrs. Marvin H. DavidsonMrs. Hilary DickWebb Egerton
Ruth G. FleischmannMrs. Lars ForsbergMrs. Robert M. GardinerMrs. Mark V. GiordanoMrs. Peter S. GregoryMrs. Roger P. Griswold, Jr.Alexia Hamm RyanMrs. Andrew P. HeaneyMrs. Kenneth JosephVictoria Greenleaf KempnerMrs. Michael KennedyMrs. Richard S. LeFrakMrs. Roman Martinez IVMrs. Brian A. McCarthy
Mrs. S. Christopher Meigher IIIMrs. Richard A. MillerMrs. George F. MossMrs. George K. MossMrs. Richard T. PerkinDebra L. PipinesMrs. Samuel F. Pryor IVMrs. Bambi PutnamMs. Dee Dee RicksShafi RoepersMrs. Louis RoseMrs. Benjamin M. RosenMrs. Elizabeth SavageMrs. Paul C. Schorr IV
Mrs. Stephen C. SherrillMrs. Bryan SnyderMrs. Paul SorosMrs. Richard J. SterneMrs. Andrew S. ThomasBarbara Dana TollisMrs. Jerome L. VillalbaMrs. Douglas A. Warner IIIMrs. Martha WebsterMrs. Thomas E. Zacharias
Mrs. Thomas V. LeedsPresident
Mrs. John B. Glass, Jr. Vice President
Mrs. Scott C. JohnstonTreasurer
Mrs. James Halsey BellAssistant Treasurer
Mrs. Thomas S. GloverVice President
Mrs. Thomas M. Fitzgerald III Secretary
Alexis Robinson WallerAssistant Secretary
Dr. Annette U. RickelVice President
ADMINISTRATIVE BOARD
Mrs. Andres BausiliMrs. Kevin A. BousquetteMrs. Henry R. BreckMrs. D. Wayne CallowayMrs. W. Ward CareyMrs. Edmund M. CarpenterNancy Mulholland ConroyMrs. James F. Curtis III
Mrs. Christopher R. DavisMrs. James H. DeanMr. Thompson DeanAntonia Paepcke DuBrulMrs. Thomas J. Fahey, Jr.Mrs. Lee M. Gammill, Jr.Mrs. Roberto de GuardiolaMrs. Peter K. Hills
Mrs. John S. HilsonMrs. Ann F. JefferyJulie KammererJeanette W. LoebSuzanne McDonnell LongMrs. Minot K. MillikenMrs. Charles H. MottMrs. Charles D. Peebler, Jr.
Mrs. François de Saint PhalleMrs. Roy R. PlumEvelyn Angevine SillaLeith Rutherfurd TalamoMrs. Michael L. TarnopolMrs. Cecil WolfsonDebbie Zoullas
SUSTAINING BOARD
Mrs. Rand V. AraskogMrs. Charles A. Dana, Jr.
Mrs. John R. Drexel IIIMrs. Donald B. Marron
Mrs. Milton PetrieLinda Gosden Robinson
Mrs. H. Virgil Sherrill
ADVISORY COUNCIL
FOUNDER
Mrs. Edward C. Delafield
Mrs. Coleman P. BurkeMrs. Edwin M. BurkeMrs. William M. CarsonMrs. Walter B. DelafieldMrs. Charles H. Dyson
Mrs. Bruce A. GimbelMrs. William O. HarbachAlison Barr HowardMrs. Peter D. JonesMrs. Kerryn King
Mrs. Arie L. KopelmanMrs. Derek L. LimbockerJean Remmel LittleMrs. M. Anthony MayMrs. Jay H. McDowell
Mrs. Frank A. Metz, Jr.Mrs. Bijan Safai
PAST PRESIDENTS
58 MSKCC
THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER
Founded in 1946, The Society of MSKCC is a volunteer organization that works to ensure the well-being and comfort of patients, raise funds for cancer research and treatment, and provide public education on the prevention, early detection, and treatment of cancer.
The Society’s annual Health Education Seminar in March drew Society supporters to hear Peter T. Scardino, Chair of MSKCC’s Department of Surgery, Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs, and Moshe Shike, Director of Clinical Nutrition, discuss “Hot Topics in Cancer Prevention.”
An evening of dining and dancing and a performance by Grammy Award winner Mary J. Blige brought more than 400 guests to The Society’s third annual Spring Ball in May at The Pierre hotel. The event honored Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program (HOPP). A live initiative entitled Putting Genomes into Practice, led by Sotheby’s auctioneer and MSKCC Board member James G. Niven, raised funds to support HOPP research in the area of cancer genomics. The event raised $1,400,000 and was sponsored by David Yurman.
Members of The Society’s Children’s Committee helped with everything from dress and tuxedo donations and distributions to the pinning on of corsages and boutonnieres at June’s Pediatric Prom. The event, one of the most highly anticipated days of the year in MSKCC’s Department of Pediatrics, allows children and teenagers who are being treated for cancer — many of whom may have been forced to miss their own school proms — to celebrate one of life’s special moments with friends, family, and Pediatrics’ doctors, nurses, and other support staff.
Established in 1946, the Annual Appeal is The Society’s oldest fundraising cam-paign. For more than six decades, Society members have raised funds for a specific MSKCC program. In 2010, the Appeal, called “Targeting Melanoma,” raised $1 million to support melanoma research at the Center. In
21
MSKCC 592010 ANNUAL REPORT
particular, the funds will support the develop-ment of targeted therapies designed to attack this deadly form of skin cancer.
A tradition since 1989, The Society’s Annual Preview Party for the International Fine Art and Antique Dealers Show in October drew more than 1,000 guests to the Park Avenue Armory for a private preview of vetted museum-quality art and antiques. The event raised more than $660,000 for MSKCC’s programs in patient care, research, and education. It was sponsored by Giorgio Armani and 1STDIBS with additional support from ELLE DECOR.
New York’s Four Seasons restaurant was the setting in November for the annual Fall Party hosted by the Associates Committee, which raised funds for The Society’s Pediatric Family Housing Endowment. The endow-ment pays for overnight stays for children and their families who go for treatment in MSKCC’s Department of Pediatrics and are unable to afford this expense on their own. The Associates Committee has pledged to raise $2 million over five years for the program. The evening of cocktails, dinner, and dancing raised more than $340,000. The event was sponsored by Gucci.
In March, the Associates Committee transformed the iconic toy store FAO Schwarz into a children’s wonderland for the
20th annual Bunny Hop. Also benefiting the Pediatric Housing Endowment, the event raised more than $353,000. The event was sponsored by Brooks Brothers with additional support from UBS Private Wealth Management. Tina Fey was Honorary Chairman and attended the party.
Funded by the Social Services Committee, the Social Work Fellowship offers a singular learning opportunity for social work students enrolled in a master’s degree program. For ten weeks during the summer, the students — who have completed one year of field study and are about to begin their second year — work at MSKCC, learning about the needs of oncol-ogy patients in a multidisciplinary context that provides both classroom and clinical components. Fellows then return to MSKCC for the fall and spring semesters as second-year interns. Since its establishment in 1996, 43 fellows have completed the program.
Since The Society’s inception, a corner-stone of its mission has been funding leading-edge research. Many of the projects The Society has supported have since become permanent programs and fixtures of MSKCC. The Society’s Research Grants support important clinical and translational research projects of the Center’s medical faculty and nursing staff. In 2010, six research proposals received grants.
1 Young partygoers dance up a storm at the annual Pediatric Prom.
2 (From left) Annual Appeal Vice Chairmen Elizabeth Miller and Lavinia Snyder, Society President Heather Leeds, Annual Appeal Chairman Eleanora Kennedy, and Annual Appeal Vice Chairman Burwell Schorr.
3 (From left) Antique Show Co-Chairmen Libby Fitzgerald, Lisa McCarthy, Michel Witmer, Daisy Soros, Melinda Blinken, and Society President Heather Leeds.
4 (From left) Health Education Seminar (HES) Associates Committee Co-Chairman Susie Kovner, HES Co-Chairman Jamee Gregory, HES presenters Peter Scardino and Moshe Shike, HES Co-Chairman Karen LeFrak, HES presenter Larry Norton, Associates Committee Co-Chairman Kate Schroeder, and Society President Heather Leeds.
5 (From left) Spring Ball Co-Chairmen Shelley Carr and Dee Dee Ricks, Society President Heather Leeds, honoree Charles Sawyers, and Spring Ball Co-Chairmen Tory Burch and Jamie Tisch.
6 (From left) Fall Party Co-Chairmen Allison Aston, Eleanor Ylvisaker, Ferebee Taube, and Veronica Swanson Beard.
5
3 4
6
60 MSKCC
WAYS OF GIVING TO MEMORIAL SLOAN-KETTERING
Those generous friends and benefactors who wish to support the Center as part of the Campaign for Memorial Sloan-Kettering can choose from a range of initiatives designed to benefit the institution at every level — its talented people; its outstanding programs of research, education, and cancer care; and the ongoing demand for the most up-to-date facilities and equipment. The Center especially welcomes donations that help meet its general operating needs, since these provide maximum flexibility in seizing new opportunities as they arise.
All gifts, regardless of size, really do make a difference. Contributions may take a number of forms, including:
• Gifts of cash or cash equivalents, either paid outright in a single installment or as a pledge to be fulfilled over a period of several years. A cash gift may entitle the donor to a charitable deduction of up to 50 per-cent of adjusted gross income annually, with a carry-over provision of up to five years should the value of the gift exceed 50 percent of the individual donor’s adjusted gross income.
• Gifts of appreciated securities, which offer donors a range of potential benefits such as the avoidance of capital gains taxes when the securities have been held long term — that is, for more than one year. Such gifts are deductible up to 30 percent of adjusted gross income annually, with a carry-over provision of up to five years should the value of the gift exceed 30 percent of the individual donor’s adjusted gross income.
• Planned gifts, which may help particular donors realize their philanthropic goals more efficiently and comfortably than through outright gifts. These arrangements also allow larger contributions than might otherwise be possible. Planned gifts take a variety of forms, including life income plans such as charitable gift annuities with their relatively generous payout rates and charitable remainder and lead trusts. Individuals who opt to support Memorial Sloan-Kettering through planned gifts may also do so through bequests provided for in their estate plans or by naming the Center as beneficiary of insurance policies or pre-federal income tax qualified plans such as an IRA and certain retirement plans.
• Gifts of real estate and personal property, which may also provide significant tax benefits. In most cases, gifts of real estate allow a donor to claim a tax deduction based on the full market value of the property when it has been held for at least one year.
For information about these and other ways of making a gift to the Campaign, please contact:
Richard K. NaumVice President for DevelopmentMemorial Sloan-Kettering Cancer Center633 Third Avenue, 28th FloorNew York, NY 10017646-227-3529 Telephone646-227-3909 Fax
Memorial Sloan-Kettering Cancer Center’s commitment to conduct business in a sustainable way includes adopting green practices with respect to this report. This Annual Report is printed on Utopia One X: Green and is FSC-certified, contains a minimum of 20% post-consumer recovered fiber, and is manufactured with electricity in the form of renewable energy.
FSC is the Forest Stewardship Council, a nonprofit organization devoted to encouraging the responsible management of the world’s forests. FSC sets high standards that ensure forestry is practiced in an environmentally responsible, socially beneficial, and economically viable way.
Special thanks toHalina Frydman, CJ Postighone, Michael Quinlan, and Stephanie Luedke for sharing their experiences with us.
Design byIdeas On Purpose, New York www.ideasonpurpose.com
Photography byMario Morgado Matthew Septimus
Additional photography byAmos Chan Richard Dewitt Patrick McMullan Juliana Thomas
Printing byFinlay
© Copyright 2011 Memorial Sloan-Kettering Cancer Center
Produced byThe Department of Public Affairs Memorial Sloan-Kettering Cancer Center 1275 York Avenue, New York, NY 10065 212-639-3573 Telephone 212-639-3576 Fax [email protected]
Vice President, Public AffairsKathy Lewis
Director, Public Affairs and Editorial StrategiesAnne B. O’Malley
WriterCelia Gittelson
Annual report contributorsAnne Clear Julie Grisham Eva Kiesler Ha Ly Joe Pisarchick Christina Schoen James Stallard
62 MSKCC
1275 York Avenue New York, NY 10065
General Information212-639-2000
Physician Referral Service800-525-2225
On the Internetwww.mskcc.org
www.mskcc.org/annualreport2010
Follow us on www.facebook.com/sloankettering www.twitter.com/sloan_kettering www.youtube.com/mskcc